-j9国际站|(集团)点击登录
%pdf-1.5
%����
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2020-08-18t18:30:28 08:00
2020-08-18t18:30:28 08:00
2020-08-18t18:30:28 08:00
adobe indesign cc 2017 (windows)
uuid:84bec82a-7f73-45ae-afd2-38ee666a12ea
xmp.did:84d5c0ab092068118083cb443d98f834
xmp.id:4bd07e23-a43f-8142-a8bb-60c4159bb222
proof:pdf
xmp.iid:c9655367-9669-2546-b93b-31d58a4db675
xmp.did:51bcc154-ad34-5944-9944-677e16f4e3f0
xmp.did:84d5c0ab092068118083cb443d98f834
default
converted
from application/x-indesign to application/pdf
adobe indesign cc 2017 (windows)
/
2020-08-18t18:30:28 08:00
application/pdf
adobe pdf library 15.0
false
opentype - ps
times lt std
0
adobe systems
2.050
0
2774354800
2774354800
timesltstd-roman
opentype - ps
times lt std
0
adobe systems
1.040
0
989104708
989104708
timesltstd-bolditalic
opentype - ps
times lt std
0
adobe systems
1.040
0
1073800842
1073800842
timesltstd-bold
opentype - ps
times lt std
0
adobe systems
1.040
0
1867305106
1867305106
timesltstd-italic
opentype - ps
mheihk
0
monotype typography
3.0
0
1391941157
1391941157
mheihk-bold
truetype collection
pmingliu
0
--
7.00
0
1199607162
1199607162
pmingliu
opentype - ps
msunghk
0
monotype typography
3.0
0
3919942988
3919942988
msunghk-light
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
7 0 obj
<>
endobj
8 0 obj
<>
endobj
24 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
25 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
26 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
27 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
28 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
29 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
30 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
31 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
32 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
47 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 24 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(publication of the interim results and interim report)tj
/t1_0 1 tf
0.068 tc 0.07 tw 0 -2.333 td
[(th)0.5 (e)12.9 ( )0.5 (in)0.5 (te)0.5 (rim)13 ( r)0.5 (es)0.5 (ul)0.5 (ts)13 ( a)0.5 (nno)0.5 (un)0.5 (ce)0.5 (me)0.5 (nt)12.9 ( )0.5 (is)13 ( p)0.5 (ub)0.5 (lis)0.5 (he)0.5 (d)12.9 ( )0.5 (on)12.9 ( )0.5 (th)0.5 (e)12.9 ( )0.5 (we)0.5 (bs)0.5 (it)0.5 (e)12.9 ( )0.5 (of)12.9 ( )0.5 (th)0.5 (e)12.9 ( )0.5 (sto)0.5 (ck)13 ( e)0.5 (xc)0.5 (ha)0.5 (nge)43.1 ( )]tj
0.025 tc 0.049 tw 0 -1.167 td
(\(www.hkexnews.hk\) as well as the website of the company \(www.kdl-int.\
com\). the group\222s )tj
0.053 tc 0.07 tw 0 -1.167 td
[(2)12.5 (0)12.4 (2)12.5 (0)12.5 ( interim)12.4 ( report)12.5 ( will)12.5 ( be)12.4 ( dispatched)12.4 ( to)12.4 ( the)12.4 ( shareholders)12.5 ( and)12.5 ( will)12.4 ( be)12.5 ( published)12.5 ( on)12.5 ( the)28 ( )]tj
0.025 tc 0 tw t*
(aforementioned websites in due course.)tj
/t1_1 1 tf
-0.025 tw 0 -2.333 td
(appreciation)tj
/t1_0 1 tf
0.02 tw t*
(lastly, i would like to thank all the staff and the management team for \
their hard work during )tj
0.031 tc 0.077 tw 0 -1.167 td
[(the)6 ( )0.5 (reporting)6 ( )0.5 (period.)6 ( )0.5 (i)6 ( )0.5 (would)6 ( )0.5 (also)6.1 ( like)6.1 ( )0.5 (to)6.1 ( )0.5 (express)6 ( )0.5 (heartfelt)6 ( )0.5 (gratitude)6 ( )0.5 (to)6 ( )0.5 (all)6 ( )0.6 (of)6 ( )0.6 (our)6 ( )0.5 (users)6 ( )0.5 (and)6 ( )]tj
0.025 tc 0.05 tw t*
(business partners on behalf of the group, and wish for their continuous \
support in the future. )tj
0.03 tw 0 -1.167 td
[(we )0.6 (will )0.6 (keep )0.5 (working )0.5 (closely )0.6 (with )0.5 (our )0.5 (shareholders )0.6 (and )0.6 (employees )0.5 (to )0.5 (steer )0.6 (the )0.5 (group )0.5 (to )0.6 (turn )]tj
0 tw 0 -1.167 td
(to a new chapter in its development.)tj
23.708 -2.333 td
(by order of the board)tj
/t1_1 1 tf
-6.37 -1.167 td
(shanghai kindly medical instruments co., ltd.*)tj
/c0_0 1 tf
-0.025 tw 3.333 -1.167 td
<026a090e0a7011430d3a153c1415129c0adb0670038503de082202ae0321>tj
/t1_1 1 tf
0 tw 3.64 -1.167 td
(dr. liang dongke)tj
/t1_2 1 tf
-0.025 tw 1.919 -1.167 td
(chairman)tj
/t1_0 1 tf
0 tw -26.231 -2.333 td
(shanghai, the prc)tj
t*
(august 18, 2020)tj
/t1_2 1 tf
0.027 tc 0.081 tw 0 -2.333 td
[(as)2 ( )0.5 (at)2 ( )0.5 (the)2 ( )0.5 (date)2 ( )0.5 (of)2 ( )0.5 (this)2 ( )0.5 (announcement,)2 ( )0.5 (the)2 ( )0.5 (board)1.9 ( )0.5 (comprises)2 ( )0.5 (dr.)2.1 ( liang)2 ( dongke)2 ( )0.5 (and)2 ( )0.5 (mr.)2 ( )0.5 (wang)2 ( )]tj
0.063 tc 0.07 tw 0 -1.167 td
[(cailiang)12.6 ( as)12.6 ( executive)12.6 ( directors;)12.6 ( mr.)12.6 ( zhang)12.6 ( weixin,)12.6 ( ms.)12.5 ( chen)12.6 ( hongqin)12.6 ( and)12.6 ( mr.)12.5 ( fang)38 ( )]tj
0.025 tc 0.015 tw t*
(shengshi as non-executive directors; and mr. dai kerong, mr. jian xigao,\
dr. ge junbo and )tj
0 tw 0 -1.167 td
(mr. hui hung kwan as independent non-executive directors.)tj
10 0 0 10 56.6929 323.0479 tm
(*)tj
/span<>> bdc
( )tj
emc
1.55 0 td
(for identification purposes only)tj
et
endstream
endobj
48 0 obj
<>
endobj
36 0 obj
<>
endobj
37 0 obj
<>
endobj
43 0 obj
<>
endobj
54 0 obj
<>
endobj
55 0 obj
<>stream
h�\�͊�@�}���&1u���`k7�� ƙ�i��$��·�:9m�� i��ǒj�;�}7���44�8�ss�
�s�)^�>[��������\�1�����6��?yu��g�x���{ض�)>f����s�_�ï������q����]�6��s�� �����e�ӡm��������}��\~��i�6�ƺ�s�_bv�q�[zm�ط�]���n��w=eu���"}������f^#o���;� �y�������l��~żb.�kd�쑅y�s@vfe6fc������pz:=����%e�a`�a`�a`�a`�a`�a{�&�mл�7ao�ɯ��*�à��@s�9� `4���@g�3�`sv��d9_1_9_1_9_1_9_1_ى��^���{)�rv��d��.��e'�n�(;qt��dщ�e'�n ����o����o����o����o�����b�d� �z���a�8q8r���>�s�>m�(/��� ��v}�|���*��� ���
endstream
endobj
56 0 obj
<>stream
h��t{pg�e�y]p��1��b�(�w`�s��0"ַ ��� ���"!.
q�-�(" g�#�]�ș��d
*��d=�j��#�!�vy�t��*���������e�� &�ǝ�*�)�� �5t�"ɴ�.�2u�d�cd<�j8� ݠ���,�3d�%��õk}d��z �a �#l�gfo�ba6��sڐ�$
�` 8�=,�h\��%�0��p��e k�i h��"��uq; ���
�=����}�ť�y����7xt`�_l2��@^��#tfiir�\��w���&���l'}<�6�ۓ�1)���}��u��xoc�)/��ɯ�ɏ�֭�^k�=l�d�� %�(���qx1
�_3�e��voxn�%� 9�[��/�����>��rx��5�#���m��jd����rw
�ȥ5��;{�e�|y��𦊫qr��h,e^g �m �=�#�z�ֿ�_a �����o���ù7��v��͈�0��~�x�~�g �����u���a�#|o��d����p�~�͡o�r@��uk�`�bnk�z�r�� _��ڈ ���ԍ��ma���tf�������g���
��"z5���l
�t ���4�{�ko49!g4s� r� ����f�y����x䅶�5� @� �g�`��s����tl�>&�sn�x�\j��hxb�i�ba%7/�fg]����hoեr� �yh�c �zυ�����zs��!yՙ�,��ד ��w が��av���gp��\i���&�fpa.�� _~� �os�g�2�<:��|�õsp�=�n���t�6�&o�ba��v�a��ߵol� ��#��{b�d~�l �!>.�'�� �ԙ�m�a�
�in:7u):ut����j[t��e�zpt�% �#!\bb���p hy^��])u�]��; ��)v��h���_�ݱ��3����{��ӑi��j�%4
l)��0$we��oe�`m�(��錩� �,k�n��l_��»��.���a!� ��ێ\���ڈ���/��t�8n��g��1����� �a
!%�:�2�dk���h�6�c(��
�����s6�g����5̇ŏa�a�qvi(�3wr��o�l� ��_
��t9�l�gp=?
n����=���x�a�4:nb�6q��^u �qx��\�'tsw��� 9��m��s>��p/��� ��(�%�� �.�ri��?k��#���!��o?�ň�m�=v�(0���ln����iw*�vuiuy�"�4o[�b�!1pmn������x����h��iy������ �g���iɫ��wla��u�4xt ȱ�p�6��� �b��8` 7� ir]�a!i��*��7�f��9
�cw����vnv&��'�>ƺ��y� ���h8qa'j�,�p|�
1�e a��;�ah��a���d�6���/�#y��.�z ������%�e�$1z� ����̐�ţ\4�-��=��7na3���y��o�� ���ݐm�u�z��v���;�c� =6ܤ��c9lw�l�pi�b[7��x���'?@*y\�>u� ڂ�� ��b�a}.�i
�2���b������z%�-n'�z�|(��$o��0�ď?u�o8�w�u�&[��n�֩f�n�h�,�������nj��i(��ދۘb��h�e�y��;|����j��,�`����o�9<�.�:ԙ@�� ��-��*��8����mn��`�� p�.go�ρq��{� ���s��p��ᜂk�q�$p����\��]� ��n�k�������n�0ob$|&���w���$�g@a�na�mxnsc���r����{ !�(dv��o��
z3 ����h�a���߈� �@r!�y�f"a`�bgiy܌$�;d�>����<:ô�z�=�{���;o�p� ��`�zuu^]�� ����}��@1 y�p�i�d/b"2q�j�� ���o�g�j�^w
���1,a6�n^�8s7�u�}v������w�)��)߿�[-�5h� 4mde( '�v��a $a5�ҁ�h'��gp�������gi(� �>����t t��3=�c4��s�|!����b�*������
v�k7�`6{n�!��5�n�a�u��d8k�jk�,$��p�;�n1�йw-z�"��*�v�l�ln�v�fm�z���s�eo���( j�2=�=����/ݾka�5g�7��ҷ3(eu�l�˱l���5��d�˶�l� �w��g:c�,!�ȃ^�����hill�;(�pc�kb�=*��ua��}x����e���*!��*m�x�t��$ny�s�x��?��c4z,�e���q��w-{�j,k
-� t�� ����ug�c�� �io��;����-g�χ}�a�m�v 4 �����������r/z��v����(*�*ߔ�ߣǔ~�
b ��t����
ng\&g��*s��b�0 �'�g,��܇�
���f���o�� ѐ&��.h�?2z ����c�y��;��:��j�k�&c֮(4m!� �a��!��5���k��ѡ mr�"�7����ɴ� �3:�0�!o�� % ��kh�mb7��&��a�ζ�n�iu1��&�ҹ��~z��;38ar� j��~ɓ�t����lfq�h�.���".�p���d w���_�{k#�u�.�p���c��ea0 yb߬ ���j��f����`1q�j�j��v�t�f�u4�����ڼ=nvqpz�-�b��b�fy�y7멓�r�� �"\�]��r�ƅ��
g��
��ס6��w�~���8<��_�� ��i.'sqt�����|���=2p xd(8����/�uřea����֡,�viu��g#�kd�$�9&2����� ���4�-k
t��l���ҋ��l�"��d1�sp@q7&��ws>f2_k�ϝ9���s߽߭wߓk���� g� �(�e�kb���?ϋ�*�k�}�]i�!0�: ('3�y�e���m����s�r� &ԃzud�o� �=he�v�k�l l�4��&�<�$t�&������0;3wg=}
�0�%�
�r�u�p�r�ild� 'rx��xy%s�<�����mkpz��-z���f] 9�.xb]>u�-�s2��,z:�&r�&��#�l�u���v��^� ɪs r�� �4��.xl��n�q�f e�� _�ªajm��>tؑje`���e��(�&�qph#��༮v�c�kr29e�&�v��,uf�1��s��6 ǻ
d(� �mp���r|��.� ��$��g�(o�2c�k��i�i�.�ٌ�{��/��[��ɑ�(znh �`7�l���gxv��7߈�a��\�g��9� ���?ct���9�v��s�~�n��!��es���j��u�l�cu\ufkb mޫ�ws=��o���d�!&�e�&jy��/���6_�`��@ǥ�.���� �?4>j�df�qd�i
t-�ȡ��h�o�w�]v{���fx��\�k4�*nm����a,z���1a�.u���1�t��c-:r7��8:�\n����v|��^ޡ�f�k����d?�a@�
���1�⢲��|=��t8{�b��i�j z�8[ʝ؊r蓚ýc�.]9�6�jʜ�/���[k�*��7 ��2k�t�b�s �`wtԧr�{>l�"�� טh�� ;���ם����l�`�λ���lgo�%�u�d:w�q���l�"��p���?r\�i��w@x�z��c a!{ 8r�1�'�8y|�9�x�i��� � ɹ�^#�b w�?�a���v�%�i�od�;�4�8ub¶�0<��� �`g�� ;j�ϭ/��n��x�s
m�g8,t��^a�y �0���'=!f�5����< g��j~�r�@�h�l��>� q�۳}�y��o|��b�y�1q��w�;�w���h�{��k����_�����rj��{��]��ѭ��;�� fs"d�/�y�k#s�#,oӄ�)�~>\��\7�dbqi��vxz� {��ro/3��7�c�o)k. �mui��3�x4�;��{�i� �s\��f��y�f.�b̮a�
7�p ���n����x쿺�d�6w�g�r�,nb� ��v��a~�ٱ�!��n<��qɂ�hm�6�;��.h�umf�=3a�^hٗ�^o.om �؈τ�s��ǿ,g�w)�k�sk�4pr@�
�zq��lrx��fb�\�y'�*�[�k��gf�d��x�� y�trxsڪ��,6hv��xdr�2u^?���s������;�@�d��s�(� ��nl u�ot����^s{c��βc� w�_�%��*@t�pxq �� �x�
x�.����e ?
��w���a��&�n���xлp�8�l#�ft`nl��k�^-a�o���ĭt(�1>�� �g�gx���s ��ci2c��7aշh������3�3�y��@�_z{��.ag�3���ڎ��e]�l7f��(�hma��l=�l�h�m�i� �
�}e t�])��n�t
�`����ej���?����.9$�*��� ڳ~�ln o*���v9ݡ1~�_���8k8��ܸ�#����s�����%m�?���a[ ey�q����:� ��s���c �n��g��l}��?onil;� � ȗ�$ e�l��z�7�_�j��k)���������[�|r^�3�u��2t�𩕋��h
< z~a3�y��f0⽋�[hku�~q�d����l��9�.�m��ba�h����?�1�ω��m�b��/nl���u���a��`�b@k��阞p�i5ؓd�k`gg���i,=�j�7����t� h���w���a}džmz���|� c�~�?l��ۆ��<v-5e����a�q�ib�ɾ���b.��r�]��f>ne���r���b�b�o�%��%� �)�h��c����f��ɼx�&�u�
i�7�� cn,s��h��\t�� d�_ gtg�z
}-rm>(bݯ�$�a_[�� f8d��k_�^,'��� �� ��j�\�0x����,��<���.��bn��ag� �����a� �*.��x�
] ʨ�jz�w-{ը�iezp�1�#�ː,�k�4f�0�����bų�� ì �cw��}��#����_*�te
endstream
endobj
52 0 obj
<>
endobj
53 0 obj
<>stream
h�\�͊�@��>e-������i7d1?lf �h%#lt�y����'���g���8p ��w���]�}�c�ݩ��)\���w �o�µ]3?����r�i ��9\��ih�ʥ?���<��ӧ ��9i�mm����~m�.=���o��~v�[�]nq�/�����.�^�m|�������?�cp��s��p �&lui��k���x��з���dz��]oiu��,���_�_�w� �
�y˼e�1�ߙߑ?��@ur���9s�\0�%s�,̂�=�2 �12�k8�t.�\ҹ��� �
��� �
��� �
��� �
��� �
��pߘߐٛ�7ao�ބ� z�&�ͳ7��<�=�=�=�=�=�=�=�=�=�=�=�=�=�=�=�=�=��,k�r��,k�r��,k�r��,k�r��,]x�jѕ� ewʮ])�rt��jѕ� ewʈ ]�
�f�����o�7��
�f�����o�7��
�f��
�"�w��=� �o �9��m��x/g�2ϙ����8�.��/� �0��
endstream
endobj
57 0 obj
<>stream
h��u pw�� q���f7[����� ��od@< x!����&�(��"z ���ca��je룾���|p�s�w2�չ�6���-̴7wӛ����������~��f1����0��e��cc��iucd\�i��bc�z�j��1�ݑ��b������ w:��q� e˷�jԍvϙ6k�����l4�ĩ�j&�����$͘s��f���=:iút����a��lvktk�lz���sr�j���. ,��o���� 8milܨ1�qk����u*��,���_q!x)(�|�ub/�7��ҡ��p.�^v� s e��:�>�*��a/tz��t�9ܹ���q�ɲvq�|�*u�t}.��֍�:�w�{n���v��ȥ�m� ��x�ƚ�}�,&�:q9����c�������y�k�w?c�x{����>�b�#g�e�-8��>̓�"��.�0j� �v|���!�ƹ/�����@)z�5� ������ �� ����x�q�nmdwn}���b~�r����1��
>��~��a$�k�p2�e*4uq�&�
�ȍn�m�����օ�_�?��b>���w�a��zb�t� n�a�2�w1��pߊ��xz
/���f�r��f0qk���`����6{8�eptf�a"nr��s���c�s��5�ok��du܁�����rqů=��;*z������e�s�(��� -��
������vop�*�i�o2����|ge ж�>��@��n�w0lwv�����e���$���%��g�d������h��q���^ea� �0 $�(�y8k�$��o�s�n� �|@nhk����ӭ�������d�e�֛1#| � �ed ����^� ��5ټ���� h�%��\q�e���s��k�݂)
�?���no�*4�f�8}4�|� �߃ ���� $��*h����όa� 䢎���l����l�
�����>}���ú�*�8ʢf�t���k���e��%�$�xh!��2�� o��t f��p��'(�c�[#�[��7�l7�����sl�c��9#w�f�
7],�����xm�n(�ľ>��<^�z���zؒ �d�s��ľ�-�b^t�}< ��%oәr# ���
r` %���pc;���e�"�y�zzz�> 䖘�#���)b.��ܒ9�iȅ�fn� ��
>7a(f�&"
ipqt�k ���0�j~��s�����nn���g81�>�/ (���d��.�r.���1x*oܚf��:}�_�x�d��x�k��p!��5�o]pkƚ h�r���$��c�(�s�1�!� �]�p�ؾ4>�p��� ���z !ֈ�����e���5���{���k��x
�(�i�t<��z|�h��ai8�`o��_�s6��&pe@�{�@^0�x!�#����g��z�v%�wk�wt ��aj h4=l��g*1 ��f� ^�ly�
�
��?�s���ïۆ(��դ� m #'{���ds}w��d%��������͂ڮ-
�y�g���x^�#'�h�u�
qn�����4h�j���b�qs�puiym �*;tq�w-z�����%d �r��֛_ݨ�d�lek-9t���� �ҝ�./p��e���_)�w�ц�}gx_;�s�½f���n�y��'��b ۖԓ%�ɯ��
d䎉 8�
��.]����^,$ԋ�e���tuugs?
����s 2���]��4 �b�����*iw[��sp���z�k��d4�z��?��8�y��].�be�!uvu͕: -m�\nd=>���l����d��:h�}��w�ct��h=wd
� %�
ﶜ�d9e�*�j �-���csj��e��?���� ��am1�9�4o<.�j�&*�d�aqq7*�v%��)�d��a��6qa\"hl��&g����j��}�;=��f��_�w�o�w�{���{d_���tm�=/j�z;g�博�.�� <�=
s���q�ab�xrb wulko����ɷ���q�caάdy��[w4j>�����h?��������x�ɣ�4
�y�:
��n��,w@$gm-�ޙf�u������*���t¼2������u���w*k�t=�ֻr� ��j��"�f� ���e�ӊ�mr 6���� qձ��
ɓ�q��m<�c� im�t������p��8�l� ��-뵚�ǹw�h@ʹ[
\����p"8%`�d��c2�e���k$x �s��p���ro �pj��� �������,i&ji!���p��w���xd/�j-a�x�!1j:.5��� ��� p����e���h�^)�j� �? ��k��>pwշk�#7��_���p�g۠fr��g_�ur�� �}�������l$|(�� j7�6��'l-���e�dj�*��h�qum�}���
��;;��;hh�i����� ����܁�@2 �vdo�w)@�h�j���䄹m0��m a
��u��h�vws��6��\d�yz2��/�ֺ<0&q����r����4>zc�� %�'
9ky1��:���� ��
۽�j��lk*��7́y�'��zj�$�˦b�v^�� `f3�)�so�ȧ�>p=���v��2kh���c��y;s����!�� y��7i�s��b #@��f� [>'���kd-�[�գ��g���@�f&ʼ���h��j��ob4��d�@ڍ0���p�ƙ�&�ըt[��
t�oiw�g�����'� ��m7x!��u:�������jy��}a�n�� c�y� !˓sv� fk��]�\?d��t��
��7oa_ۨef��h����w�8�q�ʐ�3ĩ����ߢ��g�cٟ�9�a&�8�*n�����5�|u��==|�8�k�pm��pjq'pַ �qv���� [~����
>8ju<�������jgrvq���s��@
�af�������2sa��μh-����*xsi`^d`#�5���p�w��>���'��de�ј�=z}��j�*.���c¬3��]�7[�nm۶�|�����apk�y��d���-��)>x��h
�]�ۻ��w>�ߺ�pwf5���;>?���$��5 ���/�ƥ��ps���j��u 2u�9�l�y��\2
kq�g5k�0��ϛ1��fka�@no������f�w��a�\��.�� ��w- ����ċ� sad=�h���b���pn�>e��/���pa��c a����-²� -� }%goi�z�������by~g ��vek�r/p� ����զͼ.5.}�� ��7��&�j�#e֯5�is�~se(�q>��j��� �,,��=� ��&8�j���z?e*
�zkc���s�9m@|�x�1p�1��*/�뫳\��-�vk~ja|�do ���# �cl���|���vxy�f�ް7��:�p>�b!p�`v�0����z�ia���hww�&ȯk�et%� = �x�"�b����v ��;�$���,6��ե�/�o(��xp k���c�'a��h#]�����e7�%�e��c8r��2{������j�2`$ck�����p؛�\bi��gv��(q��w�^���is���t������ͳp�χt���!��r�*���.�쓻�z呵#$�af�'\� եjkc�fs�i o-���>��;������eg�g� )�f� ��j�/|��o��8vr���~_i��{r����ܼ�=������]�aqdwx��4e6��6�=��j�j���� z���d�]a@�d y 2 �`�����cy�4���\p ��p%�e`5 1v�h��m�6���m��hm��twͽ}�w����߱�(p�jmk���)ԝ��[�f�quz��v0�a����x�$��}/qpq:9��j@@��le5]�ň�a[� ��o����ش[�j�]�'x&navt���9_ٮc�`u �3scɋ9���^�o�u � �.��vêٛ=7d�c*��t ��l�b�,�l��oa^k3-l�(%1�k��ѧ�e��-�� �c�!�����v뗝�a�_[f�e5x!�1�9�sb'�w�u?�3 �gd����[eج=l�
�vswgu���)��
���*!�l��l�j�z��}:v��d��hre s{_�y��ʉ8mp��~ ��m;�����x�waj�$
� �mg��0m��'33o��b6 v�k[��a ΅k�� tnr`�'����~%�}�1<����njq�t8h ���.?i��ts� m؍������-c��x��n��g�k�op� ���;j��>.a �ԡ� �l���7}���h���*��d��#�^r��dy�,:�$.��� �"a*]�(�zq2lk��a��ͩ�)�05�s�f)�֪r*[��h��mi'm�e��� }yś�dec^b����9l,��$m(/.�(�}nx����oy�
���9�f�t2d��@�f��gl���ċ� ��r슗zn��� ⮠o�dc�,�=��md� $����s���]u,�}� o�!8�v7����{)�as�m�<:�$���$����o���{�,jⓐ4#��ځ��s�.5���l����t98�$
�� <��d�q|��6�_��t�z���g^�"�2s�e����v��pi4�\ebq���mg�m4�b��vau�pu/z�ÿ�$����qej�uߐe�����y�&y& ��fs��mw��� k4f_(��d .a@g�������x%a�5j-^�:�ԅ��#�i��hlb��famm_ua}�jg, s"���*���h�
���|)$�tzqvavr�$��kp�3�֢�?$�a �x"��5�
3�f�\�x�v�l*n͡st�|�`ņ� �iu��
��?<�s�sro� >�d�4�r�o6,p�s�]�$*m�w�,#�����:��b��^o�x}k�]����� �)�!�������o���!��)����8�4o�loitv�ql�ln�{�'����"������
��~�(r�x��8��z�����u�}��*��v��s�����|� �cy� �
� ��� �xb9
endstream
endobj
50 0 obj
<>
endobj
51 0 obj
<>stream
h�\�͎�@�=oq��e�n� �1��;q1?g @�thf � �~�p:=ɘ��� '���~������ǿ>�ɝۮ㭿�ut�xi�lq��������� �,o�������g������i|��mӟ�s��8���=�� �]~�ßx���
�^�&�� }9_����y�˾i���������c������}oñ�㱻�lu��ڭ��k�ů�����ӹ�} �u���"}� ��y�\1w��
�y��c�!�1�!�3'��s��,�`^ ��%�g���,ȴyؼ2 �12� fo�����a��̯��{�=� f�m`�6�m`�6�m`�6�m`�6�m`�6�m`�6a��n�n���v�m`���́�s�9� h0�́�s�9� � p*�q�������������������������������gяr��sُ� e?�~��(�q���gُ� c?�~�~���7��~���7��~���7��~���7��~���7� �-���jf\syf�k%̸�*̹��r�[e�2?� o2 ��#��}���c�b�mk�;�k�]��ن~pi��_�*),
endstream
endobj
58 0 obj
<>stream
h�lt t��awvee�a�ř��hq�d^z��pi5�xdy�] �p�,���c%� �l$>q���x5ql�ѥ���yr谩m��3�|�����ν����cb �q�u �.��r uaq�����5je�� ��q�y̻l��?j}���#��n棧4��o�1�q|�2mz�v�����x�7o y�g }<,�eak��ۂ®���'��ur��:�r�㖧�i�i�b��w�sr8 ���*uj�ai�e�e�q�s��s��sq��^����sz�je&'����8�v���f�%oժt�8�j��{g��p �o-��o�suj�o�!��p7��ȩ�`!�l�0\x0 �y�0[;�ű�1/ �a�4��0
��1,ê1,bp �~��� �f��*ӫ��ոh�(zd=/g� ����n.���h ���fk �jk~�n�s�x�މvc'vo�n�:�� �j��,g�3y��";�v��nq��n�`�d� �k��a�c�k�ԑr w��ը�-n��*����|�������ϻx�d� ��4zz}� �� ��3/�lb�� >z$�2t�bk` �ġ�����q�&�� !����d��o3�l5����cr�і� �?� �ɋa�\^j!�_ ���-!�`�\a�ziy"[��:ے��� �.\i���� "_���a<��%�-��e��uy,�>x��]�q�l\ѵ9��%� �p�;kn � ��u��t�j�w5�tճ��h� �s"�}ϩx}헏 ���ڜ����mey �h�l����̔a!md�>�j����k�qd�^��=�!��n�h,�srrɣ�. )����ܖ�i������x�st��)���\q��˾xɯ��
��ry�i�7�f�����2?�����3(��/qh`�ﭿ�(��ߍ�,7�i�7!�,��] �ƞ�08�e���z�'ǰ��yc؊v �j;]�;�e� ?spk�';��$����x�g��lc��t����ubt
�=�}�����i�t}o�kˋ�v���%�䵇*�^
h����!^�\sܤ�t�r�cv0�]d��ұ�ctu~c�qm�g67���9r���y%]��iiƈ�gnǰ�ٱ(��d-�
�6���c4�"�~����l���а����ڠ�
�onhe\ ����)yt��c�y���f�z��1�֬:f�_n0g�;� ��)t�2&nkdٍf�f��k�z)�23c�c)� �_���9��on��np`�(l�2�
�mgz��vѓ-�( ��2s��w���`��5����,�j�_�b=�l�n��r�jj7�� j�#�������a詈��4*g��(a��%��!ν2��� ^�7��j����:��?$��u1 ��(e�<-�e�⇮������;0 swj
om���\��b�ݘpe�fy�ިy��£�&�f���'�yr���xg���� *�3m�cjvm5���}�֬s������ �w���� ς�o�,j �y�n�f ��
�߈�ޤ�q;a�(�>������(x'9�ߴ��=�lg9�=og^� )%g;cqy�^9`� �#��f���lt����8s���� vo��y^s�%6���c~�ֲ�&^�9�ð���_m�pa�0�v��4j�6|
�����鑆��(�d߃ ���q,j�̙���k�b���z�ъ
�hé}�ry�� ��?�e|�ٕ�h�6��<�o\:q��gj z?:l�h �<��1˚����@s'�� �$��g �iw�a )�|7� 0��pg��fy _jq��1�g�'@|��
�_��@w��t���xov�l߳�'�b�ghl�b� x�ϣ:�_�?p2:� 2a�e�=�z@�j
������`|%�����0vc
~s�@��� ����� ��>ǔh���^� w�le���`>6(2��ӷ�o뇟�� �
ge��0d�̸�l��ŏ��8�d!� ��ɣi���e6��w$�m��]%�m\g!v p�c�٥܅�p�6� �s���͕ �(��,��z�,lcْ,_��d{-_�6�1�����r��f�(e��� m�bڡ������{�������}�x����kg�s���,ɚ��6���k�]s�;���
dɧ�ev���������9�c8�@�}�sa#=< ������j*~������
dh7�c�.z��t� {�g�l��7m.sqxp$���-��i��`�xdw�ca]�4�%t�y0��װ��"9e��x[a6i�6 ����p�|����g���;it2951!l�ch�ڂ�* ~����k��ɓith�hdnb� l 0����2�0$�
n�bs[�z`�vvkd�"x��m��yk�-�÷�ǿ�o�73 ����k���#ç�*�t���g7d�y��|�0t��1�i�k� }_�t�� �42��cn>"� �|w� �i�� ]^�u��*}��r��drf|�¿n"������ 0=r� �[���b��7l�n��3�d��^�u��&�fq� ��q�������l9[����� ����ag��`�-�ܧ��:�� v�w��t%����27�z!���py��
�1kg9y�'z�$bo�p�f�$����il%=�wi�s� �t��� ��l q��!�$�c/|ߡ�)�2l��� v���q)�����d�p� ��\t���'�"�lqn�>s�̥�ȇ";̻�<)q]٦�j�3��"0�4�5�|s�e"�jm�z��ˬ<�q$��� n���z�ѥ��$��r�g4����\,l���^v:�p��� :�q����p%4m�ƭ�̕�!}]���~�5���i�c./��;�h�2� ��2b`��xvf�8���}:�*�?y���c[�=ɩ����� �u_⪦a�.�8d_��s�so��ж�?y��l�o�b&���5��r�1a��g�eǚ��kl(�j ��ds�?���m��zd��1���-)�3�e0id�cun='��qw�����l�ٮ3.�3��^_���{6����ɉ��&�
f n� q�u�y��a`dx� � � �(�[�e��km<��y��9��� ����s������o���k=�=�i�m
4�l��f�ey��m3i�ny�xp��mj��� j�
�w˔� �k�����d��g
�j�(�f-�
sxh�nxo�,шqy����ka�d9cݎ� ���[���,;��?�. �.m���\^�1/���-%�ǯ��ώtg� ����� �gcd {`�h�h�p�����jj�'�vǁaxp�#�v������$ss3���{<����n!���eɭ��u�|�a���u�-��k8 d���~�q�<�k0�����.n��/���h� ttm��˰l8�p�n�cg�ݍ�g �t����'o5� ��i=�/u�q?�> ���w[�wv�mn��rahj0��҃�nj�_tj*b��䉓/�f�4; ��(~��ب�5��u��4:�yk�ikzb1_$ �u�4��z���l��5����&d�d�p��^�_m�7��# =c(&�*��ئh�4���n��?^���"�~�z���0��������yj,�m���t�ˈw�k��st��pŋqs\by8��#��s58 �(�ouu5uqf)��
����w��t#�im�: ^�h"� a ��ޝ����f�pe
�����ؿ�w}�&�����s����r ߃����!�n�w�~�l �8�
��9�`w�k� �g����28��[>�ck�� ;��b/^��_ _��tey9
x�gs^�e��3r�ig�k� ��b\���biz�q�4٨�����k薪��.�_wg���t w 7��[�����=� �~f���u�w�w`&yf�|���'w9��l�q��^��i�b9o� �d�1��x����)<�[��aҫ��ƌ&-g � ��� ���)|: [����:��e�����z������u��� �a�ɬj]=�l�y]�7��cw� x��y f=y0 ��2(>0�u!lf7l*�o�;�v����$r
�(-w�f'z��fv�.�ah��d 1�ك��80��w��_����'v�.yt�t]���*c=@9�����m��v���������peo2r��%�ߴ�<������&�o���9��i �h٩_�?�ra�rӗ@.zw!�u�5�qǖ�@�� ���b(2� �����af�
5��s���_&��r��v���v�*�%qfyq/�d���fi��$k�h��}�ri�t�9b���f67i�x��4 ��t�w�/3k_�&���-:!�lj��r�o�j�����miz_2����]w�~�e�'�ogq�i���]y$o{� g `�� ?s}�2éhc�1l�'r�3?��6�q�az�|� g�/թ���"y@)fɏ��-ud@�������^9ח�з�ݾ3>̗ ez�� u�hb�n*d..} ��s��j�
�ܳ���:v�)��цl��ȿ �����u����=_���h�*�5ia
�0c�g
� ϧp�ș� ��ܝi��)��o�t6�����ʟ:b�ncf9v�30�t.аp�� ��r�o���[?
^~v�����xe��8�
6��nb��q;�ʃ�q�j��ƚ
�
uh��h���v[f �
�m~l�u��w�%��\��&�&4� v��5n$�%���p�j�i��>\4l�d�ق?iū�(㶅 ��į�-��l9
��qp��;!���"r�,~o>����q�'g�z*y ����~f$�2�qxiz� ��,�b�q�?���mj��>m��a�#�?��w�� {��<�� �� ﲬ�.�����vz�ڸmg�p�9��:cya�ڎ�l
�1�؆������x�g���ț�jr���[�%���m�:�\�t��p9u��
�#�v���k4u���dj�� �a��j����1�{��cq�bx��\��-�fo<�%d ;_��t��r�x�qm%e�el���{e��х[p o��iw$qu��5lcm���c��h��ŷ� f�p��эb�e�e�id�n2�,;�1����p^��mua o3na-�w����6$n�� g@����f>h�q�a !{�����n���]o{��ۭ�m����`�.52 �c#!x"�4�$�$$� �o�� ����/�i���d��d�������g�e֓�<��{����ϭp�}w�����9���[�s�����&�9 �i�i����:1�#��;��� w����=��d �!/�qy8#�0i��?��j���j�z
ń�/�%��(q�>�4� h�����z�yyc)2�?���&ۺ���0b�sae ������v md&�j�����/���`664�h#��i 4���u){���z��� ���&��c ԍ�=��zc��q141�a��ɾb�o@����t ϋ�i-� -�ҁybm#�-vh��sx��(�a��qihy&�c��t�i�� '��� �a�w⥎ȱ@�i%f y ��2� �����
(sz��r�l��m5z�{��-s"46�c�?�[_qv� �� ��-��t*s.w�&���()d8�
��ng�g:���d)���:y4 �e��n��y��� �& ���h^������l�4[�������d�a�������s0�ጘ��c����`w'a0l��@6�o� ���f�th� �ƚ�-< �$�g,���� �]8 ��3g =w�����^v����4���u\�?���� ���ԝ��o$�]��� a
0�n��
�
tް$%��b�5��g[4#��ƫا�x���qp�?�����>�� ��c5|���ph��f^�-��m���l۲mee��mv��tzش������<�����c�n�`��8 &�b��������cv�?�y��skl�5�����w_� 7
����#^d�jo��fx5� �� ��
endstream
endobj
49 0 obj
[59 0 r]
endobj
59 0 obj
<>
endobj
60 0 obj
<>
endobj
61 0 obj
<>
endobj
62 0 obj
<>stream
h�j`�"p��l��hlm5@y��i��j�hvn�@e��� � �d�j�fv�_
endstream
endobj
63 0 obj
<>stream
h�l�yptwƛ�."��\��[\�k�ŕev�@ (�,��:�lvnn��@�y�md@p��&*��8�t�p������r5�<���=�_�w��%��hii�<��l�����aq�]�����}j�qk�u����gz��>���~,�8�����qv�&� �5�,��떹�o�zz��a��s����0{w���t��>^���$6߿��>2*.d|,m &vk����%��ķ��b�o�d�wxbxbr��l������byx�_v�� �����4$��r�@� �ݡ�a'_g��&k�zr���گ�hdq�:m�f�%0h�5�f�j����-th�q�ql &�dے,�}3�yʎx�f���=�r��m�h�e��^�dž wqk)���0
��h��m@i�"�����$? � ��k d���a��wo�j�'��e* ȣ����6����l dz�h �i}��`]
�����
n(�an��o���k����� &� ��)��y��f&�e1g6�z��8��t�ka��l��sw�aʱ���5�xf~f
k v�8q���~�w�
� �pp�z�� "�i���` �hݽ��3�o����z�ֳ��bf�?7'� �n�o���t��!#d�v�ucato����e� �4��g�����d�1�hs4:��d�=!�_j(*�u"x���sh�"�
,�'2a%��k�҃���
uwy[p���vw�]�m9m
��$�����!��z" n��9��yl�wz]��l�w ���7wԫ�[i��?a(*�u=\ko�d��z����"���w&�d9v8�3'�js� �d�����r{a!3�2�9/$��9�@u�� }�p���p���ncx�`ovil�r=��qdix�� m2��h�kd��h[��x�o�`�⽨.�gb����4���\�� ��d��k��@��f�̝� n�g���6s9�y�}��� u�o��^�κm�mw/_'�e, ��'u���_�{�p�/g�i�x����g��&:g2e,�^@:=e�>��)b*�*"�~�a)�v���c����ݽ�5l���(�v�:��x������2<.�tx�qé�̺ӓ� _yz��&��se�,ܦ߱��o�{��m�g�� b���e
7�f � ��0�&�ac���@=e����s�p�c&�)�.�h8���|latbjbj�2��f �^�y�y٣�qv�f^���f�ϟp���� ʆȹq|[z�|f�\�'��5��u-\
ko�lj���:e�: ڲ}���v7�5Ԫ�w����5�� ����p��hy��ڔr
�c���&�l��q�
�q�
6�ߩ��^�b#e8��_qv�`��}� f��,��l��@@ �y�l{�k召n`��)oi�0�� _�p��w�1��l����d�=5i8&�m҃ƀ�4zs�� ���d
���$�xz��!����~�%�b&��� � cf�-n�� �o�$~g�y~� ���yó �r�v���a:%r7ȃ�"_{k��y�h��%r$p�h��/fdrj��em�l8�a����s�h��.�=�.�!��txu<~ү�>ƞ�[�6�8�2�bޝ>�q��ێ�-�;���&i�#w�-�* &q'������[q-�c�� ��">��ըy
ҳ�1�1p��o?\b4���� ��`�� �eb ��e���3;dxt&��c:�f� ��ܣ� a��g/1�r�obf>�� �2�2��f���<�b� �4��bo*�}eb���n��a�і�c�cr[���9?ȧl�!1�8|���;�&��g��:>��q[�r�(:� ��'��b:ag�s/%��5��,�h���m���y̞� ge���ad���z�{�ū��z���"%���bâbk�a�a$� � y�a��b\z�,b�*(v� 믎�ik�w�����93�_�=�s�7 �d��l�4g�x_zwsי�fg��,���#���
��ip��?�..�ujc��%~'w*�[�o>�x�pr sw�����)�٤7��i�c���у1cɗ읽cvg�lrt!�c {�mp��5��� `��;p�����#���������#ў��9��`c�pîs�v���e l]�0
�*�o z}���m��#f�n� l%������_f���j�2���$�`j��k/�b���s|� �q�-�e n�x f ������
����ub��w�d�=��3���=�5)8k �^�-����~ ,/�( ��e��ia2uݙ�n�uq���dμ�z�ya9u�|�c/gv�o| u�-0� �a�6a_ub�s�s��)��5���q�������e�� ҫ�@^|����i��b�^;خ�
�vԙsyx�����<�����y�礟�������!��s� %��˘�r�9 �{,�0�)�6h���)�9�88�l3f�f�*��r�l{r��5�u-'�m��n��i ��ܢ�t�~�=��ń�gr>ϻ�h�&�{;�
��f�$����g�k{�������a6��hau� %��j[4�':�q���&�1 �*�qɩ��� ��|3e��x� )�$����8��w�ncw�u���2���ʸ�s�a=���5�lzz"wtklyz�u�)-*-�)km�ne;��gƻ��g/����[����rb01��)%�|t�p��c�'��eb c<�����yӥu�p s��y����њy�u��e��ܬ^� �!�h����vǩ��|g�:5b�\q�]�g;�#|�m#3 c�z�>x�n��g�*�ll ���<@�nra��� (�c;����x����:
fmz��-8��� 6^��c�zfu��.)^��ԙ�f�0@ר���-t}k��v�`��́(� ��gw'ӹ��"��d�b?c���r߬ y�*e9b�dxdv6�v��u��sqw�p���a2 ���^d�ȯn�9t�۰\�4~�g�=���-�o#�
z�m��*���u���%յ��rkm ���b�o��4��ϯ�m�
���jg��
m(lh`�z�o�_�v����^��e�t}��w ��ק�x�� �-�[x���o�ɔ dѐ���[u����9
�wk�����r�'
endstream
endobj
34 0 obj
<>
endobj
46 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 23 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(compliance with the corporate governance code)tj
/t1_0 1 tf
0.014 tw 0 -2.333 td
(during the reporting period, the company has complied with all the code \
provisions set forth )tj
0.031 tc 0.077 tw 0 -1.167 td
[(in)6 ( )0.5 (the)6 ( )0.5 (corporate)6 ( )0.5 (governance)6 ( )0.5 (code)6 ( )0.5 (contained)6 ( )0.5 (in)6 ( )0.5 (appendix)6 ( )0.5 (1)6 (4)6 ( )0.5 (of)6 ( )0.5 (the)6 ( )0.5 (listing)6 ( )0.5 (rules,)6 ( )0.5 (with)6 ( )0.6 (the)6.1 ( )]tj
0.025 tc 0.002 tw 0 -1.167 td
(exception of code provision a.2.1 of the corporate governance code that \
requires the roles of )tj
0.037 tc 0.071 tw t*
[(chairman)12 ( )0.5 (and)12 ( )0.5 (chief)12 ( )0.5 (executive)12 ( )0.5 (should)12.1 ( )0.5 (be)12 ( )0.5 (separate)12 ( )0.5 (and)12 ( )0.5 (should)12 ( )0.5 (not)12 ( )0.5 (be)12 ( )0.5 (performed)12 ( )0.5 (by)12 ( )0.5 (the)12 ( )0.5 (same)12 ( )]tj
0.025 tc 0.039 tw 0 -1.167 td
(individual. dr. liang dongke is our chairman of the board and the genera\
l manager \(same as )tj
0.024 tw 0 -1.167 td
(a chief executive\) of the company. dr. liang has extensive experience i\
n the medical devices )tj
0.028 tc 0.08 tw t*
[(industry)3 ( )0.5 (and)3 ( )0.5 (have)3 ( )0.5 (served)3 ( )0.5 (in)3 ( )0.5 (the)3 ( )0.5 (company)3 ( )0.5 (since)3 ( )0.5 (its)3 ( )0.5 (establishment.)3 ( )0.5 (he)3 ( )0.5 (is)3 ( )0.5 (in)3 ( )0.5 (charge)3 ( )0.6 (of)3 ( )0.5 (overall)3 ( )]tj
0.025 tc 0.077 tw 0 -1.167 td
(management, business, strategic development and scientific research and \
development of the )tj
0.038 tc 0.07 tw 0 -1.167 td
[(group.)12.1 ( the)12.2 ( board)12.2 ( considers)12.2 ( that)12.2 ( vesting)12.2 ( the)12.2 ( roles)12.2 ( of)12.2 ( chairman)12.1 ( and)12.2 ( general)12.1 ( manager)12.2 ( in)12.1 ( the)13 ( )]tj
0.023 tc 0 tw t*
[(same person is beneficial to the management of the group. the balance of\
power and authority)-2 ( )]tj
0.029 tc 0.079 tw 0 -1.167 td
[(is)4.1 ( )0.5 (ensured)4 ( )0.5 (by)4 ( )0.5 (the)4.1 ( )0.5 (operation)4 ( )0.5 (of)4 ( )0.5 (the)4 ( )0.5 (board,)4 ( )0.5 (the)4 ( )0.5 (supervisors)4 ( )0.5 (and)4 ( )0.5 (our)4 ( )0.6 (senior)4 ( )0.5 (management)4 ( )0.5 (of)4 ( )0.6 (the)4.1 ( )]tj
0.054 tc 0.07 tw 0 -1.167 td
[(company,)12.3 ( which)12.2 ( comprises)12.2 ( experienced)12.2 ( and)12.2 ( visionary)12.2 ( individuals.)12.2 ( the)12.2 ( board)12.3 ( currently)29 ( )]tj
0.03 tc 0.078 tw t*
[(comprises)5.1 ( )0.5 (two)5 ( )0.5 (executive)5 ( )0.5 (directors)5 ( )0.5 (\(including)5 ( )0.5 (dr.)4.9 ( )0.6 (liang\),)5 ( )0.5 (three)5 ( )0.5 (non-executive)5 ( )0.5 (directors)5.1 ( )0.5 (and)5 ( )]tj
0.025 tc 0.016 tw 0 -1.167 td
[(four )0.5 (independent )0.5 (non-executive directors, )0.5 (and )0.5 (therefore has )0.5 (a )0.5 (strong independence )0.5 (element in )]tj
0.041 tc 0.07 tw 0 -1.167 td
[(its)12.1 ( composition.)12.1 ( the)12.1 ( board)12 ( shall)12.1 ( review)12.1 ( the)12.1 ( structure)12.1 ( from)12 ( time)12.1 ( to)12 ( time)12.1 ( to)12.1 ( ensure)12.1 ( that)12 ( the)16.1 ( )]tj
0.076 tc t*
[(structure)12.5 ( facilitates)12.5 ( the)12.5 ( execution)12.4 ( of)12.4 ( the)12.5 ( group\222s)12.4 ( business)12.5 ( strategies)12.5 ( and)12.4 ( maximizes)51 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(effectiveness of its operation.)tj
/t1_1 1 tf
0 -2.333 td
(audit committee)tj
/t1_0 1 tf
0.047 tc 0.07 tw 0 -2.333 td
[(the)12.8 ( company)12.7 ( has)12.8 ( established)12.7 ( an)12.7 ( audit)12.7 ( committee)12.7 ( \(the)12.8 ( \223)]tj
/t1_1 1 tf
[(audit)12.7 ( committee)]tj
/t1_0 1 tf
[(\224\))12.7 ( with)12.7 ( written)22 ( )]tj
0.053 tc 0 -1.167 td
[(terms)12.8 ( of)12.8 ( reference)12.8 ( in)12.8 ( compliance)12.8 ( with)12.8 ( rule)12.8 ( 3)12.8 (.)12.8 (2)12.8 (1)12.8 ( of)12.8 ( the)12.8 ( listing)12.8 ( rules)12.8 ( and)12.8 ( the)12.8 ( corporate)28 ( )]tj
0.025 tc 0.055 tw 0 -1.167 td
(governance code and corporate governance report as set out in appendix 1\
4 to the listing )tj
0.039 tc 0.07 tw 0 -1.167 td
[(rules.)12.1 ( the)12.1 ( audit)12 ( committee)12.1 ( comprises)12 ( three)12.1 ( members,)12.1 ( namely,)12 ( mr.)12 ( hui)12 ( hung)12.1 ( kwan,)12.1 ( mr.)14 ( )]tj
0.048 tc t*
[(jian)12.3 ( xigao)12.4 ( and)12.3 ( mr.)12.4 ( fang)12.3 ( shengshi.)12.3 ( mr.)12.3 ( hui)12.3 ( and)12.3 ( mr.)12.3 ( jian)12.3 ( are)12.4 ( independent)12.3 ( non-executive)23 ( )]tj
0.042 tc 0 -1.167 td
[(directors)12.8 ( and)12.7 ( mr.)12.8 ( fang)12.7 ( is)12.7 ( a)12.8 ( non-executive)12.7 ( director.)12.7 ( mr.)12.7 ( hui)12.7 ( is)12.7 ( the)12.7 ( chairman)12.8 ( of)12.7 ( the)12.7 ( audit)17 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(committee, who possesses suitable professional qualifications.)tj
0 -2.333 td
(the audit committee has reviewed the company\222s unaudited interim resu\
lts for the reporting )tj
0.041 tc 0.07 tw 0 -1.167 td
[(period)12.4 ( and)12.4 ( confirms)12.4 ( that)12.4 ( the)12.4 ( applicable)12.4 ( accounting)12.4 ( principles,)12.4 ( standards)12.4 ( and)12.5 ( requirements)16 ( )]tj
0.076 tc t*
[(have)12.9 ( been)12.8 ( complied)12.9 ( with,)12.9 ( and)12.9 ( that)12.9 ( adequate)12.9 ( disclosures)12.8 ( have)12.9 ( been)12.8 ( made.)12.9 ( the)12.8 ( audit)51 ( )]tj
0.032 tc 0.076 tw 0 -1.167 td
[(committee)7 ( )0.5 (has)7 ( )0.5 (also)7 ( )0.5 (discussed)7 ( )0.5 (the)7.1 ( )0.5 (risk)7 ( )0.5 (management,)7 ( )0.5 (internal)7 ( )0.5 (control)7 ( )0.5 (and)7 ( )0.5 (financial)7 ( )0.5 (reporting)7 ( )]tj
0.025 tc -0.025 tw 0 -1.167 td
(matters.)tj
/t1_1 1 tf
0 tw 0 -2.333 td
(independent review of interim financial report)tj
/t1_0 1 tf
0.047 tc 0.07 tw 0 -2.333 td
[(kpmg,)12.4 ( the)12.3 ( company\222s)12.3 ( auditor,)12.3 ( has)12.4 ( reviewed)12.4 ( the)12.4 ( company\222s)12.4 ( unaudited)12.4 ( interim)12.4 ( financial)22 ( )]tj
0.077 tc 0 -1.167 td
[(rep)0.5 (ort)12.9 ( for)12.9 ( t)0.5 (he)12.9 ( re)0.5 (porting)12.9 ( pe)0.5 (riod)12.9 ( in)12.9 ( )0.5 (accord)0.5 (ance)12.9 ( w)0.5 (ith)12.9 ( hong)13 ( kong)12.9 ( s)0.5 (tandard)12.9 ( )0.5 (on)12.9 ( revi)0.5 (ew)52 ( )]tj
0.025 tc 0.071 tw 0 -1.167 td
(engagements 2410, \223review of interim financial information performed \
by the independent )tj
0.043 tc 0.07 tw t*
[(auditor)12.7 ( of)12.7 ( the)12.8 ( entity\224)12.8 ( issued)12.8 ( by)12.8 ( the)12.7 ( hong)12.8 ( kong)12.8 ( institute)12.8 ( of)12.8 ( certified)12.8 ( public)12.8 ( accountants)18.1 ( )]tj
0.085 tc 0 -1.167 td
[(whose)12.8 ( unmodified)12.8 ( review)12.9 ( report)12.8 ( is)12.9 ( included)12.8 ( in)12.8 ( the)12.9 ( interim)12.8 ( report)12.8 ( to)12.8 ( be)12.9 ( sent)12.9 ( to)12.9 ( the)60 ( )]tj
0.025 tc -0.025 tw 0 -1.167 td
(shareholders.)tj
et
endstream
endobj
45 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 22 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(foreign exchange risk)tj
/t1_0 1 tf
0.031 tc 0.077 tw 0 -2.333 td
[(during)6.1 ( )0.5 (the)6 ( )0.5 (report)6 ( )0.5 (period,)6 ( )0.5 (the)6.1 ( )0.5 (group\222s)6.1 ( )0.5 (operations)6 ( )0.5 (were)6 ( )0.5 (primarily)6 ( )0.5 (based)6 ( )0.5 (in)6 ( )0.5 (the)6.1 ( )0.5 (prc.)6 ( )0.5 (assets,)6 ( )]tj
0.037 tc 0.071 tw 0 -1.167 td
[(liabilities)12 ( )0.5 (and)12 ( )0.5 (transactions)12 ( )0.5 (in)12 ( )0.5 (the)12 ( )0.5 (prc)12.1 ( )0.5 (are)12 ( )0.5 (denominated)12 ( )0.6 (in)12 ( )0.5 (rmb,)12 ( )0.6 (while)12.1 ( )0.5 (overseas)12 ( )0.5 (assets)12 ( )0.5 (and)12 ( )]tj
0.025 tc 0.073 tw 0 -1.167 td
(transactions are mainly denominated in us dollars. there were currency f\
luctuations among )tj
0.039 tc 0.07 tw t*
[(us)12.4 ( dollars,)12.4 ( euro,)12.4 ( rmb)12.4 ( and)12.4 ( hong)12.3 ( kong)12.4 ( dollars)12.4 ( during)12.4 ( the)12.4 ( reporting)12.3 ( period,)12.4 ( the)12.4 ( group\222s)14 ( )]tj
0.025 tc 0.058 tw 0 -1.167 td
(operational results and financial condition may be affected by changes i\
n the exchange rates. )tj
0.033 tc 0.075 tw 0 -1.167 td
[(as)8 ( )0.5 (the)8 ( )0.5 (group)8 ( )0.5 (reasonably)8 ( )0.5 (arranges)8 ( )0.5 (the)8 ( )0.5 (currency)8.1 ( )0.5 (structure,)8.1 ( )0.5 (which)8 ( )0.5 (effectively)8 ( )0.5 (reduces)8 ( )0.5 (foreign)8 ( )]tj
0.029 tc 0.079 tw t*
[(exchange)4.1 ( )0.5 (risk,)4 ( )0.5 (the)4 ( )0.5 (directors)4.1 ( )0.5 (believe)4 ( )0.5 (that)4 ( )0.5 (there)4 ( )0.5 (is)4 ( )0.5 (no)4.1 ( )0.5 (significant)4 ( )0.5 (foreign)4 ( )0.5 (exchange)4 ( )0.5 (risk)4 ( )0.5 (to)4 ( )0.5 (the)4 ( )]tj
0.025 tc 0.051 tw 0 -1.167 td
(group at the current stage. therefore, the group had not implemented any\
formal hedging or )tj
0.06 tw 0 -1.167 td
(other alternative policies to deal with such exposure during the reporti\
ng period. the group )tj
0.037 tw t*
(will continuously monitor its foreign exchange exposure and will conside\
r hedging of foreign )tj
0 tw 0 -1.167 td
(currency risk should the need arise.)tj
/t1_1 1 tf
0 -2.333 td
(charge on group assets)tj
/t1_0 1 tf
0 -2.333 td
(as at june 30, 2020, the group did not have any charges on its assets.)tj
/t1_1 1 tf
t*
(capital commitment)tj
/t1_0 1 tf
0.032 tc 0.076 tw 0 -2.333 td
[(the)7 ( )0.5 (group\222s)7 ( )0.5 (outstanding)7 ( )0.5 (capital)7 ( )0.5 (commitments)7.1 ( )0.5 (authorized)7 ( )0.5 (but)7 ( )0.5 (not)7 ( )0.5 (contracted)7 ( )0.5 (for)7 ( )0.5 (at)7 ( )0.5 (june)7 ( )0.5 (3)7 (0)7 (,)7 ( )]tj
0.044 tc 0.07 tw 0 -1.167 td
[(2)12.5 (0)12.5 (2)12.5 (0)12.5 ( not)12.5 ( provided)12.5 ( for)12.6 ( in)12.5 ( the)12.5 ( financial)12.5 ( statements)12.5 ( amounted)12.5 ( to)12.5 ( approximately)12.5 ( rmb)12.5 (5)12.5 (9)12.5 (9)12.5 (.)12.5 (4)12.5 (1)19 ( )]tj
0.078 tc 0 -1.167 td
[(million)12.7 ( \(december)12.7 ( 3)12.7 (1)12.6 (,)12.7 ( 2)12.7 (0)12.7 (1)12.7 (9)12.7 (:)12.7 ( rmb)12.7 (4)12.7 (1)12.7 (8)12.7 (.)12.7 (7)12.7 (7)12.7 ( million\).)12.7 ( the)12.7 ( group\222s)12.7 ( outstanding)12.7 ( capital)53 ( )]tj
0.05 tc t*
[(commitment)12.4 ( contracted)12.3 ( for)12.4 ( at)12.4 ( june)12.3 ( 3)12.4 (0)12.4 (,)12.3 ( 2)12.4 (0)12.4 (2)12.4 (0)12.4 ( not)12.4 ( provided)12.4 ( for)12.4 ( in)12.4 ( the)12.4 ( financial)12.3 ( statements)25 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(amounted to approximately rmb49.46 million \(december 31, 2019: nil\).)tj
/t1_1 1 tf
0 -2.333 td
(material events after the reporting period)tj
/t1_0 1 tf
0.04 tc 0.07 tw 0 -2.333 td
[(on)12.8 ( july)12.8 ( 2)12.7 (4)12.8 (,)12.8 ( 2)12.8 (0)12.8 (2)12.7 (0)12.8 (,)12.8 ( the)12.8 ( company)12.8 ( paid)12.8 ( capital)12.8 ( call)12.7 ( of)12.8 ( rmb)12.7 (2)12.8 (4)12.8 (.)12.8 (0)12.8 (0)12.7 ( million)12.8 ( to)12.8 ( the)12.8 ( ruixin)12.7 ( fund)14.9 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(according to the partnership agreement.)tj
0.055 tw 0 -2.333 td
(on august 14, 2020, all partners of the int fund entered into the int lp\
a, pursuant to which )tj
0.056 tc 0.07 tw 0 -1.167 td
[(the)12.2 ( company\222s)12.2 ( capital)12.2 ( contribution)12.2 ( commitment)12.2 ( was)12.2 ( rmb)12.1 (5)12.2 (0)12.2 (.)12.2 (0)12.1 (0)12.2 ( million)12.2 ( which)12.2 ( shall)12.2 ( be)31.1 ( )]tj
0.025 tc 0.034 tw 0 -1.167 td
(payable on or before december 31, 2021. on august 18, 2020, the int fund\
was registered in )tj
0 tw 0 -1.167 td
(the prc as a limited partnership.)tj
/t1_1 1 tf
0 -2.333 td
(compliance with the model code for securities transactions by )tj
-0.025 tw 0 -1.167 td
(directors)tj
/t1_0 1 tf
0.039 tc 0.07 tw 0 -2.333 td
[(t)0.5 (he)13 ( c)0.5 (omp)0.5 (an)0.5 (y)12.9 ( )0.5 (ha)0.5 (s)13 ( a)0.5 (dop)0.5 (te)0.5 (d)12.9 ( )0.5 (th)0.5 (e)12.9 ( )0.5 (mo)0.5 (de)0.5 (l)12.9 ( )0.5 (co)0.5 (de)13 ( f)0.5 (or)13 ( s)0.5 (ec)0.5 (ur)0.5 (it)0.5 (ie)0.5 (s)12.9 ( )0.5 (tr)0.5 (an)0.5 (sa)0.5 (c)0.5 (ti)0.5 (ons)13 ( b)0.5 (y)12.9 ( )0.5 (di)0.5 (re)0.5 (c)0.5 (tor)0.5 (s)12.9 ( )0.5 (of)13 ( t)0.5 (he)14 ( )]tj
0.045 tc 0 -1.167 td
[(l)0.5 (i)0.5 (st)0.5 (e)0.5 (d)13 ( i)0.5 (s)0.5 (s)0.5 (ue)0.5 (r)0.5 (s)13 ( )0.5 (\(t)0.5 (h)0.5 (e)13 ( \223)]tj
/t1_1 1 tf
9.133 0 td
[(m)0.5 (o)0.5 (de)0.5 (l)13 ( )0.5 (co)0.5 (d)0.5 (e)]tj
/t1_0 1 tf
5.697 0 td
[(\224)0.5 (\))13 ( a)0.5 (s)13 ( )0.5 (s)0.5 (et)13 ( )0.5 (o)0.5 (ut)13 ( )0.5 (in)13 ( )0.5 (a)0.5 (pp)0.5 (e)0.5 (n)0.5 (di)0.5 (x)13 ( )0.5 (1)12.9 (0)13 ( )0.5 (o)0.5 (f)12.9 ( )0.5 (t)0.5 (h)0.5 (e)12.9 ( )0.5 (r)0.5 (u)0.5 (le)0.5 (s)13 ( )0.5 (g)0.5 (ov)0.5 (e)0.5 (r)0.5 (ni)0.5 (n)0.5 (g)13 ( t)0.5 (h)0.5 (e)20 ( )]tj
0.025 tc 0.045 tw -14.83 -1.167 td
(listing of securities on the stock exchange of hong kong limited \(the \223\
)tj
/t1_1 1 tf
(listing rules)tj
/t1_0 1 tf
(\224\) as )tj
0.079 tw 0 -1.167 td
(its code of conduct for directors\222 securities transactions. having ma\
de specific enquiry with )tj
0.057 tc 0.07 tw 0 -1.167 td
[(the)12.4 ( directors,)12.3 ( all)12.3 ( of)12.3 ( the)12.3 ( directors)12.3 ( confirmed)12.3 ( that)12.3 ( they)12.4 ( have)12.4 ( complied)12.3 ( with)12.3 ( the)12.3 ( required)32 ( )]tj
0.025 tc 0 tw t*
(standards as set out in the model code during the reporting period.)tj
et
endstream
endobj
44 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 21 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(purchase, sale or redemption of the company\222s listed securities)tj
/t1_0 1 tf
0.026 tc 0.082 tw 0 -2.333 td
[(neithe)0.5 (r)1 ( )0.5 (the)1 ( )0.5 (company)1 ( )0.5 (nor)1 ( )0.5 (an)0.5 (y)0.9 ( )0.6 (of)1.1 ( )0.5 (its)1 ( )0.5 (subsidiarie)0.5 (s)0.9 ( )0.6 (has)1 ( )0.5 (purchase)0.5 (d,)1 ( )0.5 (sold)1 ( )0.5 (or)1 ( )0.5 (redee)0.5 (me)0.5 (d)1 ( )0.5 (any)1 ( )0.5 (of)1 ( )0.5 (the)1 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(company\222s listed securities during the reporting period.)tj
/t1_1 1 tf
0 -2.333 td
(significant investments and future plans for material )tj
0 -1.167 td
(investments or capital assets)tj
/t1_0 1 tf
0.047 tc 0.07 tw 0 -2.333 td
[(e)0.5 (x)0.5 (c)0.5 (e)0.5 (p)0.5 (t)12.9 ( )0.5 (f)0.5 (o)0.5 (r)13 ( )0.5 (t)0.5 (he)13 ( )0.5 (s)0.5 (u)0.5 (b)0.5 (s)0.5 (cr)0.5 (i)0.5 (p)0.5 (t)0.5 (i)0.5 (o)0.5 (n)12.9 ( )0.5 (o)0.5 (f)13 ( )0.5 (p)0.5 (a)0.5 (r)0.5 (tn)0.5 (e)0.5 (r)0.5 (s)0.5 (h)0.5 (i)0.5 (p)12.9 ( )0.5 (i)0.5 (n)0.5 (t)0.5 (e)0.5 (r)0.5 (e)0.5 (s)0.5 (ts)13 ( )0.5 (f)0.5 (u)0.5 (n)0.5 (ds)13 ( )0.5 (d)0.5 (i)0.5 (s)0.5 (c)0.5 (l)0.5 (os)0.5 (e)0.5 (d)13 ( )0.5 (i)0.5 (n)13 ( t)0.5 (h)0.5 (e)13 ( )0.5 (s)0.5 (e)0.5 (c)0.5 (t)0.5 (io)0.5 (n)13 ( )0.5 (h)0.5 (e)0.5 (a)0.5 (d)0.5 (e)0.5 (d)21.9 ( )]tj
0.025 tc 0.035 tw 0 -1.167 td
(\223subscription of partnership interests in the int fund and the ruixin\
fund\224, the group has no )tj
0.046 tc 0.07 tw 0 -1.167 td
[(significant)12.4 ( investment,)12.4 ( or)12.4 ( plan)12.4 ( authorized)12.4 ( by)12.4 ( the)12.4 ( board)12.5 ( for)12.4 ( other)12.5 ( material)12.4 ( investments)12.4 ( or)21 ( )]tj
0.025 tc 0 tw t*
(additions of capital assets during the reporting period.)tj
/t1_1 1 tf
0 -2.333 td
(material acquisitions and disposal of subsidiaries, associates )tj
0 -1.167 td
(and joint ventures)tj
/t1_0 1 tf
0.055 tc 0.07 tw 0 -2.333 td
[(the)12.6 ( group)12.6 ( has)12.6 ( no)12.6 ( material)12.6 ( acquisitions)12.6 ( or)12.6 ( disposal)12.6 ( of)12.5 ( subsidiaries,)12.6 ( associates)12.6 ( and)12.5 ( joint)30 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(ventures during the reporting period.)tj
/t1_1 1 tf
0 -2.333 td
(contingent liabilities)tj
/t1_0 1 tf
0.052 tw t*
[(as )0.5 (at june )0.5 (30, )0.5 (2020 and december 31, )0.5 (2019, )0.5 (the group did )0.5 (not )0.5 (have )0.5 (any material contingent )]tj
-0.025 tw 0 -1.167 td
(liabilities.)tj
/t1_1 1 tf
0 tw 0 -2.333 td
(financial instruments)tj
/t1_0 1 tf
0.031 tc 0.077 tw 0 -2.333 td
[(as)6 ( )0.5 (at)6 ( )0.5 (june)6.1 ( )0.5 (3)6 (0)6 (,)6 ( )0.5 (2)6 (0)6 (2)6 (0)6 ( )0.5 (and)6 ( )0.5 (december)6 ( )0.5 (3)6 (1)6 (,)6 ( )0.5 (2)6 (0)6 (1)6 (9)6 ( )0.5 (the)6 ( )0.5 (group)6 ( )0.5 (did)6 ( )0.5 (not)6 ( )0.5 (have)6 ( )0.5 (any)6 ( )0.5 (outstanding)6 ( )0.5 (hedge)6.1 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(contracts or financial derivative instruments.)tj
/t1_1 1 tf
0 -2.333 td
(capital expenditure)tj
/t1_0 1 tf
0.067 tc 0.071 tw 0 -2.333 td
[(the)12.1 ( )0.5 (capital)12 ( )0.6 (expenditure)12.1 ( )0.6 (of)12.1 ( )0.5 (the)12.1 ( )0.6 (group)12 ( )0.6 (for)12.1 ( )0.5 (property,)12 ( )0.6 (plant)12 ( )0.6 (and)12.1 ( )0.5 (equipment)12 ( )0.6 (\(the)12.1 ( )0.5 (\223)]tj
/t1_1 1 tf
-0.067 tw (ppe)tj
/t1_0 1 tf
0.025 tc -0.025 tw [(\224)-42.5 (\))-42.4 (, )]tj
0.048 tw 0 -1.167 td
(construction in progress, intangible assets, right-of-use assets and dep\
osits for ppe amounted )tj
0.03 tc 0.078 tw 0 -1.167 td
[(t)0.5 (o)5 ( )0.5 (ap)0.5 (pr)0.5 (ox)0.5 (im)0.5 (a)0.5 (te)0.5 (ly)5 ( )0.5 (r)0.5 (m)0.5 (b)5 (2)5 (3)5 (.)5 (9)5 (4)5 ( )0.5 (mi)0.5 (ll)0.5 (io)0.5 (n)5 ( )0.5 (fo)0.5 (r)5 ( )0.5 (t)0.5 (he)5 ( )0.5 (r)0.5 (ep)0.5 (o)0.5 (rt)0.5 (in)0.5 (g)5 ( )0.5 (pe)0.5 (ri)0.5 (o)0.5 (d)5 ( )0.5 (\(s)0.5 (ix)0.5 (-m)0.5 (on)0.5 (th)5 ( )0.5 (p)0.5 (e)0.5 (ri)0.5 (od)5 ( )0.5 (e)0.5 (n)0.5 (de)0.5 (d)5 ( )0.5 (ju)0.5 (ne)5.1 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(30, 2019: approximately rmb24.37 million\).)tj
et
endstream
endobj
42 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 20 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(use of proceeds from the global offering)tj
/t1_0 1 tf
0.076 tw 0 -2.333 td
[(upon )0.5 (completion )0.5 (of )0.5 (the )0.5 (global )0.5 (offering, )0.5 (the )0.5 (company )0.5 (raised )0.5 (net )0.5 (proceeds )0.5 (of )0.6 (approximately )]tj
0.004 tw 0 -1.167 td
(rmb797.62 million \(after deducting the listing fees and other expenses\)\
. as at the date of this )tj
0.066 tc 0.07 tw 0 -1.167 td
[(announcement,)12.6 ( the)12.6 ( company)12.7 ( has)12.7 ( utilized)12.6 ( approximately)12.7 ( rmb)12.7 (6)12.6 (6)12.7 (.)12.6 (4)12.7 (3)12.6 ( million)12.7 ( of)12.7 ( the)12.7 ( net)41 ( )]tj
0.052 tc t*
[(proceeds.)12.2 ( as)12.3 ( disclosed)12.3 ( in)12.3 ( the)12.2 ( section)12.2 ( headed)12.2 ( \223future)12.3 ( plans)12.2 ( and)12.2 ( use)12.3 ( of)12.3 ( proceeds\224)12.3 ( in)12.3 ( the)27 ( )]tj
0.034 tc 0.074 tw 0 -1.167 td
[(prospectus)9 ( )0.5 (of)9 ( )0.5 (the)9 ( )0.5 (company)9 ( )0.5 (dated)9 ( )0.5 (october)9 ( )0.5 (2)9 (8)9 (,)9 ( )0.5 (2)9 (0)9 (1)9 (9)9 ( )0.5 (and)9 ( )0.5 (the)9 ( )0.5 (announcement)9 ( )0.5 (of)9 ( )0.5 (the)9 ( )0.5 (company)9 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(dated july 7, 2020, the details of intended application of net proceeds \
are set out as follows:)tj
/t1_1 1 tf
-0.025 tw 8.4 0 0 12 296.7275 573.0479 tm
(revised )tj
0 tw -2.067 -1.167 td
(allocation of )tj
-0.085 -1.167 td
(net proceeds)tj
8.88 3.5 td
(utilized net )tj
-1.356 -1.167 td
(proceeds up to )tj
-0.133 -1.167 td
(the date of this )tj
-0.025 tw 0.127 -1.167 td
(announcement)tj
0 tw 8.636 3.5 td
(unutilized net )tj
0.029 -1.167 td
(proceeds as of )tj
-0.356 -1.167 td
(the date of this )tj
-0.025 tw 0.127 -1.167 td
(announcement)tj
10.87 4.667 td
(expected )tj
0 tw -3.003 -1.167 td
(timeline of fully )tj
1.38 -1.167 td
(utilization of )tj
-0.445 -1.167 td
(the unutilized )tj
0.552 -1.167 td
(net proceeds)tj
/t1_2 1 tf
-25.779 -1.167 td
(\(rmb million\))tj
8.436 0 td
(\(rmb million\))tj
8.436 0 td
(\(rmb million\))tj
/t1_0 1 tf
-42.826 -2.333 td
(set up a research and development center and an )tj
1.144 -1.167 td
(additional facility in jiading, shanghai)tj
-0.025 tw 28.04 0 td
(271.99)tj
9.486 0 td
(1.43)tj
7.386 0 td
(270.56)tj
0 tw 4.653 0 td
(december 2021)tj
-50.709 -1.167 td
(purchase additional and replacement of existing )tj
1.144 -1.167 td
(production equipment and automate production lines)tj
-0.025 tw 28.04 0 td
(110.07)tj
9.486 0 td
(4.33)tj
7.386 0 td
(105.74)tj
0 tw 7.028 0 td
(june 2022)tj
-53.085 -1.167 td
(expand our distribution network and coverage, )tj
1.144 -1.167 td
(collaborate with local distributors and intensify our )tj
0 -1.167 td
(marketing efforts)tj
-0.025 tw 28.565 0 td
(69.39)tj
0 tc 0 tw 10.286 0 td
(\226)tj
0.025 tc -0.025 tw 6.586 0 td
(69.39)tj
0 tw 4.128 0 td
(december 2022)tj
-50.709 -1.167 td
(fund potential strategic investments including )tj
1.144 -1.167 td
(acquisition, partnership and license-in)tj
-0.025 tw 28.04 0 td
(156.33)tj
0 tc 0 tw 10.811 0 td
(\226)tj
0.025 tc -0.025 tw 6.061 0 td
(156.33)tj
0 tw 4.653 0 td
(december 2021)tj
-50.709 -1.167 td
(general corporate purposes and fund our working capital)tj
-0.025 tw 29.708 0 td
(79.84)tj
8.436 0 td
(58.17)tj
8.436 0 td
(21.67)tj
0 tw 4.128 0 td
(december 2020)tj
-50.709 -1.167 td
(construction new factory project of zhuhai derui)tj
-0.025 tw 29.183 0 td
(110.00)tj
9.486 0 td
(2.50)tj
7.386 0 td
(107.50)tj
0 tw 4.653 0 td
(december 2021)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 266.4566 358.2488 cm
0 0 m
59.528 0 l
s
q
bt
0 tc 0.07 0 0 0.1 260.7874 358.0158 tm
( )tj
et
q 1 0 0 1 337.3228 358.2488 cm
0 0 m
59.528 0 l
s
q
bt
0.07 0 0 0.1 331.6535 358.0158 tm
( )tj
et
q 1 0 0 1 408.1889 358.2488 cm
0 0 m
59.528 0 l
s
q
bt
0.07 0 0 0.1 402.5197 358.0158 tm
( )tj
0.025 tc -0.025 tw 8.4 0 0 12 56.6929 332.0388 tm
(total)tj
29.183 0 td
(797.62)tj
8.961 0 td
(66.43)tj
7.911 0 td
(731.19)tj
et
1.11 w
q 1 0 0 1 266.4566 327.048 cm
0 0 m
59.528 0 l
s
q
0.45 w
q 1 0 0 1 266.4566 324.948 cm
0 0 m
59.528 0 l
s
q
bt
0 tc 0 tw 0.07 0 0 0.1 260.7874 324.62 tm
( )tj
et
1.11 w
q 1 0 0 1 337.3228 327.048 cm
0 0 m
59.528 0 l
s
q
0.45 w
q 1 0 0 1 337.3228 324.948 cm
0 0 m
59.528 0 l
s
q
bt
0.07 0 0 0.1 331.6535 324.62 tm
( )tj
et
1.11 w
q 1 0 0 1 408.1889 327.048 cm
0 0 m
59.528 0 l
s
q
0.45 w
q 1 0 0 1 408.1889 324.948 cm
0 0 m
59.528 0 l
s
q
bt
0.07 0 0 0.1 402.5197 324.62 tm
( )tj
0.026 tc 0.082 tw 12 0 0 12 56.6929 300.683 tm
[(as)1 ( )0.5 (at)1 ( )0.5 (the)1 ( )0.5 (date)1 ( )0.5 (of)1 ( )0.5 (this)1 ( )0.5 (announcement,)1 ( )0.5 (the)1 ( )0.5 (unutilized)1 ( )0.5 (net)1 ( )0.5 (proceeds)1 ( )0.5 (has)1 ( )0.6 (been)1 ( )0.5 (deposited)0.9 ( )0.6 (in)1 ( )0.5 (bank)1 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(accounts maintained by the company.)tj
/t1_1 1 tf
0 -2.333 td
(employee remuneration and relations)tj
/t1_0 1 tf
0.057 tw t*
(as at june 30, 2020, the group had a total of 1,018 employees, comparing\
to 757 employees )tj
0.026 tc 0.082 tw 0 -1.167 td
[(as)1 ( )0.5 (at)1 ( )0.5 (d)0.5 (ecember)1 ( )0.5 (3)1 (1)1 (,)1 ( )0.5 (2)1 (0)1 (1)1 (9)1 (.)1 ( )0.5 (the)1 ( )0.5 (tota)0.5 (l)1 ( )0.5 (cost)1 ( )0.5 (of)1 ( )0.5 (employees)1 ( )0.5 (for)1 ( )0.5 (th)0.5 (e)1 ( )0.5 (reporting)1 ( )0.5 (period)1 ( )0.5 (amounted)1 ( )0.5 (to)1 ( )]tj
0.048 tc 0.07 tw t*
[(approximately)12.7 ( rmb)12.8 (4)12.7 (9)12.7 (.)12.7 (7)12.8 (7)12.7 ( million)12.7 ( \(six-month)12.7 ( period)12.8 ( ended)12.8 ( june)12.7 ( 3)12.7 (0)12.7 (,)12.7 ( 2)12.7 (0)12.7 (1)12.8 (9)12.7 (:)12.7 ( approximately)23 ( )]tj
0.055 tc t*
[(rmb)12.5 (3)12.5 (9)12.5 (.)12.5 (9)12.5 (5)12.5 ( million\).)12.5 ( the)12.5 ( group)12.5 ( provides)12.5 ( employees)12.5 ( with)12.5 ( competitive)12.5 ( remuneration)12.5 ( and)30 ( )]tj
0.025 tc 0.019 tw 0 -1.167 td
(benefits, and the group\222s remuneration policies are formulated accord\
ing to the assessment of )tj
0.053 tw 0 -1.167 td
[(individual )0.5 (performance )0.5 (and )0.5 (are )0.5 (periodically )0.5 (reviewed. )0.5 (the )0.5 (group )0.5 (provides )0.5 (training )0.5 (programs )]tj
0.024 tc 0 tw t*
[(to employees, including new hire training for new employees and continui\
ng technical training)-1 ( )]tj
0.025 tc 0 -1.167 td
(primarily for our research and development team to enhance their skill a\
nd knowledge.)tj
et
endstream
endobj
41 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 19 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(profit for the period)tj
/t1_0 1 tf
0.079 tc 0.07 tw 0 -2.333 td
[(the)12.7 ( group\222s)12.7 ( profit)12.7 ( for)12.7 ( the)12.7 ( reporting)12.7 ( period)12.7 ( was)12.7 ( approximately)12.7 ( rmb)12.7 (6)12.7 (4)12.7 (.)12.6 (7)12.7 (0)12.7 ( million,)54 ( )]tj
0.026 tc 0.082 tw 0 -1.167 td
[(representing)1 ( )0.5 (an)1.1 ( )0.5 (increase)1.1 ( )0.5 (of)1 ( )0.5 (approximately)1 ( )0.5 (3)1 (9)1 (.)1 (5)1 (9)1 (%)1 ( )0.5 (as)1 ( )0.5 (compared)1 ( )0.5 (to)1 ( )0.5 (approximately)1 ( )0.5 (rmb)1 (4)1 (6)1 (.)1 (3)1 (5)1 ( )]tj
0.033 tc 0.075 tw 0 -1.167 td
[(million)8 ( )0.5 (for)8 ( )0.5 (the)8.1 ( )0.5 (six-month)8 ( )0.5 (period)8 ( )0.5 (ended)8 ( )0.5 (june)8 ( )0.5 (3)8 (0)8 (,)8 ( )0.5 (2)8 (0)8 (1)8 (9)8 (,)8 ( )0.5 (which)8 ( )0.5 (was)8 ( )0.5 (due)8.1 ( to)8 ( )0.5 (the)8 ( )0.5 (manufacturing)8 ( )]tj
0.025 tc 0 tw t*
(and sales of masks with higher profit margin.)tj
/t1_1 1 tf
0 -2.333 td
(liquidity and financial resources)tj
/t1_0 1 tf
0.043 tw t*
(the group has maintained a sound financial position during the reporting\
period. as at june )tj
0.038 tc 0.07 tw 0 -1.167 td
[(3)12.7 (0)12.7 (,)12.6 ( 2)12.7 (0)12.7 (2)12.7 (0)12.7 (,)12.6 ( the)12.7 ( group\222s)12.7 ( cash)12.6 ( and)12.7 ( cash)12.6 ( equivalents)12.7 ( amounted)12.6 ( to)12.7 ( approximately)12.7 ( rmb)12.7 (1)12.6 (,)12.7 (0)12.7 (5)12.7 (9)12.7 (.)12.7 (8)12.6 (9)13 ( )]tj
0.025 tc 0.017 tw t*
(million \(december 31, 2019: rmb1,036.78 million\). for the six-month pe\
riod ended june 30, )tj
0.06 tc 0.07 tw 0 -1.167 td
[(2)12.3 (0)12.3 (2)12.4 (0)12.3 (,)12.3 ( net)12.3 ( cash)12.3 ( flow)12.4 ( from)12.3 ( operating)12.3 ( activities)12.3 ( of)12.4 ( the)12.4 ( group)12.3 ( amounted)12.3 ( to)12.3 ( approximately)35 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(rmb46.90 million \(six-month period ended june 30, 2019: rmb42.70 millio\
n\).)tj
0.019 tw 0 -2.333 td
(the group recorded total current assets of approximately rmb1,159.92 mil\
lion as at june 30, )tj
0.028 tc 0.08 tw 0 -1.167 td
[(2)3 (0)3 (2)3 (0)3 ( )0.5 (\(december)3 ( )0.5 (3)3 (1)3 (,)3 ( )0.5 (2)3 (0)3 (1)3 (9)3 (:)3 ( )0.5 (approximately)3 ( )0.5 (rmb)3 (1)3 (,)2.9 (1)3.1 (2)2.9 (3)3.1 (.)2.9 (6)3 (6)3.1 ( )0.5 (million\))3 ( )0.5 (and)3 ( )0.5 (total)3 ( )0.5 (current)3 ( )0.5 (liabilities)3 ( )]tj
0.025 tc 0.054 tw t*
(of approximately rmb68.63 million as at june 30, 2020 \(december 31, 201\
9: approximately )tj
0.02 tw 0 -1.167 td
(rmb59.20 million\). the current ratio \(calculated by dividing the curre\
nt assets by the current )tj
0.035 tc 0.073 tw 0 -1.167 td
[(liabilities\))10 ( )0.5 (of)10 ( )0.5 (the)10 ( )0.5 (group)10.1 ( )0.5 (was)10 ( )0.5 (approximately)10 ( )0.5 (1)10 (6)10 (.)10 (9)10 (0)10 ( )0.5 (as)10 ( )0.5 (at)10 ( )0.5 (june)10 ( )0.5 (3)10 (0)10 (,)10 ( )0.5 (2)10 (0)10 (2)10 (0)10 ( )0.5 (\(december)10 ( )0.5 (3)10 (1)10 (,)10 ( )0.5 (2)10 (0)10 (1)10 (9)10 (:)10 ( )]tj
0.025 tc 0 tw t*
(approximately 18.98\).)tj
/t1_1 1 tf
0 -2.333 td
(borrowings and gearing ratio)tj
/t1_0 1 tf
0.008 tw t*
(the group has no bank borrowings or other borrowings as at june 30, 2020\
and december 31, )tj
0 tw 0 -1.167 td
(2019. as such, the gearing ratio is not applicable.)tj
/t1_1 1 tf
0 -2.333 td
(capital structure)tj
/t1_0 1 tf
0.03 tc 0.078 tw 0 -2.333 td
[(total)5 ( )0.6 (equity)5 ( )0.5 (attributable)5 ( )0.5 (to)4.9 ( )0.6 (equity)5 ( )0.5 (shareholders)5 ( )0.5 (of)5 ( )0.5 (the)5 ( )0.5 (company)5 ( )0.5 (amounted)5 ( )0.5 (to)5 ( )0.5 (approximately)5 ( )]tj
0.06 tc 0.07 tw 0 -1.167 td
[(rmb)12.6 (1)12.6 (,)12.6 (2)12.6 (5)12.6 (5)12.5 (.)12.6 (1)12.6 (1)12.6 ( million)12.6 ( as)12.6 ( at)12.6 ( june)12.6 ( 3)12.6 (0)12.6 (,)12.6 ( 2)12.6 (0)12.5 (2)12.6 (0)12.6 ( as)12.6 ( compared)12.6 ( to)12.6 ( approximately)12.6 ( rmb)12.6 (1)12.6 (,)12.6 (2)12.6 (1)12.5 (6)12.6 (.)12.6 (3)12.6 (8)35 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(million as at december 31, 2019.)tj
/t1_1 1 tf
0 -2.333 td
(interim dividend)tj
/t1_0 1 tf
0.075 tw 0 -2.333 td
(the board resolved not to declare any interim dividend for the six-month\
period ended june )tj
0 tw 0 -1.167 td
(30, 2020.)tj
et
endstream
endobj
40 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 18 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(finance costs)tj
/t1_0 1 tf
0.063 tc 0.07 tw 0 -2.333 td
[(during)12.5 ( the)12.5 ( reporting)12.5 ( period,)12.4 ( the)12.4 ( finance)12.5 ( cost)12.5 ( was)12.5 ( approximately)12.5 ( rmb)12.5 (0)12.5 (.)12.5 (0)12.4 (5)12.5 ( million)12.5 ( as)38 ( )]tj
0.025 tc 0.077 tw 0 -1.167 td
(compared to approximately rmb1.47 million for the six-month period ended\
june 30, 2019. )tj
0 tw 0 -1.167 td
(the finance costs were interests arising from lease liabilities.)tj
/t1_1 1 tf
0 -2.333 td
(distribution costs)tj
/t1_0 1 tf
0.061 tc 0.07 tw 0 -2.333 td
[(the)12.1 ( distribution)12.1 ( costs)12.1 ( in)12.1 ( the)12.1 ( reporting)12.1 ( period)12.1 ( were)12.1 ( approximately)12.1 ( rmb)12.1 (1)12.1 (2)12.2 (.)12.1 (7)12.1 (6)12.1 ( million,)36 ( )]tj
0.064 tc 0 -1.167 td
[(i)0.5 (nc)0.5 (re)0.5 (a)0.5 (se)0.5 (d)13 ( b)0.5 (y)12.9 ( )0.5 (a)0.5 (pp)0.5 (ro)0.5 (xi)0.5 (ma)0.5 (t)0.5 (el)0.5 (y)12.9 ( )0.5 (2)13 (6)12.9 (.)13 (8)12.9 (4)13 (%)12.9 ( )0.5 (o)0.5 (r)12.9 ( )0.5 (ap)0.5 (p)0.5 (ro)0.5 (xi)0.5 (ma)0.5 (t)0.5 (el)0.5 (y)12.9 ( )0.5 (r)0.5 (mb)13 (2)12.9 (.)13 (7)12.9 ( )0.5 (m)0.5 (il)0.5 (li)0.5 (on)13 ( a)0.5 (s)13 ( c)0.5 (o)0.5 (mp)0.5 (ar)0.5 (e)0.5 (d)12.9 ( )0.5 (to)39 ( )]tj
0.057 tc 0 -1.167 td
[(approximately)12.6 ( rmb)12.6 (1)12.6 (0)12.7 (.)12.6 (0)12.6 (6)12.6 ( million)12.6 ( for)12.6 ( the)12.6 ( six-month)12.6 ( period)12.6 ( ended)12.6 ( june)12.7 ( 3)12.6 (0)12.6 (,)12.6 ( 2)12.6 (0)12.6 (1)12.7 (9)12.6 (,)12.6 ( which)32.1 ( )]tj
0.025 tc 0.008 tw t*
(increased in line with revenue. it constituted 7.42% of the total revenu\
e as compared to 7.45% )tj
0 tw 0 -1.167 td
(for the six-month period ended june 30, 2019, which remained stable.)tj
/t1_1 1 tf
0 -2.333 td
(administrative expenses)tj
/t1_0 1 tf
0.06 tc 0.07 tw 0 -2.333 td
[(the)12.2 ( administrative)12.1 ( expenses)12.2 ( of)12.2 ( the)12.2 ( group)12.2 ( in)12.2 ( the)12.2 ( reporting)12.2 ( period)12.1 ( were)12.2 ( approximately)35 ( )]tj
0.024 tc 0 tw 0 -1.167 td
[(rmb19.08 million, as compared to approximately rmb11.30 million for the \
six-month period)-1 ( )]tj
0.023 tc 0 -1.167 td
[(ended june 30, 2019. the rise was mainly due to the increase in professi\
onal services expenses)-2 ( )]tj
0.025 tc 0.016 tw 0 -1.167 td
[(after )0.5 (the global )0.5 (offering )0.5 (and the )0.5 (increase )0.5 (in )0.5 (payroll )0.5 (and )0.5 (other compensation )0.5 (of )0.5 (administrative )]tj
0 tw t*
(staff as a result of the business expansion.)tj
/t1_1 1 tf
0 -2.333 td
(research and development expenses)tj
/t1_0 1 tf
0.08 tc 0.07 tw t*
[(t)0.5 (h)0.6 (e)13 ( )0.6 (r)0.6 (e)0.5 (s)0.6 (e)0.5 (a)0.6 (r)0.5 (c)0.6 (h)13 ( )0.6 (a)0.5 (n)0.6 (d)13 ( )0.6 (d)0.5 (e)0.6 (v)0.5 (e)0.5 (l)0.6 (o)0.5 (p)0.6 (m)0.5 (e)0.6 (n)0.5 (t)13.1 ( )0.5 (e)0.6 (x)0.5 (p)0.6 (e)0.5 (n)0.6 (s)0.5 (e)0.6 (s)13 ( )0.6 (o)0.5 (f)13 ( )0.6 (t)0.5 (h)0.6 (e)13 ( )0.6 (g)0.6 (r)0.5 (o)0.5 (u)0.6 (p)13 ( )0.6 (i)0.5 (n)13.1 ( )0.5 (t)0.6 (h)0.5 (e)13 ( )0.6 (r)0.5 (e)0.6 (p)0.5 (o)0.6 (r)0.5 (t)0.6 (i)0.5 (n)0.6 (g)13 ( )0.6 (p)0.5 (e)0.6 (r)0.5 (i)0.5 (o)0.6 (d)13 ( )0.6 (w)0.5 (e)0.6 (r)0.5 (e)55.1 ( )]tj
0.048 tc 0 -1.167 td
[(ap)0.5 (pro)0.5 (xima)0.5 (te)0.5 (ly)12.9 ( )0.5 (rmb)13 (3)12.9 (0)12.9 (.)13 (2)12.9 (2)12.9 ( m)0.5 (ill)0.5 (ion,)13 ( re)0.5 (pr)0.5 (ese)0.5 (nti)0.5 (ng)12.9 ( )0.5 (an)12.9 ( )0.5 (inc)0.5 (rea)0.5 (se)13 ( of)13 ( ap)0.5 (pro)0.5 (xima)0.5 (te)0.5 (ly)12.9 ( )0.5 (1)12.9 (3)12.9 (8)12.9 (.)13 (9)12.9 (0)12.9 (%)13 ( or)23 ( )]tj
0.035 tc 0.073 tw t*
[(approximately)10 ( )0.5 (rmb)10 (1)10 (7)10 (.)10 (5)10 (7)10 ( )0.5 (million)10 ( )0.5 (as)10 ( )0.6 (compared)10 ( )0.5 (to)10 ( )0.5 (approximately)10 ( )0.5 (rmb)10 (1)10 (2)10 (.)10 (6)10 (5)10 ( )0.5 (million)10 ( )0.5 (for)10 ( )0.5 (the)10 ( )]tj
0.026 tc 0.082 tw 0 -1.167 td
[(s)0.5 (ix)0.5 (-m)0.5 (on)0.5 (th)1 ( )0.5 (p)0.5 (er)0.5 (io)0.5 (d)1 ( )0.5 (en)0.5 (de)0.5 (d)1 ( )0.5 (j)0.5 (un)0.5 (e)1 ( )0.5 (3)1 (0)1 (,)1 ( )0.5 (2)1 (0)1 (1)1 (9)1 (.)1 ( )0.5 (t)0.5 (he)1 ( )0.5 (r)0.5 (is)0.5 (e)1 ( )0.5 (w)0.5 (as)1 ( )0.6 (pr)0.5 (ima)0.5 (r)0.5 (il)0.5 (y)1 ( )0.5 (du)0.5 (e)1 ( )0.5 (to)1 ( )0.5 (t)0.5 (he)1.1 ( )0.5 (gr)0.5 (ou)0.5 (p\222)0.5 (s)1 ( )0.5 (c)0.5 (on)0.5 (ti)0.5 (nu)0.5 (ed)1 ( )]tj
0.048 tc 0.07 tw 0 -1.167 td
[(development)12.7 ( and)12.8 ( commercialisation)12.7 ( of)12.7 ( the)12.8 ( existing)12.8 ( and)12.8 ( new)12.8 ( pipeline)12.8 ( products,)12.7 ( including)23 ( )]tj
0.025 tc 0 tw t*
(masks, during the reporting period.)tj
/t1_1 1 tf
0 -2.333 td
(income tax expenses)tj
/t1_0 1 tf
0.048 tc 0.07 tw t*
[(the)12.3 ( income)12.3 ( tax)12.3 ( expenses)12.3 ( in)12.4 ( the)12.3 ( reporting)12.4 ( period)12.4 ( was)12.3 ( approximately)12.3 ( rmb)12.3 (1)12.3 (1)12.4 (.)12.3 (8)12.3 (2)12.3 ( million,)23.1 ( )]tj
0.049 tc 0 -1.167 td
[(repres)0.5 (enting)12.9 ( an)12.9 ( inc)0.5 (rease)12.9 ( of)12.9 ( a)0.5 (pproximately)12.9 ( 4)12.9 (9)12.9 (.)12.9 (6)12.9 (2)12.9 (%)13 ( or)12.9 ( approximate)0.5 (ly)12.9 ( rmb)12.9 (3)12.9 (.)12.9 (9)12.9 (2)12.9 ( million)12.9 ( a)0.5 (s)23.9 ( )]tj
0.025 tc 0.077 tw t*
(compared to approximately rmb7.90 million for the six-month period ended\
june 30, 2019. )tj
0.07 tw 0 -1.167 td
(the effective income tax rate was 15.4% for the reporting period as comp\
ared to 14.5% for )tj
0.04 tc 0 -1.167 td
[(the)12.6 ( six-month)12.6 ( period)12.6 ( ended)12.6 ( june)12.7 ( 3)12.6 (0)12.6 (,)12.6 ( 2)12.6 (0)12.6 (1)12.6 (9)12.6 (,)12.6 ( which)12.6 ( was)12.6 ( primarily)12.6 ( due)12.6 ( to)12.6 ( growth)12.6 ( in)12.6 ( business)15 ( )]tj
0.025 tc 0.016 tw t*
(scale of certain subsidiary which did not enjoy sme preferential tax rat\
e during the reporting )tj
-0.025 tw 0 -1.167 td
(period.)tj
et
endstream
endobj
39 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 17 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(financial review)tj
-0.025 tw 0 -2.333 td
(revenue)tj
/t1_0 1 tf
0.065 tc 0.07 tw 0 -2.333 td
[(the)12.9 ( group\222s)12.9 ( revenue)12.9 ( in)12.9 ( the)12.9 ( re)0.5 (porting)12.9 ( period)12.9 ( was)12.9 ( approximately)12.9 ( rmb)12.9 (1)12.9 (7)12.9 (1)12.8 (.)12.9 (8)12.9 (4)12.9 ( million,)40 ( )]tj
0.042 tc 0 -1.167 td
[(representing)12.3 ( an)12.3 ( increase)12.3 ( of)12.3 ( approximately)12.3 ( 2)12.3 (7)12.2 (.)12.4 (2)12.2 (3)12.3 (%)12.3 ( or)12.3 ( approximately)12.3 ( rmb)12.3 (3)12.3 (6)12.3 (.)12.3 (7)12.3 (7)12.3 ( million)12.3 ( as)17 ( )]tj
0.049 tc 0 -1.167 td
[(compared)12.2 ( to)12.2 ( approximately)12.1 ( rmb)12.2 (1)12.1 (3)12.2 (5)12.2 (.)12.2 (0)12.1 (7)12.2 ( million)12.1 ( for)12.2 ( the)12.2 ( six-month)12.2 ( period)12.1 ( ended)12.1 ( june)12.2 ( 3)12.2 (0)12.2 (,)24 ( )]tj
0.031 tc 0.077 tw 0 -1.167 td
[(2)6 (0)6 (1)6 (9)6 (.)6 ( )0.5 (the)6 ( )0.5 (increase)6.1 ( )0.5 (was)6 ( )0.5 (mainly)6 ( )0.5 (due)6 ( )0.5 (to)6 ( )0.5 (the)6 ( )0.5 (contribution)6 ( )0.5 (from)6 ( )0.5 (the)6 ( )0.5 (manufacturing)6 ( )0.5 (and)6 ( )0.5 (sales)6 ( )0.5 (of)6 ( )]tj
0.025 tc -0.025 tw t*
(masks.)tj
0.043 tc 0.07 tw 0 -2.333 td
[(wi)0.5 (th)12.9 ( )0.5 (re)0.5 (spe)0.5 (ct)13 ( to)13 ( re)0.5 (ve)0.5 (nue)13 ( c)0.5 (ate)0.5 (gor)0.5 (iz)0.5 (ed)12.9 ( )0.5 (by)12.9 ( )0.5 (dif)0.5 (fer)0.5 (en)0.5 (t)12.9 ( p)0.5 (rod)0.5 (uct)0.5 (s,)12.9 ( )0.5 (the)13 ( g)0.5 (rou)0.5 (p\222s)13 ( r)0.5 (eve)0.5 (nue)13 ( g)0.5 (ene)0.5 (ra)0.5 (ted)18 ( )]tj
0.052 tc 0 -1.167 td
[(from)12.9 ( sales)12.9 ( of)12.9 ( interventional)12.8 ( medical)12.8 ( devices)12.9 ( in)12.9 ( the)12.9 ( reporting)12.8 ( period)12.8 ( was)12.9 ( approximately)27 ( )]tj
0.088 tc 0 -1.167 td
[(rmb)12.3 (1)12.3 (1)12.3 (6)12.4 (.)12.3 (7)12.3 (0)12.3 ( million)12.3 ( \(six-month)12.3 ( period)12.4 ( ended)12.3 ( june)12.4 ( 3)12.3 (0)12.4 (,)12.3 ( 2)12.3 (0)12.4 (1)12.3 (9)12.3 (:)12.3 ( rmb)12.3 (1)12.4 (2)12.3 (3)12.3 (.)12.3 (1)12.3 (7)12.4 ( million\),)63 ( )]tj
0.039 tc 0 -1.167 td
[(representing)12.5 ( a)12.6 ( decrease)12.5 ( of)12.5 ( rmb)12.5 (6)12.5 (.)12.6 (4)12.5 (7)12.4 ( million)12.5 ( as)12.5 ( compared)12.5 ( to)12.5 ( those)12.5 ( of)12.5 ( the)12.5 ( six-month)12.5 ( period)14 ( )]tj
0.059 tc t*
[(ended)12.3 ( june)12.3 ( 3)12.2 (0)12.3 (,)12.2 ( 2)12.2 (0)12.3 (1)12.3 (9)12.2 (.)12.3 ( the)12.3 ( group\222s)12.3 ( revenue)12.3 ( generated)12.3 ( from)12.3 ( sales)12.3 ( of)12.3 ( masks)12.3 ( and)12.3 ( medical)34 ( )]tj
0.049 tc 0 -1.167 td
[(accessories)12.5 ( in)12.4 ( the)12.5 ( reporting)12.4 ( period)12.5 ( was)12.4 ( approximately)12.4 ( rmb)12.5 (4)12.4 (3)12.4 (.)12.5 (6)12.4 (8)12.4 ( million)12.5 ( and)12.4 ( rmb)12.5 (6)12.4 (.)12.4 (1)12.5 (8)24 ( )]tj
0.026 tc 0.082 tw 0 -1.167 td
[(million)1 ( )0.5 (\(six-month)1 ( )0.5 (period)1 ( )0.5 (ended)1 ( )0.5 (june)1 ( )0.5 (3)1 (0)1 (,)1 ( )0.5 (2)1 (0)1 (1)1 (9)1 (:)1 ( )0.5 (nil)1 ( )0.5 (and)1 ( )0.5 (rmb)1 (7)1 (.)1 (4)1 (9)1 ( )0.5 (million\))1 ( )0.5 (respectively.)1 ( )0.5 (the)1 ( )]tj
0.044 tc 0.07 tw t*
[(masks)12.8 ( business)12.9 ( which)12.9 ( launched)12.8 ( in)12.9 ( early)12.9 ( 2)12.9 (0)12.9 (2)12.9 (0)12.9 ( to)12.9 ( respond)12.9 ( covid-)12.8 (1)12.9 (9)12.9 ( outbreak)12.9 ( contributed)19 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(25.42% revenue of the reporting period.)tj
/t1_1 1 tf
0 -2.333 td
(cost of sales)tj
/t1_0 1 tf
0.041 tw 0 -2.333 td
(the cost of sales in the reporting period was approximately rmb58.02 mil\
lion, representing )tj
0.048 tc 0.07 tw 0 -1.167 td
[(an)12.3 ( increase)12.4 ( of)12.4 ( approximately)12.4 ( 1)12.4 (1)12.3 (.)12.4 (3)12.4 (6)12.3 (%)12.4 ( or)12.4 ( approximately)12.4 ( rmb)12.4 (5)12.3 (.)12.4 (9)12.4 (2)12.3 ( million)12.4 ( as)12.3 ( compared)12.3 ( to)23.1 ( )]tj
0.025 tc 0.013 tw 0 -1.167 td
(approximately rmb52.10 million for the six-month period ended june 30, 2\
019. it was due to )tj
0 tw 0 -1.167 td
(the increase in revenue.)tj
/t1_1 1 tf
0 -2.333 td
(gross profit and gross profit margin)tj
/t1_0 1 tf
0.07 tc 0.07 tw 0 -2.333 td
[(during)12.2 ( the)12.2 ( reporting)12.1 ( period,)12.2 ( gross)12.1 ( profit)12.1 ( was)12.1 ( approximately)12.1 ( rmb)12.2 (1)12.1 (1)12.1 (3)12.1 (.)12.1 (8)12.2 (2)12.1 ( million,)12.1 ( as)45 ( )]tj
0.025 tc 0.034 tw 0 -1.167 td
[(compared )0.5 (to )0.5 (approximately )0.5 (rmb82.97 )0.5 (million )0.5 (for )0.5 (the )0.5 (six-month )0.6 (period )0.6 (ended )0.6 (june )0.5 (30, )0.5 (2019. )]tj
0.073 tw 0 -1.167 td
(gross profit margin increased from 61.43% for the six-month period ended\
june 30, 2019 to )tj
0 tw t*
(66.24% for the six-month period ended june 30, 2020. the increase in gro\
ss profit margin was )tj
0.065 tw 0 -1.167 td
(mainly contributed from the sales of masks with a higher profit margin g\
iven the covid-19 )tj
-0.025 tw 0 -1.167 td
(outbreak.)tj
/t1_1 1 tf
0 tw 0 -2.333 td
(other income)tj
/t1_0 1 tf
0.087 tc 0.07 tw 0 -2.333 td
[(during)12.8 ( the)12.7 ( reporting)12.8 ( period,)12.8 ( other)12.8 ( income)12.8 ( was)12.8 ( approximately)12.8 ( rmb)12.7 (2)12.8 (4)12.8 (.)12.7 (8)12.8 (2)12.7 ( million,)62 ( )]tj
0.035 tc 0.073 tw 0 -1.167 td
[(representing)10 ( )0.5 (an)10 ( )0.5 (increase)10 ( )0.5 (of)10 ( )0.5 (approximately)10 ( )0.5 (2)10 (6)10 (5)10 (.)10 (0)10 (0)10 (%)10 ( )0.6 (or)10 ( )0.5 (approximately)10 ( )0.5 (rmb)10 (1)10 (8)10 (.)10 (0)10 (2)10 ( )0.5 (million)10 ( )0.5 (as)10 ( )]tj
0.025 tc 0.077 tw 0 -1.167 td
(compared to approximately rmb6.80 million for the six-month period ended\
june 30, 2019. )tj
0.039 tc 0.07 tw t*
[(the)12.7 ( increase)12.8 ( was)12.7 ( mainly)12.7 ( due)12.7 ( to)12.7 ( the)12.7 ( increase)12.7 ( in)12.7 ( interest)12.7 ( income)12.7 ( arising)12.6 ( from)12.7 ( bank)12.7 ( deposits)14.1 ( )]tj
0.025 tc 0.082 tw 0 -1.167 td
(after receiving the net proceeds from global offering in late 2019 as we\
ll as the increase in )tj
0 tw 0 -1.167 td
(government grants.)tj
et
endstream
endobj
33 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 16 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(risks faced by the group)tj
/t1_0 1 tf
0.026 tw 0 -2.333 td
(during the reporting period, the group is also faced with the following \
industry-related risks )tj
0.053 tw 0 -1.167 td
(and uncertainties which may have significant impact on our financial per\
formance and future )tj
0 tw 0 -1.167 td
(business development:)tj
-0.025 tw 0 -2.333 td
(\225)tj
/span<>> bdc
( )tj
emc
/t1_2 1 tf
0.006 tw 1.89 0 td
(price control in the prc)tj
/t1_0 1 tf
(. our products\222 prices are subject to price control in the prc, by )tj
0.031 tc 0.077 tw 0 -1.167 td
[(which)6 ( )0.5 (the)6.1 ( )0.5 (government)6 ( )0.5 (agencies)6 ( )0.5 (and)6 ( )0.5 (hospital)6.1 ( )0.5 (set)6 ( )0.5 (a)6 ( )0.5 (price)6.1 ( limit)6.1 ( )0.5 (for)6 ( )0.5 (each)6 ( )0.5 (product)6 ( )0.5 (and)6 ( )0.5 (may)6 ( )]tj
0.025 tc 0 tw t*
(have significant impact on our operations of business and financial perf\
ormance.)tj
-0.025 tw -1.89 -2.333 td
(\225)tj
/span<>> bdc
( )tj
emc
/t1_2 1 tf
0.053 tc 0.07 tw 1.89 0 td
[(healthcare)12.2 ( reform)12.1 ( in)12.1 ( the)12.2 ( prc)]tj
/t1_0 1 tf
[(.)12.2 ( pursuant)12.2 ( to)12.2 ( the)12.2 ( notice)12.1 ( of)12.1 ( \223publishing)12.2 ( opinions)12.1 ( on)28 ( )]tj
0.064 tc t*
[(implementing)12.8 ( \221two-invoice)12.8 ( system\222)12.9 ( in)12.9 ( drug)12.9 ( procurement)12.9 ( among)12.9 ( public)12.9 ( medical)39 ( )]tj
0.057 tc 0 -1.167 td
[(institutions)12.5 ( \(for)12.4 ( trial)12.4 ( implementation\)\224)12.5 ( \()]tj
/c0_0 1 tf
0.045 tc -0.045 tw 18.901 0 td
<009003990cef>tj
/t1_0 1 tf
0 tc 0 tw (<)tj
/c0_0 1 tf
0.045 tc -0.045 tw 3.742 0 td
<15eb05f503af02ae036d153c141512da0ff415b906dc0aae148502950aaa>tj
/t1_0 1 tf
0 tc 0 tw 15.649 0 td
( )tj
/c0_0 1 tf
0.025 tc -0.025 tw -38.293 -1.167 td
[<0411>296 <009805470b4305530099>304.1 <06590fbc07440e080508>361.5 <0080>82 <0f0a>-3.5 <0411>108 <0081>]tj
/t1_0 1 tf
0 tc 0 tw 13.902 0 td
(>)tj
/c0_0 1 tf
0.025 tc -0.025 tw 0.589 0 td
<06590bb7065d0091>tj
/t1_0 1 tf
0.05 tw 3.778 0 td
(\) issued on december 26, 2016 and the notice )tj
0.046 tc 0.07 tw -18.269 -1.167 td
[(o)0.6 (n)13 ( )0.5 (c)0.6 (o)0.5 (n)0.6 (s)0.5 (o)0.6 (l)0.5 (i)0.6 (d)0.5 (a)0.6 (t)0.5 (i)0.5 (n)0.6 (g)13 ( )0.6 (t)0.5 (h)0.6 (e)13 ( )0.6 (r)0.5 (e)0.6 (s)0.5 (u)0.6 (l)0.5 (t)0.5 (s)13.1 ( )0.6 (i)0.5 (n)13 ( )0.6 (e)0.5 (l)0.6 (i)0.5 (m)0.6 (i)0.5 (n)0.6 (a)0.5 (t)0.6 (i)0.5 (n)0.5 (g)13.1 ( )0.5 (t)0.6 (h)0.5 (e)13.1 ( )0.5 (m)0.6 (e)0.5 (c)0.6 (h)0.5 (a)0.6 (n)0.5 (i)0.6 (s)0.5 (m)13.1 ( )0.5 (o)0.6 (f)13 ( )0.6 (r)0.5 (e)0.6 (p)0.5 (l)0.6 (e)0.5 (n)0.6 (i)0.5 (s)0.5 (h)0.6 (i)0.5 (n)0.6 (g)13 ( )0.6 (m)0.5 (e)0.6 (d)0.5 (i)0.6 (c)0.5 (a)0.6 (l)21 ( )]tj
0.04 tc t*
[(costs)12.2 ( with)12.2 ( drug)12.2 ( selling)12.2 ( profits)12.3 ( and)12.2 ( further)12.2 ( deepening)12.2 ( the)12.2 ( comprehensive)12.3 ( reform)12.2 ( of)15 ( )]tj
0.057 tc 0 -1.167 td
[(public)12.6 ( hospitals)12.6 ( \()]tj
/c0_0 1 tf
0.044 tc -0.044 tw 7.969 0 td
<009015eb05f512690578094e09f002f815b90efe153c03d30608073516830b0902b702ae036d153c09eb105d03a504b7082706590bb7065d0091>tj
/t1_0 1 tf
0.025 tc -0.025 tw 29.966 0 td
(\) )tj
0.035 tw -37.935 -1.167 td
(issued on march 5, 2018, a \223two-invoice\224 system is implemented to \
limit the distribution )tj
0.034 tc 0.074 tw 0 -1.167 td
[(of)9 ( )0.5 (pharmaceutical)9 ( )0.5 (products)9 ( )0.5 (to)9 ( )0.5 (a)9 ( )0.5 (single)9 ( )0.5 (level)9 ( )0.5 (of)9 ( )0.5 (distributors)9 ( )0.5 (for)9 ( )0.5 (sale)9 ( )0.5 (to)9 ( )0.5 (public)9 ( )0.5 (hospitals.)9.1 ( )]tj
0.083 tc 0.07 tw 0 -1.167 td
[(the)12.8 ( two-invoice)12.9 ( system)12.9 ( requires)12.9 ( one)12.8 ( invoice)12.9 ( to)12.8 ( be)12.9 ( issued)12.9 ( from)12.9 ( pharmaceutical)58 ( )]tj
0.047 tc t*
[(manufacturers)12.6 ( to)12.6 ( pharmaceutical)12.6 ( distributors)12.6 ( and)12.6 ( the)12.6 ( other)12.6 ( invoice)12.7 ( to)12.6 ( be)12.6 ( issued)12.7 ( from)22 ( )]tj
0.034 tc 0.074 tw 0 -1.167 td
[(pharmaceutical)9 ( )0.5 (distributors)9 ( )0.5 (to)9 ( )0.5 (medical)9 ( )0.5 (institutions,)9 ( )0.5 (which)9.1 ( )0.5 (has)8.9 ( )0.6 (the)9 ( )0.5 (effect)9 ( )0.5 (of)9 ( )0.5 (centralizing)9 ( )]tj
0.053 tc 0.07 tw 0 -1.167 td
[(the)12.8 ( procurement)12.7 ( and)12.7 ( sale)12.7 ( of)12.7 ( high)12.7 ( value)12.8 ( medical)12.7 ( consumables,)12.7 ( and)12.7 ( may)12.8 ( have)12.7 ( certain)28 ( )]tj
0.028 tc 0.08 tw t*
[(impacts)3 ( )0.5 (on)3 ( )0.5 (our)3 ( business)3 ( )0.5 (operations)3 ( )0.5 (and)3 ( )0.5 (business)3 ( )0.5 (performance.)3 ( )0.5 (while)3.1 ( )0.5 (some)3.1 ( )0.5 (provinces)3 ( )0.5 (in)3 ( )]tj
0.025 tc 0.045 tw 0 -1.167 td
(china have extended the two-invoice system to medical devices, the healt\
hcare reform is )tj
0.023 tc 0 tw 0 -1.167 td
[(still in progress and the influence of the two-invoice systems on our fi\
nancial performance)-2 ( )]tj
0.025 tc t*
(and future business development remains uncertain.)tj
0.012 tw -1.89 -2.333 td
[(the )0.5 (group will )0.5 (continue to )0.5 (closely )0.5 (monitor )0.5 (and actively )0.5 (adapt )0.5 (to )0.5 (the )0.5 (regulatory policies )0.5 (in the )]tj
0.03 tc 0.078 tw t*
[(industry,)5.1 ( )0.5 (in)5 ( )0.5 (order)5 ( )0.5 (to)5 ( )0.5 (reduce)5 ( )0.5 (impacts)5 ( )0.5 (of)5 ( )0.5 (regulatory)5 ( )0.5 (changes)5 ( )0.5 (to)5 ( )0.5 (our)5 ( )0.5 (financial)5 ( )0.5 (performance)5 ( )0.5 (and)5 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(future business development to the extent possible.)tj
/t1_1 1 tf
0 -2.333 td
(outlook for the second half of 2020)tj
/t1_0 1 tf
0.082 tw 0 -2.333 td
(the outbreak of the covid-19 \(\223)tj
/t1_1 1 tf
-0.025 tw (covid-19)tj
/t1_0 1 tf
0.082 tw (\224\) since the beginning of 2020 is a challenging )tj
0.055 tc 0.07 tw 0 -1.167 td
[(situation)12.7 ( faced)12.6 ( by)12.7 ( the)12.7 ( society)12.6 ( on)12.7 ( a)12.7 ( global)12.7 ( basis.)12.7 ( as)12.7 ( a)12.7 ( result,)12.6 ( the)12.6 ( group\222s)12.7 ( main)12.6 ( business)30 ( )]tj
0.025 tc 0.046 tw 0 -1.167 td
(performance in the first half year, the progress of use of proceeds from\
the global offering of )tj
0.039 tw 0 -1.167 td
(the company \(the \223)tj
/t1_1 1 tf
(global offering)tj
/t1_0 1 tf
(\224\) and the progress of research and development pipeline )tj
0.032 tc 0.076 tw t*
[(are)7 ( )0.5 (therefore)7 ( )0.5 (affected)7 ( )0.5 (to)7 ( )0.5 (some)7.1 ( )0.5 (extent.)7 ( )0.5 (although)7 ( )0.5 (the)7 ( )0.6 (global)7 ( )0.5 (spread)7 ( )0.5 (of)7 ( )0.5 (covid-)7 (1)7 (9)7 ( )0.5 (has)7 ( )0.5 (not)7 ( )0.5 (yet)7 ( )]tj
0.053 tc 0.07 tw 0 -1.167 td
[(been)12.9 ( effectively)12.8 ( contained,)12.8 ( the)12.9 ( production)12.8 ( and)12.8 ( life)12.8 ( order)12.8 ( in)12.8 ( the)12.9 ( prc)12.9 ( has)12.9 ( been)12.9 ( gradually)28 ( )]tj
0.029 tc 0.079 tw 0 -1.167 td
[(restored.)4 ( )0.5 (in)4 ( )0.5 (the)4 ( )0.5 (second)4 ( )0.5 (half)4 ( )0.5 (of)4.1 ( )0.5 (2)4 (0)4 (2)4 (0)4 (,)4 ( )0.5 (we)4 ( )0.5 (will)4 ( )0.5 (\()4 (1)4 (\))4 ( )0.6 (fully)4 ( )0.5 (leverage)4.1 ( )0.5 (on)4 ( )0.5 (its)4 ( )0.5 (brand)4 ( )0.5 (recognition)4 ( )0.5 (and)4 ( )]tj
0.025 tc 0.075 tw t*
(sales distribution network to further expand its market shares, and stre\
ngth and maintain our )tj
0.029 tc 0.079 tw 0 -1.167 td
[(leading)4 ( )0.5 (position)4 ( )0.5 (in)4 ( )0.5 (the)4.1 ( )0.5 (interventional)4 ( )0.6 (medical)4 ( )0.5 (devices)4.1 ( )0.5 (industry;)4 ( )0.5 (and)4 ( )0.5 (\()4 (2)4 (\))4 ( )0.5 (further)4.1 ( )0.5 (development)4 ( )]tj
0.025 tc 0.009 tw 0 -1.167 td
[(the )0.6 (product )0.6 (pipeline, )0.6 (allocating )0.5 (more )0.6 (resources )0.5 (for )0.6 (research )0.6 (and )0.5 (development, )0.5 (further )0.6 (progress )]tj
0.048 tc 0.07 tw t*
[(on)12.1 ( the)12.1 ( research)12.1 ( and)12.1 ( development,)12.1 ( core)12.1 ( product)12.1 ( pipeline)12.1 ( and)12.1 ( obtaining)12.1 ( approvals)12.1 ( for)12.1 ( new)23.1 ( )]tj
0.025 tc -0.025 tw 0 -1.167 td
(products.)tj
et
endstream
endobj
35 0 obj
<>
endobj
38 0 obj
<>
endobj
65 0 obj
<>
endobj
66 0 obj
<>stream
h�\��n�0e��
/�e��b�h"��c��c�t�eȃ��'j�z {��w3��x�q�����v9��w��7ׁ��u4"�e?v�}����z��ٖ�� �(
|`py�&����;�� �h���jv2hn���f��,k�à�����@^��{���g�_��fa�~ ��n�a�m�5we����g)�����e���n�(bjc����9gn8'��4��r�6%mzd>"g��h��6#m�ڌ�*�2� ��1gċykfm��*�w�ge�u�\� e~ԉ�d|f�b�}j�٧&���h�s攘�i�s~ f�/���tz|!����� ��?#�k��h����l%��� ���
endstream
endobj
67 0 obj
<>stream
h��u{tg�!l�2����w߂ku� p�z�"�&�<�d1d �
�d�w-�u��v-���[<�uo�ٶ��;�qzv���8��s�|�ν����� ���a8�o ���yn�f�6�fe����ui��!��� c�s�܄ ^ځtov��k�� c�&ȳ�1��l���5�t�ij6r ����7$�
k�!�?x.��v�a)~]8�b. a�s�e� f��������t=�2��qii�pjǫ
j>s���jtz�)]ͅhw�� �m�4n�yu�z��s9}�?c$�i�6�n�4:θ���"�q"y��s���_��5��a�ve�ē�=:^�u�[/�ṕ]�ɛ��7j�:���:�v�_x�yn#������(�782jhy�%�1 ��
�aspl��ð��1,âݱ0w,r�m����6`�0�_�?t[�v]�����"�/�>�f�t�y�����ymyް�%��b(���c��p��^��ic�=�м�4����x2� hj�� �\�����w!c�¾^�b��g;�! �hȇ���/l. o��� f8`�ex@�״��u�ȕ;���
#ip���,rja.�h�]�c��x �b�>�������,0��"��ҳ��lom��!/믊���� ˳@ӆ��<��%�{��f���2d��0ȋ�#��z��|���w u*�u�o�ƌl.�c�o8
k�6�|`�ͬh- 䂿� ] ���
ݒ�inj]�\�n7�t�7�� ���j(9w6މ:yyw���t8�8�y� ct�
w�u�����n� ���fkj�>��>ex ��p�)�z��h����s�xo�e�����w� =2��;�3�:�u@"�m0�x$������%���� �&u
���l'li��n2'� �$��x��-ھ׃�x�,�,��]wy����v���l�3�i4i���f�.4j0:;b� ii�vʶ92���5e�%�y9�����g��" ��_��ɒ���0���ԙrv*v�1w3y���\�͇�[�#�t:ǒb��"��
cq�~��[��c� am�:p���� �u��\�$���%|�
���`���j��n3�����~�57ɲ�����_�4���93?��!l9�[d>z�:��~j�%���f�� �n���q��ɛ�ii
����%�6���y��ϻ�`$����s��j��w� u6}���߾>��ӡ����c��#�_�c�-��m���s�kb %�f��ۭ�m͛d͙�@k��|謼i�]�u��v� 乽k{�� yޙ0
vԑdž` )
������w~p{���� i�dʞ(qe�v�� ��m;��r1��
2�y糎s
g1a���魿�=q�����,��n)�\푏n�����m�uk�e�b�<�[��� a,�/ ��$js|bj ��=��{� ���)r3������x��x�#�cb�t��e�gqw��y��"�6y�xkw��@l��$����q�� �ђ(��_b�
�if�����ޯ����-l0tq.;��5}.z7yq��&�b��j _�t���nx���
j�wz�k��p~�9t�ȭ(���m��2o54u���wc�^�4a�j�u�=i�rrf� h�6wk4c������u'��}�x,/;ٔ~�p: i���~)���3� �z`�ug����ٯ��_
��k�� ��a"%_�o�*�4sմ�jw|�n�shr�)���ȯ*dm2�sh�:s ��o�}����'a�ޯc�w��t�#y�u����clu��8hn��?�����0�3}ȣɸk6��7݆�@3q�l�l���ďg�oz uh鵕gk�r�x
�<:|����d a��ttn3&��g�]0k�������9��:���䲏уy��́��[�u���m��-*% �e�%�=��a� �]4�[�!ݟ�vn?d���f߯�~@թb�)�y���(��kd$�p��������la���:/~'��l��ck�# o>g�9xx�:���| ���d5q�^�w� �i([�.����a/��,��褰�`3�p�.t�9ғ���t!���)6� �?k������vv��� ���{�'.5q��ԛ<�8��6�݆2��ݪ��@�yʂp1�x����农}(< � � q��_83��\c�kw�u�y�ctu8�]�c�v�#�81ua�q �agan�jv wq';���?�a��҄g��la�^�&���g
��q�r ���t���e�hv�i�i�6r�ܪf��t[{����?�=�����ǫ�cߴf�ԓ،���`�kpi)�����h�vs2�с[r������c(d?
:����f/ύ��j gu|$^�z�d�\��np����=o��������o�/ffk�p��ɉ�2c��>8�7)���}s~p# ��ǿ�n�u��lfk?��j ���
쨄�t��#pl��gn�?�m
�2qiv*�p�n���co )8f{�q*m��j.���f���"ȋt� ���x;�>��l�<��?~�}�ߗѿ/��
0z�c
endstream
endobj
64 0 obj
[68 0 r]
endobj
68 0 obj
<>
endobj
69 0 obj
<>
endobj
70 0 obj
<>
endobj
71 0 obj
<>stream
h��pi! spsl@�=�y�g<��&!�� ���vȱ((w��@�qɦ_[@�֖��� � � ��u�<|�<�6=���}�t���"�^��x5�в�,ljޥ�hm��z������de�r�l��dx�o���tܲ;� ���
endstream
endobj
72 0 obj
<>stream
h�ltytsw ny��!��
a;eeqh*8n(.e�ʾ� �*ȟ�=��g����h�z� ��ӎ���t�l�9��np&�_��������~�;�~�e2�y &�i$&�ض-q�>q�8gw���y9��7�4�^���� �4ߟh�� �n�;��w5��9��@�������� ��d|w��ʶe��jje�!�=ar�dv�f� "6v� )7o|zpx&�l�*�� �j3��
�ްj��j�jʳ2�7���e
2��%n�����_a�2���y�����a�fv>�b���y�w��y/���q�y�gށ��ޗ���{'[�>����0$
9��#c����*�]��h ��i����y�|�}�}%�c�c~>~!~i~z�i�w�u�?�� ����&�u�o@p�p�l�\��%���\����eij"��#f�am^ ��l&c�y^�s�d(s��&�2�,��j����ޯ٣hꅭ�>�1�n�����3�o\^�/p����f�]!4a��8�� �2ote�$��>���������a��������/7�#2%�~tx�>��/ž�/mp�qbr�� cw|�����[��s&��z��x����s�>�7��m�s�
k�
h. ���{����(�ύ)�� r dbf"��b.~���� ��` |f/!�0�@&`�� z{�nf�� �{�5wc� �l�y��ʆ�&&��4��s
�\|!!��v:�i!;��8�1줠�bqzb��v��=�6�1����4�$�/>�t]eq��i��e-^�y(��qnl�"-�
�gh>9z�
��d����s��q�/:r�v��
#g����w"5w).�
ѻ;�z.��*���js�5ήl�a�隭��gm�� 6�[���uh�a ��j@�6| � 8��"8=�zl��l]���3��]�^�skҍt�v��s0 �� l��0i�l��@����k��/a�� �l��]mc���?�r �>0
`~2�c�9�2ҋb���g�������ԁuakm6q[���.7��c1�ћ�~ �i��&�d�؇çl2c���x g�z���?<��� 6m
�q:g��$�-r��� �p�{�p���vr;�q�u���l� �t����j�6 u��ȩ���0"g]j�(��7i[ff�o��$�ݦ~�=`�p,��n�m��\t;uf��n*�:u��w8�|�[��ʐ�ud��5�y�#g��.7������lo8{&>r�ͭ���9[�m�
م�kq��.�k����ba*<%�0� ւ�j�
dm�=מ�݃�� q�zk�y�g��;e_�̊f��5zmmt��v�e�e v�����yw;qyuy_�8��c�w�غ� 0p��:]]�@� g)��������' y��]c �m���kip: ���z�����n�u��j��|n���)lͷ�a�uz��級��/��r ��� � �㴴őρ� �)h��g z|mpzy�'���thioú��w�@ ���/vp]rԬs�q������ nu��3��0��dtb<��0h i��c5��z�h�r��r�˽�my�z����)��;a,�
�7��)_� ` ��������k� s*l�k�4r �c�x���˫=n/[ $� �z{o����!�o#�@�$ͧ��!�f,��
?�*�}nop�um�c���!(��=��he_q��yqs%;w��������ؿz̝�:�i����� f
�$�eݥ��gѷ��) ���s��7s��9�ҡ��1e{[��n�)h ͚l3�x ն�uy�.1(q�m-g�:������r���r#�kgm��0fעj{o��&��� 5x�3�&� q���n x,b閫l%viw���i|�$x�.j뼠�0@�h@y\��p�m���so�?~��ӈ?<��:$~�8��*��l�g �� uc�m�-[6����[ �e�|c���!� ����)2�4�z%i����jj�j�v�{�v���� ٥�u[ٺr�v��(he��c�"��� �!�<����wihbx�fepq[a괢��u��j۩mw��98�ם���יo���|�:_�o䍪m���%��� �p����ǧ��f����������?d�t����(yۻ�ɣ�͇v�� u cea��$���$��݉뒓sy�h����_��~����;1�{!�����ы0�z� �ƿ ����e< l �h<�ej�_�3i� ?�) ͳ o�� ��p zei�܀\���k��/3_����obuڣ-��k�
d���z�� �_k�w�5���f�o�?1o���r� u�c֢"�j\�;di8�(��7�^�y�xi���f�ft <�x�ݹ �3' {�c�34���)z�t���:%�v�v5�k����ʌ����_�|��p�7u
(�;v ��5����*���e0b
�&���75�d�s�a�8s?������d�6j
�jz�|e��`�l3���ίk�t����ms4�g��]#dx�?��w;n��fcug]"���� =c�1c7m3b�
�x����h �
�������[bn�s��n�m�jx -��*�v�'�� vr��٢��|2s5s�ˎ9�^"|7��i���d
����ux �� -�q$l�u��֡��]���q��k-�`>5蜼b�-j���8%(oof�z�z� ���w�������/���n��[x.�2u#����v@j�l�-yj��u�e�*��v��w��7�ꉹ<���n��ƚ�"~��-�pi5˰� �?����a'9^"�c���b��@���nq�dt��=�ٿ ���g\fzm��]�r��ҕ��� [i=8��?�k�q\!ϕ���{"j��n��&����
��ﱅ������vme����p=�tɷ��`�0 p�n%�"�9hj�� k\�a7��v6�!���k
2*�$*f�����q��
:�c@o)�̬q��{4�����("�p���}�?��=�{�gj��e3y.f�mou�nj:�csj:�m�ҡ�n�_��n��9�t ��v͗ jv���dϭ���g�,�cg�c � k��
&��uw���u��]�
�<:���q�:f .&q��4�p�(��i��c��u(hvj198�`b#??���e��z%�mp�|,)'5c��m�]i���;��1&��a_� ���3*�bw��a\/%v� ����f����,�e'���u�h�>g � �
a/��z�� �m�*^�yx��^���^o��g�`���ƶ�9���k8���3zz��ãg����� �e��v~h�t�� ����m� p�i.��&�;��p�����dq�b8(�p�*.��cdl2��`cl��$�k�%�]ݷd]�d]f��c��1�$�� ���&�n��l���<������fgo~o�{��� gac��0��8v��/�d�28�-c�}]�ab�6� z# ��p���&{��sp�ײ��7�����a4 lxg(�s��!�7pf
&x�z�ĉ��hq��ç����/h��fo�48�i�lޫ�9�s�t�s���-wɽ
m�vb��'�1>t�fw\#� c��/�����
�k�x���s~i��}b{�
j�����&��2i���-��f�m���qs��$g�ڭ�
}t�e>��o������ηпu|<� �7q�2�������bo���߯���%�ʱzl����@c��d�@ ������w^��m�|6v��"��<{ësf]�%8�-%㵄����d#������z���f�uw�b8ȧpi���eo�y�&
ex,�h)�j� �_�� ��x��;uaw %��
�
�ǻ%���baqs���� k@ g%�������'��od'���\�e�1�j��1yrd�^�t�a����#����o��4��5i� ������� �i��
�p^ θ���|!|zku�c#e�f��5�e��ُy
c�����
�;n���&�h��f!���9��p!:c�nl��� z:y��so(d��ӳэ!�g�� n ���df ��nco����>�f*�e*强u���|t���z�q d�k��u��ٲ[!t5�ğ �������2�w��� ��;�0�b���#u!�s �e���^�.�z����x6���e��mo����0ir
��� ̡j������p���˔3�t ��6�0(��c�%w¬��e)�fe���t�t<�ţt��=��m��>���g��\^�-�il�e�k��u�u�pv�d��ej2���#
v ���xn���}�m�4yu��ў�x��p�o��-v�
��u��������%j�tq����¾m6� n��b1;|�qe��=#�~|g�l�ko~���x���o������|�_\{)3|�:l�g�dw��4
�5�;��f�����w@��w�b�l`��ct�_�@��s���~qv��]�� ��� ���}�ŗ
�h�x�sg7� �]qe�|�����!nx7�
s�&�w� �jwv*i��c�vۮ1���@���!═l�q���'aa?�
r���j�i�\xy���c'��f��u�9|�@6�s�h�}ҫpf��4j��0 � �5 ğ���4?�lx���h�>b뺓!��j=!m���ke?�� x8q�bb[,�ƙrt� mf?aٯ�z��w(������r lxv��@` �v�g�/����2r�r��'���c�f����wt��q��,^��}�������4|^n'��c i3ǭ2k�m�� �.�mx�f�ͷ|�l�?ʤ�&���ͯ�i(\�$ݸ�9�
���;�3��#p(�̴�li�|(�d ��� b5
аh9�$��t_�v{��f/��!-��i6v��w�"�����w[mvք;���ov��~��*������
�`[;���\2todmx�b ��l."u�a}�e�5�l2tb�4z��t ��s���y����e�:��c�܃�:�0���b�!���g�5�f�l��i:�r5j51e��*� ,����\��.�g9�={9�g/�˲ (�*�[�x�m���iǚt�f&�t��0 ��ӿ���;�|��<�ﱚ '�xb�8d���� ��.2曉g��8��������۸�9*
�f��?>�)p�ԉ��9�| ӹ�3y��� �
c�3�l�j42 ��,7�v��!(#v=�s�}g�vꤼs4� h�� 5x*����ay��\� *���xdm(/�� (�l��fe�����[/��ˡ���� 10�k��m�ړk�c`1!��y���,
k��k���/�[��):=:09p���)"��c �jzi
8����t
\v_�]�
v��嘢�������x���
�� �>�|. ೳ����� s �s���n�x�x�r��ܤo��[i؈�:�w�[ij ?#�ws�< �7p=��a�ɑ����naf}�?��d�l�xe����
��8�� ����lu�u}� ��֖�2)z��5���g|�;��d�`)� �dc��4���ւ�@��=(c0�g<��d��������d`�k��`�|(�]�]�}���0��j���*���d�����[a�mq#9��·!�yb�t�w =*a)������8ʲ��2��&vom��f�������� l�(�wp����v����$�vo�cry�ԗt�����s�&
��� �ûkp����v�0��"|�����j��~���������$�c��&~$zи_[�g��,n�����]��!���ҥgf�>|�μ��o)c�3�s����c!�f�jh#�dff���;�1��;eył��_;�qm�9�j5����$��y@b("��g}�
lbf�5�οӛ:[;:u0 5-ƞ��~�9�sh�&���q�%��u����p���f8�x7�4�5r�lb���,6g�������`��
l��̺�
��
s����ro��~@l���yb0���dr��$v#o@w|}�
��5\�sp�5��y��y9e�{�m����y:�e�n��d�h��1��e���p��l��w��z�h���/�w���� qw��.mk�^�d�w��7֥���k\� 1�me�>����ub�[g�r�d���r/r�v .�k��mp����6��o⛙��p�!�?�5h����p�:��� ��k�Ꟁ����i�ap ��� b���`�w�u�m
8%z��vֻ�p#i)) �e[�ɶoo �b|��'��a x��ok���] �i��k�#@nw9<&�� ��%�n��px��\�t/x� �|����s�%�s v��{��;��� l�|�l��p2 l%a/k��o'���.}s� y�-�ciް_���������m����6�� �m�n�/zt�k���$)���u���ޞ��6�� �����땣gix��=㩸�y8v��=��:��c����� �om%����`_xo�0]��[k�c����6֞�_�kl�c^m��v�*�|
�� �x)*�7>�l5u�v�w����r��zxc��|�蝧(��i��pu����� �y���u���
�ky�mm�s��6s':�r�k�-�=b����s�h����a���ٟ�'᪃p�������g3o ���p�_vg�g�?�:j�jz�h��_� %h�`?^1$�ū��/�� ���2u�θv*���{d��>�7�p�/�*��燦��ip�_��������m�a�h�� �9�p}?�b� ��ϋk���� ��w~v\��j�?�ϸ��r|����᮰ $�{|)����e�rn)���1:�:fxv/o�'�wgu��h�v���v�$~y��b�1e9q&6�enҡ
'�ik�(���39�nf��9fdz��c��0z sp�6�6�v >e�a&9���'�8���������[m
��]i-����o�s��g������$�vu�� n �e�;]|��j��� ��9d!� ��e��zl���6_�_*.�:jh�u<ʀ�#���r�r��:��˖9�mz�`rp��'��n xu�� v�i�j�ġ1 �����boى�=��6;-�w啻r[�4f1x�6�do�?��4hl��`�ed/f�jj��&�]k0z�v�6���e��/�;ۇ�=�t ��s�z��6e��o���_3-������ń[]�#`^p�諩�&��3�"��ġy��r��3�s�a붟'���i��\.{�җf�ĺ��c� xۺ�rަ�y�
���b��#t ץ��c�i�����k��f��dc��ǘ���!�k �l�vz�����!��sc�� nwi�!
c6�w�w��j��d� ��u�����`�`��n\3��o� ��;�������� �}0�s8m�h0�̈́��6��%�nkp�jp�y���2�8����k��*�q7���kt���r��[��q���c:^_0�st��*?;idc�zo�n9�0 a��ӳ���/������mw|]�yp1\�gc���̞�ζӯ����>: 絭
���������n����n��k �3���vsk����f��w���ʈ��j��9��e�d�l����� �{�0�m5̎~if���$u�� �lz)���֖�;�y�� u����a�z���hq����۪��a�?�o !�#�ӓ��j{ sl/"�en�u�y��u _���k�`н � ���#�^v9�
������z{!���� ai��@6g^�f2�k��\���|��|;x �i����%��cu8�^fg�)-;ȏ4��e#3�cum��eş̃qd���a:�n����r{���@���v��ԙ��2�~�t��j(�[��i�m�������p �%���� ��6g�k�fc�@��6���df��ͅ�b�v� �kwg*�nt˷�8�şykv����{g&'ʈ��b|�=嬰�_�
��}�ɔl�q�t#1wٴɳ\�f�9.�ѿ��� �f��lxcқ9�ȣ���s`����p.x #
k�m
�!>x�f��c��:<3�o���f~��wb��%���%��m�[�7�n���,�(�-o�%�$ge�쨋��z3��v��t��)�3e��9f��� ��
��zc��k5���:���;k8����dji4��ь�2 ���y�d����� �ç��o9� w�f��
zkso�����v������o] �n=�
�p%%s�q�q��n�ml�4� n�k���;��ƚ�&�sy����b� <��^tc'u��?� ��_y�#�z&�伄kه��8�~1v�(��� �b(��d���%���"�q��n0�ia��c��fw�vd��̇ �j^�18�h ����@ٽv�p)ʽ�yf�
�ރ �a
�]o>^ �������q 2y# ������sc�q����q��fq�qj�3!��t֖l�� ��d�i1������l}`/�]���^�����ڙ����� >0��
l(������v�d�p�gd�>[�h}t�'}����o���h�ِ��ݾ��'5�f��\��k�b;p �ă �gq.*6��ct!��
7�������f�a�^�[n$p�
~3������a��0�x�dg�mi��p\��z���{��\�s� ߞ�����3e �[��z�zw�e�py�6j����"y�mc�:j[���g,%vb:��ڠ�y �q����� �b �v��q~4�d����6����̢�a��;��f̸qnm�.���co� �q���'�n�ݫ�q3rfዽ/b��{d$��a�.<���
���-ۨ'�� n��r��ϟ��/j�t���x������cv��p�x��7�ok��˜dy]'i!#w�!����o����?pop��<����k� �r?e�w��~[! x����wf�yk�9b�2�c~u�w��w��m���=�n��t�����#o���y/�3".�ϗ`��] ��zܫ�e�^p���
�=؇7n�9_�spl�7��7���_���n�g�ժq���e`^a�e��ab ��tϊe
l�ߍn�[ ����#b�!d|�� w��u5��k��wn;����z���'��[�4� �_c>=.w���a���oֳg�鷰 �̨ ���hg��hiwy��i�����l�-#�9����l͠��b���h�$ysu� �,�
� 0��b)��w������3x�� ��¾
�`�v�t�!��b��b8�3���g�b�.e����/l]$�v���k�2��g¡zf�ɖ����h&eu"դ�i � ���b,��up�3 ��r�)y\��k��7��!v�� dct����g>�n�ӆ���p� �`�r��{�� � ��}y`2�
��x�w�� ���x|̧t�dְ�o �a�n�i%�dk�y�˟�2ts�:1{�:�#��� 3a6��⯢" �7^v;pe�� 9r8y����vmh�j�i�l���,b�nx�e�n���zzm�r�����$ q���ǔb�n��b��^���`�k��2�tt���o�s�
f4"ɡ�� [��u'`5\��:��>qa���'x���8�&po�j�n��
�g�����90��=�a��h��� ����ƣnb�xih{����p�k��r��k�tĺn:tn"n�$�$8��>�d��(f��ptzycecy���<�e��kt��p�ba_e��y� ��5�v�&�v���z�� lɗn� �
���'�g�>4��3y���*ݪ[uzc��m��6���9��҇�g{/�r�p""�nj"z,��:�!���"j��ܧj� ���ݬuj��# �h<� � �� kp�n�>\�s\%< �a�� �rc{m�)�2/id0�%�:�����xg��ÿ�6�z���^to�t��g�����x �i�� 0b��y���\u����q��q^�c�s�(�a\uke9�eg�u>{�*�� 8�!�nn�0��y�n ��o��ڀ���<#���?e�y�
�d!�ՙ?�=�)k�6z-[��^�>���ӡ�$k�e�c/�nm�;�0y���x|��sx���>��a�!i;i����v�&0�t�%ޜl�k/� ��)x�n6�: 4��jzշ����^;
0�v'x��7i yr n(cj�c�� ��k:��g_����p�
�,��~�φ`��
�g;3��>���ξ�pk7��,�=�u��4�=.yn�c4��,9���nڋ��o=����������jh'>p�w �<5z�l���u��њ���9q$�'p6��h,{���ã� �xl��s�u]�o����זp���%���p�c$oaiӭ�
�h��k((�hű�������k� de:�\z���o��j�q)�( ��
3h���>� �pj�\
�u���i����
p.x�҂���x�4��v�� ����u�aҳg�n
3�����)����8@���v�c�� _61�/ز%˲�zi����fɲd�`y� ���b1hkд��lfh� �v2g�#�=.3��{οs��=��!��i��hiɖ]�7���u�� 8c�d�՚wd'�i�of�>lg � � ��9u��խxm}wш�#?k�a��&�aa]~u~��<��ݗ#�2���rzg��q[�^��vu�)xc' ������ � �®���m����&� _8��m�>m� ��c��'��/�@���ʠy`��|$�r#*e������fĝn:1v�p e�hl��@t>z� q1�i���<<r��t��_.�y�g-�<�7g!���`��g#���>��w���5�7��r��i��� "y>�v��0h���� ����z{��ճ�6���q����0'�e�frz��@�� �"������p\��;����3�k���`����6�n����w��wb�l��{u�"r�y�5xx��8p3�p���lm�1j�\��w��
^ae��%x��8k��6 �,�~��z��v �w� �t�t��֚ �y�$���{2�c�j�b�ۀ~e�v�t��r6��khz�/:�j����8�l�m�y��mi�.s�v�ٮ���r�ѣ�����,`�1i��og��
"��<�s��ڷ��ti�骲x��ǩczz"ʐ�s�s�]��r�}�h%p ng� ��f9d��zq�w�e�ѭ�e���|�n�yt9�� ���t�bfr;��z�-�f��ҹ��|�菨����l�n4(����.�4ʆfx��v��m���i���9=
�g�&}����i��� l���rgl0�i��b ��
���,�� y�u�����b�=��bc�v:8���%r�?�
_���:e�q�ž��#ɝ �!�����/@z�]�q�e��vԇԁ�hkt�yzpf��l4c��x���1j�����
�{m��g�<^s����p!�s룡bp��w;�l&����5�$��a ?�� ��a���r� =�2xjn��
�zyr� %� ��_ �@?;��5ٙf�v/�����ė�"���^��qr'��'�h�|$� �k#�0��$t�{q z� e�%���i��d���מ?���)o�meu��k�λ����v�.�{r=�n����} �;� 6�j��|�ӽo8� � nt��,n���^s~ɛ8�/�� "�r�� ��~�)���zzh��tr�r��v�gr�p�kd����r���պ�znթ�zc���]�:�$
�_껨��rz@a�~?ϋ���\�8ϝ8�i �}�@{h����i(�v �*�k�|��tx�9� r xw�@s���v�,p���4b���j[=��uz{*�1��a�t*�a2 �˟�:�no�<�/� jf�-� �a�e � �p
��7�hg�x��e�e�(e8��o�qt�[�� p��i��q�p#�6���䂥� ����&z������l8o��䳻>���-@%��jz��9�z����ܫ:7�:����͙���i7q'�ǿ~�o��c'�j*f[&�cz=f��,�[q��� s��.?(��n�?�.>�9.y:�~�;�j�ma�-�c�����y��iw�u&��hc��i����zu]�t�ԙ�����#.p.r�e��[}��c}ް{h��{�ir�4(uս����]�g&bs1�kxu �r9�]~�@4� ��<��oty0�e�w?���/3' ��gnߛ�j��[;���0��qo�aኚ�� z�v���" j)���;��{0:3j��qzv
ԣuf���f6]��m6�,*�1��ʣmg����&� ����6��uxb��� �8��k����h�ұ�p���/��^��$��_��=����i��]j��nz��h����nk��0�� ^
`���m,�b� ��ےey/[��n���y�dix�y`�c�
mh
�і��yl� ���lvf�l�䏛�����������'������?,��sb�w�������-ڃ�o��� ۆ ���s�3�me���,̷���_�x��|ŕ}>���r�m�*�{s�|"3��>>)�g ��]}#q��8� m������f��/��j�� �y;c������@^�]x�y~
@o-)�� miwű�o�9��� ��bjx #�����x2�vܬ=b����o%y�%܊7/p�n��σpx����lctr���{�>��� 2x��)��8�f�#�8�[�۩فs ����kt)� �a��1 �� �,�jc ��p?��ٔ�;�ۚ6w�fؓa���.��v�2��x-y����g9�w�s�9��?f�a�,�w�t! r�� mn�ys�x�n�'�ު@��,zd.��؈�r�h}����kz�t�ڪ��ܨzt��� \�{��ό�c
~:��,�1�-lct��;)=�d��>�����[�!�g�e̐����������gl�����ξ>
�� �{l�6$;�݆�
����!{� ��( r�߀3ٟawj�jov� xjc��gn�f��de�kx]ѷh �*�t���6_&��lwe��1ȇ��[h_$nc���>�,
#���>��-�� h�h�t�c^�5>��p��m�r�l�nt ���,�������%�֭b�n�t��j3�j���{x�:_>
�p(m���)ȧɻ�'�§�> 3:q�u"@q,faz)�t��ǩ������5rf�y�xe`���j 9�;�l�5!c��c��ܚ0�b��a��j�5�5w9�.����r�8p����^=ɠr��^��$��`��t�*���%��s���� �����/�q
��d�ݽ��e��rԟ��u$k�� �� ��fd�ࡁ*��m����ȵ���|�b��gцf��������!�����;(����m��ȉ5nb�炋�t���b3�����.��ixʁ5ݮ<ޑ��5�aow����[��y��z�@z�io)d�a>� 6iz�b�h$�� ����f:�"z� d�8�vc��h�b�@ �n�j8�ԓp� ��b�����7ɯ�!e�$�y� ߌ �ry��q;�c��z�ɨ�������j�mz3~,p��kiʸ�p�6�esko�0�m�ө��>�.9w6x�f����xk�q�`���^lj �n�-q?b�9͌���<����/�.��l���*�6]���тzn�6�u�x(b��h���kh�c�j�bk�h��2e#.* ��ev,���*�ue!s�f�d
�o�
hn?���!��4�{pt�����[&��ff�q|�z�v��qest�� (/q�-,��ov�kw�c_�y� ��tld4�� c��lb��-�6�:���[;�aڹ����{���{��~���1ƭ��i� � ���l���=f �"� ^��|,� � �"�� �(j���t��k���q�%sg�g�8i`u�9
yuyf����ȓ�?��k�k�n��p-���kz���]8!����|*fx�,x��o�rpc<}�qj:��@���3< �_"�|_��i����v`o���6��e�����q�o}e2�q�vuj��u�� i����ɩaݷ2b7��p�i ���-���`ѫ�v<'�x���k���vp�y��'y�t��f�}�t��lg�i��kq���q]��ji'|���rҁ
�@��.}hp�ӛ&5�zl9�*3���$�"�>�k��*�fu��8�u�6ި
���d���6 ��>x �*[�ї�1axp���i�u�x�ם!y�m�'���qe~͑p^&a�}7�~6�g�$^!���%eʥ1� g�(�m�ki ։����l��h5ʯi �u���)�"��&~_r"z�"bj�n6 f٬�q����v5*f/3ڛw�7������=j���$ ht*$ͷ�89n���d7}qr�l&��&�5����a|t�7o���լ��c%�� �d�s��r����?bx�zy
0u��=\��{�u}���� j^�3t��� �!��"�h���8 }��-9�κ��r��#�ҥ�p/�! mw�b��w� �ҁ�y��/��2w��>^m$���ؾ��������m�i 0
v�%�~؛�4:�<� o�ٗ{�=z@��i:.� ���z\2p�x�e��"�9��q�ym]]�谬�3��p�ű���k�ϯ�^!3��yp�b;@��v�awec�r��}^�f?ns�:jǔ#c�#�e���9�t wl% s����]�
��]i���&t��?���@���kz��b53�ہ�}�doh}��l1�j�@�x~0˛�2� �=|�!p�q���s^��� �.���lj�)�ic�j���f�
�wb���� ���=]��&��� �p!��73� s`��4-q�_����{wuمd8 $�(��߬@0f� e�k`�s��#��h7�:5ݱ�k
�5����t�ҩ-ϫ)-u�9�0�z^�����w2$>�y�b�yv�� �� ԕt���;u\9�_�\p�е��y�;e����v4��vyx�떑ee��e��l���� ��e%)�9�1� nk[c���lg
!��ڎ��m�5�x���or|\@]�v���n��5�&k�&�� �&�
@��xbڝ��& ��%o:�x����x�ԗtή&�c]
�5�����a�j�n��œ�z�u�!5ç��/wߺ u�kj`�����]_�j���- ki�7�$�nm� n�$� �l����� k�ym%0\w�1p ]b���n w�hp�f$y ����a��y
@�";8�fp�ci?���c��lmq��=uc'�f���n�z&�������pk2֔2&���f�b7-.����{�2������ǝ±���j�^�w���j�r��pԋ_��^�]y�2���>�ox�z|n���u
5���� �o��[�4������ij&��ξ���h楅g4z�v�c�� �3r� ��@!�� �;��
��d>�.�ܡd����(r8��{y�]}b�6)a�{ n��n�d��g�\��:��[�*fk�~�j�p |;�=��'�*x (b� ��* �%��
�6���)���d�گ`
�7�~�hx���%\��`�a�h��w�st[x�ѳgp���i��3�:@�(�s/�
x���&��"�
б�a� 5�p݇k�'�����b�ҙ3�h �q)��z9�����*��̩ "�k���q� r��_��<6���eg'�0m�qg�
�hq��
4�bh�%4
�rͱ��1>�� �ӻ�^3��}�����]���ɔؘp 0(( �d�"���f�u�q;�}����'�����}?�cm��wh��!щ���~�g��t����h��g:��š���%aw�vc����/�m:��s]�>k���d��v? �~��y�d�a�=���c�g�\~ψ^^��� �)�uh [y���k c�f�2zzs�@��yn`�\ˈu#q�@��u��ڠ�$�bri��4��,�fm�n�
"ʞ�� �w ]��ߩ/c֝����מ��iw�-�j׃� "a ��(8��x������&"ą8l�*t�:[ >dt�����=�l�ref�6�� x��� @�)g�pҗ�
š���x�(����\u�t�d�.�y�k �,����ak�i%�i�� b����1��q�[��z�, ���c�i���(0 vd��r��y�p ,�n�=���e���#~qqqi~ir�p��t��g)٦�dm
��=g[�"u�#oo-�<�f�r{���&j��l�|����p�uv��"�$d�ta�������>�tػ�i���c�&���d�}w�l��ꑟ�*f�ɳ`� �v�����=wa�fl��>��n_�i� ���4��p��b�^��?א=f ��sd�̊j @g�2v�n��f�`�a�@��%����a�d#a=l �̉�8��� ���0"n�3��o�o|k��}�
��n�i、v���i��hn���f�a0�z��<1�=o�j��=o���q� ѝ�u�:�� [u{��4nuܻs�����#����p�@"�9����dh��3tv���g�:�ҙt��;��� 'ȍ� �ŏ*���z�������cƅna�fv4y��=���ip$8 e��ל�o�-7t� �#�f#k�)�q*=ak��i`����q��>ñ�s��ns]c4�@�sǻ!�.řwu�#����}y�h�p`�d�3�g��>hs48�l�v��h������(��q�xtkw���zx��9�t��k�r��$�m�������-:�� o��8k���(��w�!;�'u|;�� ��f�"��m�
�s@�����@�o�6t��i"�} ަy'�4i�|�~yr�n�|�`* ���q%�3�3-��� np�\'� � ɨ 5}�e����e ᜣ�qt �`���w����ow^���ǻũ�ېf~��
t i�;�u7au:p�n>n`��#(��m_�n�&wn��dz�.��e��ne8��ء�����xvz��2�d�^�k���$m�^m�u����7_���^��m��s텆d���y���r��bc�� ���~�����;^;�j�.}6���_l}�pu��co�r,�kdޖ��8�.d�a�օ�[�䆙��ϟ�7�gd�hkzi[����c� ���lltπ�гs��� ��v \cn�,��1>��j��ɯa�ld4od����� ��a�dү�� jrtbkq�-^�l�0x�(y'�o��̓����*��s�]�7�w����k�"qŵi>� �:��x�#x��$f�֙5�]m����¯>�r�9�:�q��:z ���ܩh^ %�dw������ �t���0�c���v.�`��z�����$� w�f��b �h� �hc}��������n�l nɓv���6�����.l���(��]�� '�l��/�
�9'�c<��$� ��v��׳1�����pu��^����k�ā �{dw��z��.k���s�3� �fp��ϸ*�]��� �i��ϧ'�a���w��l]��lp��� ��8�/v1=j3�h�3�$��!1.�o�� �����s(a|7���?=�*�1��-��|�z�m� �}�#ӡv~�b��v�$v�� �����k�;���mot�bh��p)��m���w���e}� �"�a�c�m�����y�l�h�s��t*��͞)f@�? �yl� p�z�l�*a��uk����i
$�$@���������^���k�3;;;;��;{�z�� ` ��l�"җ@�*h���f��о���:����h�x#���}�gsq*jd?h����wa
|5)��pkikes9��`�&n�j�0
d�,�w��-�d`*6�c�l�|-l�:�� ���v����yu��, $���=�i��_�����$� ������َ^�x��j�h*��rc� �y�nv��� [:�x�c�ѷ��ȟ� ��{ �w��c3o��� ��mtyۚ%����&��78l䜮�`e�v���1 `ទ��p]�b���6p�=8�wڽws��
���9��n��`� ��r��;�y��;@���(�>n�)u�m\�b�n�2p���z����`r��ɏv�ȍ.�t{;��ȳi��5b��"�c���w� �s��z�@�f|��[�x'g��jĵ� �b=���h�a �@"� ��c"��r�݉n��_>��[�]h� �b�i��� �u���{ࠞ���q�o҈>��l�d�Ԥ0 w��ͳ����u��q2:h�u�p �`"� jzyj�d� ��z�
�w ߝ��v��suj~�$��x?�
�c�c��`-pn��v{=]loŭ��~b
l������bğgp�����ue0�0� ����`��5�m�=��n?��v�örp�b��w^�7hsɖ��:�>�9 ��=��������
r�%� _�^���p�����n�?�)�m'�z�ev�?mhw�r�b� ăd�q��e�;�'�ё�nkм_�fnz�p��:�����^ߕr��|ω��ʲj g��ч�_ �g/r�e��������^� �\\rp�b�0�[��tl֪�k�g\
���
���q>>� e��}�zぽy)�c%e�� �j��h��;�pz�~�j�� f�*���1�1�.�vٱ<������ﰵ��\c�`'�r22-�u�� �^w� 7ue��* 8�y ��qfu���s�*�&��{$[k���m�n��; !`�'߿��
�y�
8����&�v c_�u��ps�d��ck�"�k�:��ш�5�v��o����ss����bhe��g�#���7)�f�����������i�#8�jtn�r��s����}j�k�d
r�h%ȯ8ӕ�\�zo�[������|����/��$.,��m%��}�i9:g����8�pη̩�$�q��:]%` z�k2q�ޟ�}�@�p��ؒ��=��gw�hv�].�6��pe���2r \�w�^a �4�� ���w�� �)�z�|c���f��8 ķ[�e
z�\�ʱ&m����zl���ߞ�f��y���l��yu.`w�^��(r� 5q6`� 4f
1�� �d�g��僒ӆr�in�x��]jh�}d��z]�����e��n�k�3�ru��w�b�2�r�� �n��$#l)�t����>���g n��s� �����qx�yۃ�{gn r,��z���sabm�x����]�3�8��!���]傐��{u;3�� �� c��b16��l �h����팪o{�f�r��b qk��ʈb]d��f]d��v�8�z�v��si��v�����4â�������h �dy������܆/��e�����p*��^�k
pe^d�g\$^p�)h��� ��%���d��gu'��[/��dɑ�_�����u�:��q./;����=��:����ࢲ��(���h��-��,o�d ����fҧo[�k�fr�[w�oݸ�x:ln�8>}��|��j���e,|&�d���c����]���l�`��"7&����{�� �g�enyo
j�����u{=��w�@g���w� �~�9i�s�#n���/\��檍i���ݣvlq��ur�s,�[��o{щd�2'�
h
th ��^j� w����na�p�ԩ��pf���e1y��}����=�,ύ��y��]�o�������u�v��p�;�!�m���0ɉp�ƚ�f(�z;��n[e��o���mu�����ս�s1���(��@�* mxb�eғ����]]�1��e�j�o�v�^��@{a�p��n��m���ldasg�ssa�n�l���j]�g{{ʽ�r9m ��$�7�v�ڤґ�&��x��a� �f�%�䫪�z!�q��f�91hg�l_w .n�����e�
��f���gx�k}���� x�y��[3b a���tɐ-�z">oԣxh7�}a�n�~��či!���q��5g[�ngk3p��<�yt ���ҭ�k`�o &�ì��ge� �r�
j~jl�d�߽�2��'%�а��fr�v��kg���1:�8�t�
���~�j8k�f7���m�4˂ja�7�4�=�} s�n��7�>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
20 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
21 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
22 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
23 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
77 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 15 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(activities review)tj
-0.025 tw 0 -2.333 td
(subsidiaries)tj
/t1_0 1 tf
0.043 tc 0.07 tw 0 -2.333 td
[(in)12.8 ( march)12.7 ( 2)12.7 (0)12.8 (2)12.7 (0)12.7 (,)12.8 ( we)12.8 ( established)12.7 ( a)12.8 ( holding)12.7 ( subsidiary)12.8 ( in)12.8 ( shanghai,)12.7 ( the)12.7 ( prc.)12.7 ( as)12.7 ( at)12.7 ( june)12.8 ( 3)12.7 (0)12.8 (,)18 ( )]tj
0.059 tc 0 -1.167 td
[(2)12.2 (0)12.1 (2)12.2 (0)12.1 (,)12.2 ( the)12.2 ( group)12.1 ( was)12.1 ( comprised)12.2 ( of)12.1 ( 8)12.2 ( \(december)12.2 ( 3)12.2 (1)12.1 (,)12.2 ( 2)12.1 (0)12.2 (1)12.1 (9)12.2 (:)12.2 ( 7)12.2 (\))12.1 ( wholly-owned)12.2 ( or)12.2 ( holding)34 ( )]tj
0.06 tc 0 -1.167 td
[(subsidiaries)12.7 ( engaging)12.7 ( in)12.6 ( the)12.6 ( design)12.6 ( and)12.6 ( development)12.6 ( of)12.6 ( medical)12.6 ( devices)12.6 ( used)12.7 ( in)12.6 ( fields)35 ( )]tj
0.039 tc 0 -1.167 td
[(inc)0.5 (luding)13 ( peri)0.5 (phera)0.5 (l)12.9 ( in)0.5 (terve)0.5 (ntion,)13 ( neur)0.5 (ologic)0.5 (al)12.9 ( in)0.5 (terv)0.5 (entio)0.5 (n,)12.9 ( ca)0.5 (rdiov)0.5 (ascul)0.5 (ar)12.9 ( in)0.5 (terv)0.5 (ention)13 ( or)14 ( )]tj
0.025 tc 0.029 tw t*
(implantation, and the design and development of equipment and molds used\
for production of )tj
0 tw 0 -1.167 td
(medical devices.)tj
/t1_1 1 tf
0 -2.333 td
(subscription of partnership interests in the int fund and the ruixin fun\
d)tj
/t1_0 1 tf
0.023 tw 0 -2.333 td
(reference is made to the announcements of the company dated march 19, 20\
20 and april 29, )tj
0.01 tw 0 -1.167 td
(2020 and the circular of the company dated may 22, 2020 in relation to \(\
i\) the subscription of )tj
0.045 tc 0.07 tw 0 -1.167 td
[(limited)12.3 ( partnership)12.3 ( interests)12.4 ( by)12.4 ( the)12.3 ( company)12.4 ( in)12.4 ( shanghai)12.4 ( huaige)12.4 ( int)12.3 ( venture)12.4 ( investment)20 ( )]tj
0.054 tc 0 -1.167 td
[(partnership)12.3 ( \(limited)12.2 ( partnership\)*)12.2 ( )]tj
/c0_0 1 tf
0.042 tc -0.042 tw <026a090e157f08f80e8309070bf40e3804b30f1f03a50fab03860e38>tj
/t1_2 1 tf
0 tc 0 tw (\()tj
/c0_0 1 tf
0.042 tc -0.042 tw 31.223 0 td
<03de082203a50fab>tj
/t1_0 1 tf
0.054 tc 0.07 tw [(\))12.2 ( \(the)12.2 ( \223)]tj
/t1_1 1 tf
-0.054 tw [(int)29 ( )]tj
0.027 tc -0.027 tw -31.223 -1.167 td
(fund)tj
/t1_0 1 tf
0.081 tw [(\224\))2 ( in)2 ( )0.5 (the)2 ( )0.5 (amount)2 ( )0.5 (of)2 ( )0.5 (rmb)2 (5)2 (0)2 (.)2 (0)2 (0)2 ( )0.5 (million;)2 ( )0.5 (and)2 ( )0.5 (\(ii\))2 ( )0.5 (the)2 ( )0.5 (subscription)2 ( )0.5 (of)2 ( )0.5 (limited)2 ( )0.5 (partnership)2 ( )]tj
0.025 tc 0.017 tw 0 -1.167 td
(interests by the company in jingning huaige ruixin venture investment pa\
rtnership \(limited )tj
0.076 tc -0.076 tw 0 -1.167 td
[(partnership\)*)12.6 ( )]tj
/c0_0 1 tf
0.063 tc -0.063 tw 6.757 0 td
<0c7b0fb9157f08f80e7f06a60bf40e3804b30f1f03a50fab03860e38>tj
/t1_0 1 tf
0 tc 0 tw (\()tj
/c0_0 1 tf
0.063 tc -0.063 tw 15.283 0 td
<03de082203a50fab>tj
/t1_0 1 tf
0.076 tc 0.07 tw [(\))12.7 ( \(the)12.6 ( \223)]tj
/t1_1 1 tf
[(ruixin)12.7 ( fund)]tj
/t1_0 1 tf
[(\224\))12.7 ( in)12.7 ( the)51 ( )]tj
0.03 tc 0.078 tw -22.041 -1.167 td
[(amount)5.1 ( )0.5 (of)5 ( )0.5 (rmb)5 (5)5 (0)5 (.)5 (0)5 (0)5 ( )0.5 (million)5 ( )0.5 (\(together,)5.1 ( the)5 ( )0.5 (\223)]tj
/t1_1 1 tf
-0.03 tw (subscriptions)tj
/t1_0 1 tf
0.078 tw [(\224\).)5 ( )0.5 (the)5 ( )0.5 (subscriptions)5 ( )0.5 (have)5 ( )0.5 (been)5 ( )]tj
0.025 tc 0 tw -0 -1.167 td
(approved by the shareholders of the company \(the \223)tj
/t1_1 1 tf
-0.025 tw (shareholders)tj
/t1_0 1 tf
0 tw (\224\) on june 23, 2020.)tj
0.043 tc 0.07 tw 0 -2.333 td
[(the)12.8 ( ruixin)12.8 ( fund)12.8 ( was)12.8 ( registered)12.8 ( in)12.9 ( the)12.8 ( prc)12.9 ( as)12.8 ( a)12.8 ( limited)12.8 ( partnership)12.8 ( with)12.8 ( the)12.8 ( objective)12.8 ( of)18 ( )]tj
0.036 tc 0.072 tw 0 -1.167 td
[(investments)11 ( )0.5 (in)11 ( equity)11 ( )0.5 (interest)11 ( )0.5 (of)11 ( )0.5 (entities)11 ( )0.5 (in)10.9 ( )0.6 (the)11 ( )0.6 (medical)11 ( )0.5 (devices,)11 ( )0.5 (pharmaceutical,)11 ( )0.5 (biologics,)11 ( )]tj
0.031 tc 0.077 tw 0 -1.167 td
[(m)0.5 (e)0.6 (d)0.5 (i)0.5 (c)0.6 (a)0.5 (l)6 ( )0.5 (s)0.6 (e)0.5 (r)0.5 (v)0.6 (i)0.5 (c)0.5 (e)0.6 (s)6 ( )0.5 (a)0.5 (n)0.6 (d)6 ( )0.5 (c)0.5 (o)0.6 (n)0.5 (t)0.5 (r)0.6 (a)0.5 (c)0.5 (t)6 ( )0.5 (r)0.6 (e)0.5 (s)0.6 (e)0.5 (a)0.6 (r)0.5 (c)0.5 (h)6 ( )0.5 (o)0.6 (r)0.5 (g)0.6 (a)0.5 (n)0.5 (i)0.6 (z)0.5 (a)0.5 (t)0.6 (i)0.5 (o)0.5 (n)6 ( )0.5 (s)0.6 (e)0.5 (r)0.6 (v)0.5 (i)0.5 (c)0.6 (e)0.5 (s)6 ( )0.5 (i)0.5 (n)0.6 (d)0.5 (u)0.5 (s)0.6 (t)0.5 (r)0.5 (i)0.6 (e)0.5 (s)6 ( )0.5 (m)0.6 (a)0.5 (i)0.5 (n)0.6 (l)0.5 (y)6 ( )0.5 (i)0.5 (n)6 ( )0.5 (t)0.6 (h)0.5 (e)6 ( )0.5 (p)0.5 (r)0.6 (c)6 ( )]tj
0.025 tc 0 tw t*
(with a focus of investing in other equity funds in the medical device an\
d biomedical fields.)tj
0.023 tc 0 -2.333 td
[(as at the date of this announcement, the establishment of the ruixin fun\
d has been completed.)-2 ( )]tj
0.025 tc 0.028 tw 0 -1.167 td
(the company paid rmb1.00 million of capital contribution on june 23, 202\
0 and rmb24.00 )tj
0.04 tc 0.07 tw 0 -1.167 td
[(million)12.9 ( of)12.8 ( capital)12.8 ( contribution)12.8 ( on)12.8 ( july)12.9 ( 2)12.8 (4)12.8 (,)12.9 ( 2)12.8 (0)12.8 (2)12.9 (0)12.8 (.)12.8 ( the)12.8 ( remaining)12.8 ( capital)12.9 ( contribution)12.8 ( of)12.8 ( the)15 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(ruixin fund shall be paid within twelve months after the initial instalm\
ent.)tj
0.035 tc 0.073 tw 0 -2.333 td
[(the)10.1 ( )0.5 (primary)10 ( )0.5 (objective)10 ( )0.5 (of)10 ( )0.5 (int)10 ( )0.5 (fund)10 ( )0.5 (is)10.1 ( )0.5 (venture)10 ( )0.6 (investment)10 ( )0.5 (in,)10 ( )0.5 (among)10 ( )0.5 (others,)10 ( )0.5 (equity)10 ( )0.5 (interests,)10 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(convertible loans and/or financial assets in relation to start-ups or ea\
rly-stage businesses in the )tj
0.02 tw t*
(medical devices industry mainly in the prc. the investment priorities of\
the int fund include )tj
0.039 tc 0.07 tw 0 -1.167 td
[(start-ups)12.7 ( or)12.7 ( early-stage)12.7 ( businesses)12.7 ( principally)12.7 ( engaged)12.7 ( in)12.7 ( the)12.8 ( research)12.8 ( and)12.7 ( development)12.7 ( of)14 ( )]tj
0.038 tc 0 -1.167 td
[(cardiovasc)0.5 (ular)12.9 ( interventional)12.9 ( d)0.5 (evices,)12.9 ( neuro)12.9 ( inter)0.5 (ventional)12.9 ( procedura)0.5 (l)12.8 ( )0.5 (me)0.5 (dical)12.9 ( devices)12.9 ( )0.5 (and)13 ( )]tj
0.025 tc 0 tw t*
(other interventional medical devices.)tj
0.055 tw 0 -2.333 td
(on august 14, 2020, all partners of the int fund entered into the int lp\
a, pursuant to which )tj
0.056 tc 0.07 tw 0 -1.167 td
[(the)12.2 ( company\222s)12.2 ( capital)12.2 ( contribution)12.2 ( commitment)12.2 ( was)12.2 ( rmb)12.1 (5)12.2 (0)12.2 (.)12.2 (0)12.1 (0)12.2 ( million)12.2 ( which)12.1 ( shall)12.2 ( be)31.1 ( )]tj
0.025 tc 0.034 tw 0 -1.167 td
(payable on or before december 31, 2021. on august 18, 2020, the int fund\
was registered in )tj
0 tw 0 -1.167 td
(the prc as a limited partnership.)tj
et
endstream
endobj
78 0 obj
<>
endobj
79 0 obj
<>
endobj
80 0 obj
<>stream
h�l�?ha�w.�
�!��� ��1ƽ3q�� �@8�b)ln�1�3��9�� �x$�d; �xh;k ��n��j�2w8����=� r�!4r�rca�r�jb,檁�.�cqh�[n�e�lv�;�)c���o� '���7��)'���l�5[�,�h�\*^ o�z��dk�t'sm��b��:q(l�lė0-!q,`��o2 j �0�h@����|-y�u�a�0�q�w��a�p&[m ek�m`�x&�
râ �0o�tbh#��k߭�i
��8l��s0]�\��g���#nddj�0*��i�cz0ķox<�?ߎ����[a51w �uǿ#n��s��t��.�z�;���vo��v�s��i�9�~��go%��1�w ���6ֻ���l&q�j�w|����v��|>o���q�{w�xν���i�|=b�����q�����/��'[��-��b���^m�ן
�=�{�1`�l
endstream
endobj
76 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 14 \226)tj
/t1_1 1 tf
-18.766 58.583 td
(management discussion and analysis)tj
0 -2.333 td
(business overview)tj
/t1_0 1 tf
0.033 tw 0 -2.333 td
[(we )0.6 (are )0.5 (a )0.6 (leading )0.5 (chinese )0.5 (cardiovascular )0.6 (interventional )0.6 (device )0.5 (manufacturer )0.6 (as )0.5 (well )0.5 (as )0.6 (one )0.5 (of )]tj
0.078 tc 0.07 tw 0 -1.167 td
[(t)0.5 (h)0.5 (e)13 ( )0.5 (f)0.5 (e)0.5 (w)13 ( )0.5 (m)0.5 (e)0.5 (d)0.5 (i)0.5 (c)0.5 (a)0.5 (l)13 ( )0.5 (d)0.5 (e)0.5 (v)0.5 (i)0.5 (c)0.5 (e)13 ( )0.5 (g)0.5 (r)0.5 (o)0.5 (u)0.5 (p)0.5 (s)13 ( )0.5 (t)0.5 (h)0.5 (a)0.5 (t)13 ( )0.5 (c)0.5 (o)0.5 (v)0.5 (e)0.5 (r)13 ( )0.5 (th)0.5 (e)13 ( )0.6 (e)0.5 (n)0.5 (ti)0.5 (r)0.5 (e)13 ( )0.5 (i)0.5 (n)0.5 (d)0.5 (u)0.5 (s)0.5 (t)0.5 (r)0.5 (y)13 ( )0.5 (c)0.5 (h)0.5 (a)0.5 (i)0.5 (n)13 ( )0.5 (f)0.5 (r)0.5 (o)0.5 (m)13 ( )0.5 (d)0.5 (e)0.5 (s)0.5 (i)0.5 (g)0.5 (n)13 ( )0.5 (a)0.5 (n)0.5 (d)53 ( )]tj
0.025 tc 0.049 tw 0 -1.167 td
(development of mold and equipment, product injection, product assembly, \
product packaging )tj
0 tw 0 -1.167 td
(to sterilisation in the prc. our major products are primarily used for c\
ardiovascular surgeries, )tj
t*
(in particular percutaneous coronary intervention procedures.)tj
0.065 tc 0.07 tw 0 -2.333 td
[(the)12.9 ( group\222s)12.9 ( revenue)12.8 ( in)12.9 ( the)12.9 ( re)0.5 (porting)12.9 ( period)12.9 ( was)12.9 ( approximately)12.9 ( rmb)12.9 (1)12.9 (7)12.9 (1)12.9 (.)12.8 (8)12.9 (4)12.9 ( million,)40 ( )]tj
0.042 tc 0 -1.167 td
[(representing)12.3 ( an)12.3 ( increase)12.3 ( of)12.3 ( approximately)12.3 ( 2)12.3 (7)12.2 (.)12.4 (2)12.2 (3)12.3 (%)12.3 ( or)12.3 ( approximately)12.3 ( rmb)12.3 (3)12.3 (6)12.3 (.)12.3 (7)12.3 (7)12.3 ( million)12.3 ( as)17 ( )]tj
0.025 tc 0.013 tw 0 -1.167 td
(compared to approximately rmb135.07 million for the six-month period end\
ed june 30, 2019 )tj
0.061 tc 0.07 tw 0 -1.167 td
[(ma)0.5 (i)0.5 (nl)0.5 (y)13 ( d)0.5 (u)0.5 (e)12.9 ( )0.5 (t)0.5 (o)12.9 ( )0.5 (th)0.5 (e)13 ( c)0.5 (o)0.5 (nt)0.5 (r)0.5 (ib)0.5 (ut)0.5 (i)0.5 (on)13 ( f)0.5 (r)0.5 (om)13 ( )0.5 (th)0.5 (e)13 ( m)0.5 (a)0.5 (nu)0.5 (fa)0.5 (c)0.5 (tu)0.5 (r)0.5 (in)0.5 (g)13 ( a)0.5 (n)0.5 (d)12.9 ( )0.5 (sa)0.5 (l)0.5 (es)13 ( )0.5 (of)13 ( )0.5 (ma)0.5 (s)0.5 (ks)0.5 (.)13 ( d)0.5 (u)0.5 (ri)0.5 (ng)13 ( )0.5 (th)0.5 (e)36 ( )]tj
0.025 tc 0.071 tw t*
[(reporting period, the revenue generated from sales of masks )0.5 (was approximately rmb 43.68 )]tj
0.052 tc 0.07 tw 0 -1.167 td
[(million,)12.1 ( accounting)12.1 ( for)12.2 ( approximately)12.1 ( 2)12.1 (5)12.1 (.)12.1 (4)12.1 (2)12.2 (%)12.1 ( of)12.2 ( the)12.1 ( total)12.2 ( revenue)12.2 ( during)12.1 ( the)12.2 ( reporting)27 ( )]tj
0.025 tc -0.025 tw 0 -1.167 td
(period. )tj
/t1_1 1 tf
0 tw 0 -2.333 td
(comprehensive medical device registration certificates)tj
/t1_0 1 tf
0.081 tc 0.07 tw 0 -2.333 td
[(during)12.7 ( the)12.7 ( reporting)12.7 ( period,)12.6 ( the)12.7 ( group)12.6 ( has)12.6 ( obtained)12.7 ( 2)12.7 ( shanghai)12.6 ( medical)12.6 ( products)56 ( )]tj
0.053 tc 0 -1.167 td
[(administration)12.4 ( registration)12.5 ( certificates)12.5 ( for)12.5 ( class)12.5 ( ii)12.5 ( medical)12.5 ( devices)12.5 ( and)12.5 ( 3)12.4 ( european)12.5 ( ce)28 ( )]tj
0.049 tc 0 -1.167 td
[(certificates.)12.7 ( as)12.7 ( at)12.7 ( june)12.7 ( 3)12.7 (0)12.7 (,)12.6 ( 2)12.7 (0)12.7 (2)12.7 (0)12.6 (,)12.7 ( we)12.7 ( have)12.7 ( an)12.7 ( aggregate)12.7 ( of)12.7 ( 1)12.7 (6)12.7 ( national)12.7 ( medical)12.6 ( products)24 ( )]tj
0.033 tc 0.075 tw t*
[(administration)8 ( )0.5 (of)8 ( )0.5 (china)8 ( )0.5 (registration)8 ( )0.5 (certificates)8 ( )0.5 (for)8 ( )0.5 (class)8 ( )0.5 (iii)8 ( )0.5 (medical)8 ( )0.5 (devices,)8 ( )0.5 (1)8 (4)8 ( )0.5 (shanghai)8 ( )]tj
0.044 tc 0.07 tw 0 -1.167 td
[(medical)12.7 ( products)12.6 ( administration)12.6 ( registration)12.6 ( certificates)12.6 ( for)12.6 ( class)12.6 ( ii)12.6 ( medical)12.6 ( devices,)12.6 ( 3)12.7 (5)19 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(european ce certificates and 10 united states food and drug administrati\
on approvals.)tj
/t1_1 1 tf
0 -2.333 td
(strong research and development capabilities)tj
/t1_0 1 tf
0.002 tw 0 -2.333 td
(the company is a state-level high and new technology enterprise \()tj
/c0_0 1 tf
-0.025 tw <0a370895097409f70e2d04a60b9403860e38>tj
/t1_0 1 tf
0.002 tw (\). our )tj
0.08 tw 0 -1.167 td
(research and development team consists of professionals who possess doct\
orate degrees and )tj
0.048 tw 0 -1.167 td
(master\222s degrees and numerous talents who have over 10 years of exper\
ience in research and )tj
0.051 tc 0.07 tw t*
[(development)12.5 ( of)12.5 ( production,)12.5 ( with)12.5 ( adequate)12.4 ( capabilities)12.5 ( in)12.5 ( the)12.5 ( development)12.5 ( of)12.5 ( innovation)26 ( )]tj
0.025 tc 0.053 tw 0 -1.167 td
(products and sustainable improvement of research and development. as at \
june 30, 2020, we )tj
0 tw 0 -1.167 td
(have 92 registered patents, 91 patents under application and 5 registere\
d softwares.)tj
/t1_1 1 tf
0 -2.333 td
(extensive distribution and sales network)tj
/t1_0 1 tf
0.065 tc 0.07 tw 0 -2.333 td
[(w)0.5 (e)13 ( )0.5 (h)0.5 (av)0.5 (e)13 ( )0.5 (a)0.5 (n)13 ( )0.5 (e)0.5 (xt)0.5 (e)0.5 (n)0.5 (s)0.5 (i)0.5 (ve)13 ( )0.5 (d)0.5 (i)0.5 (s)0.5 (t)0.5 (ri)0.5 (b)0.5 (u)0.5 (t)0.5 (io)0.5 (n)13 ( )0.5 (n)0.5 (e)0.5 (tw)0.5 (o)0.5 (r)0.5 (k)13 ( )0.5 (a)0.5 (nd)13 ( )0.5 (h)0.5 (a)0.5 (v)0.5 (e)13 ( d)0.5 (e)0.5 (v)0.5 (e)0.5 (l)0.5 (o)0.5 (pe)0.5 (d)13 ( )0.5 (a)0.5 (n)0.5 (d)12.9 ( )0.5 (m)0.5 (a)0.5 (i)0.5 (n)0.5 (ta)0.6 (in)0.5 (e)0.5 (d)13 ( )0.5 (s)0.5 (ta)0.5 (b)0.5 (l)0.5 (e)40 ( )]tj
0.025 tc 0.002 tw 0 -1.167 td
(relationships with our distributors. by the end of june 30, 2020, our pr\
c distributors cover 23 )tj
0.075 tc 0.07 tw 0 -1.167 td
[(\(december)12.9 ( 3)12.9 (1)12.8 (,)12.9 ( 2)12.9 (0)12.8 (1)12.8 (9)12.9 (:)12.8 ( 2)12.8 (3)12.9 (\))12.8 ( provinces,)12.8 ( 4)12.8 ( \(december)12.9 ( 3)12.8 (1)12.9 (,)12.8 ( 2)12.8 (0)12.9 (1)12.8 (9)12.9 (:)12.8 ( 4)12.9 (\))12.8 ( directly-administered)50 ( )]tj
0.032 tc 0.076 tw t*
[(municipalities)7 ( )0.5 (and)7 ( )0.5 (4)7 ( )0.5 (\(december)7 ( )0.5 (3)7 (1)7 (,)7 ( )0.5 (2)7 (0)7 (1)7 (9)7 (:)7 ( )0.5 (4)7 (\))7 ( )0.5 (autonomous)7 ( )0.5 (regions)7 ( )0.5 (in)7 ( )0.5 (the)7 ( )0.5 (prc,)7 ( )0.5 (and)7 ( )0.5 (covering)7 ( )]tj
0.036 tc 0.072 tw 0 -1.167 td
[(1)11 (,)11 (3)11 (4)11 (9)11 ( )0.5 (\()0.5 (d)0.5 (ec)0.5 (e)0.5 (m)0.5 (b)0.5 (e)0.5 (r)11 ( )0.5 (3)11 (1)11 (,)11 ( )0.5 (2)11 (0)11 (1)11 (9)11 (:)11 ( )0.5 (1)11 (,)11 (2)10.9 (3)11 (4)11 (\))11 ( )0.5 (d)0.5 (o)0.5 (m)0.5 (e)0.5 (s)0.5 (ti)0.5 (c)11 ( )0.5 (h)0.5 (o)0.5 (s)0.5 (pi)0.5 (t)0.5 (a)0.5 (l)0.5 (s)11 ( )0.5 (in)11 ( )0.5 (t)0.5 (h)0.5 (e)11 ( )0.5 (p)0.5 (r)0.5 (c)11 ( )0.5 (i)0.5 (nc)0.5 (l)0.5 (u)0.5 (d)0.5 (in)0.5 (g)11 ( )0.5 (6)11 (3)11 (2)11 ( )0.5 (\()0.5 (d)0.5 (e)0.5 (c)0.5 (e)0.5 (mb)0.5 (e)0.5 (r)11 ( )]tj
0.025 tc 0.03 tw 0 -1.167 td
(31, 2019: 612\) tier iii hospitals. in addition, our overseas customers \
cover 47 \(december 31, )tj
0 tw t*
(2019: 44\) countries and regions.)tj
et
endstream
endobj
75 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 13 \226)tj
/t1_1 1 tf
10 0 0 10 56.6929 728.7079 tm
(11)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(investment in funds)tj
0 -2.4 td
(ruixin fund)tj
/t1_0 1 tf
0.01 tw t*
[(according )0.5 (to )0.5 (the )0.5 (company\222s )0.5 (announcements )0.5 (dated )0.5 (19 )0.5 (march )0.5 (2020 )0.5 (and )0.5 (29 )0.5 (april )0.5 (2020 )0.5 (and )0.5 (the )0.5 (circular )0.5 (dated )]tj
0.048 tc 0.07 tw 0 -1.2 td
[(2)12.4 (2)12.3 ( may)12.3 ( 2)12.3 (0)12.4 (2)12.3 (0)12.4 (,)12.3 ( the)12.4 ( company)12.4 ( and)12.4 ( ningbo)12.3 ( huaige)12.3 ( health)12.3 ( investment)12.3 ( management)12.3 ( partnership)12.4 ( \(limited)23 ( )]tj
0.025 tc 0.028 tw t*
(partnership\)* \(as the general partner and fund manager, chinese name a\
s )tj
/c0_0 1 tf
-0.025 tw <0fb9062a157f08f80a040a7004b30f1f104d0b2303a50fab03860e38>tj
/t1_0 1 tf
0 tc 0 tw t*
(\()tj
/c0_0 1 tf
0.025 tc -0.025 tw 0.358 0 td
<03de082203a50fab>tj
/t1_0 1 tf
0.083 tw [(\))-9.8 (, )0.5 (\223)]tj
/t1_1 1 tf
0.035 tc 0.073 tw 5.579 0 td
[(ningbo)10 ( )0.5 (huaige)10 ( )0.5 (health)]tj
/t1_0 1 tf
[(\224\))10.1 ( )0.5 (conditionally)10 ( )0.5 (entered)10 ( )0.5 (into)10 ( )0.5 (the)10 ( )0.5 (ruixin)10 ( )0.5 (subscription)10 ( )0.5 (memorandum)10 ( )]tj
0.025 tc 0.025 tw -5.937 -1.2 td
(\(the \223)tj
/t1_1 1 tf
(ruixin subscription)tj
/t1_0 1 tf
(\224\) in relation to the establishment of, and investment in, jingning \
huaige ruixin )tj
0.038 tc 0.07 tw t*
[(venture)12.2 ( investment)12.2 ( partnership)12.2 ( \(limited)12.3 ( partnership\)*)12.2 ( )]tj
/c0_0 1 tf
0.026 tc -0.026 tw <0c7b0fb9157f08f80e7f06a60bf40e3804b30f1f03a50fab03860e38>tj
/t1_0 1 tf
0 tc 0 tw (\()tj
/c0_0 1 tf
0.026 tc -0.026 tw 39.431 0 td
<03de082203a50fab>tj
/t1_0 1 tf
0.038 tc 0.07 tw [(\))12.3 ( \(the)13 ( )]tj
0 tc 0 tw -39.431 -1.2 td
(\223)tj
/t1_1 1 tf
0.031 tc 0.077 tw 0.475 0 td
[(ruixin)6 ( )0.5 (fund)]tj
/t1_0 1 tf
[(\224\).)6 ( )0.5 (under)6 ( )0.5 (the)6 ( )0.5 (ruixin)6 ( )0.5 (subscription,)6 ( )0.5 (the)6 ( )0.5 (total)6 ( )0.5 (contribution)6.1 ( by)6.1 ( )0.5 (the)6 ( )0.6 (general)6.1 ( )0.5 (partner)6 ( )0.5 (and)6 ( )0.5 (all)6 ( )0.5 (the)6 ( )]tj
0.045 tc 0.07 tw -0.475 -1.2 td
[(limited)12 ( partners)12.1 ( of)12.1 ( the)12 ( ruixin)12.1 ( fund)12.1 ( is)12.1 ( no)12.1 ( less)12.1 ( than)12 ( rmb)12.1 (3)12.1 (0)12 (0)12.1 (.)12.1 (0)12 (0)12.1 ( million)12.1 ( and)12 ( no)12 ( more)12.1 ( than)12.1 ( rmb)12.1 (4)12 (0)12.1 (0)12.1 (.)12 (0)12.1 (0)20 ( )]tj
0.025 tc 0.081 tw t*
[(million, and )0.5 (the capital )0.5 (contribution )0.5 (by )0.5 (the )0.5 (company )0.5 (as a )0.5 (limited partner )0.5 (will be )0.5 (rmb50.00 )0.5 (million. the )]tj
0.032 tc 0.076 tw t*
[(primary)7 ( )0.5 (objective)7 ( )0.5 (of)7 ( )0.5 (the)7 ( )0.5 (ruixin)7 ( )0.5 (fund)7 ( )0.5 (is)7 ( )0.5 (investments)7 ( )0.5 (in)7 ( )0.5 (equity)7 ( )0.5 (interest)7 ( )0.5 (of)7 ( )0.5 (entities)7 ( )0.5 (in)7 ( )0.5 (the)7 ( )0.5 (medical)7 ( )0.5 (devices,)7 ( )]tj
0.025 tc 0.031 tw t*
(pharmaceutical, biologics, medical services and contract research organi\
sation \(\223)tj
/t1_1 1 tf
-0.025 tw (cro)tj
/t1_0 1 tf
0.031 tw (\224\) services industries )tj
0.04 tw t*
(mainly in the prc and investments in other equity funds with focus of in\
vesting in the medical device and )tj
0 tw t*
(biomedical fields.)tj
0.027 tc 0.081 tw 0 -2.4 td
[(on)2 ( 2)2 (9)2 ( )0.5 (april)2 ( )0.5 (2)2 (0)2 (2)1.9 (0)2 (,)2 ( )0.5 (all)2 ( )0.5 (partners)1.9 ( )0.5 (of)2 ( )0.5 (the)2 ( ruixin)2 ( )0.5 (fund)2 ( entered)2 ( )0.5 (into)2 ( )0.5 (a)2 ( )0.5 (partnership)2 ( )0.5 (agreement)2 ( )0.5 (\(\223)]tj
/t1_1 1 tf
[(ruixin)2 ( )0.5 (lpa)]tj
/t1_0 1 tf
-0.027 tw [(\224\).)2 ( )]tj
0.034 tc 0.074 tw 0 -1.2 td
[(pursuant)9 ( )0.5 (to)9 ( )0.5 (ruixin)9 ( )0.5 (lpa,)9 ( )0.5 (the)9 ( )0.5 (company\222s)9 ( )0.5 (capital)9 ( )0.5 (contribution)9 ( )0.5 (commitment)9 ( )0.5 (was)9 ( )0.5 (rmb)9 (5)9 (0)9 (.)9 (0)9 (0)9 ( )0.5 (million)9 ( )0.5 (which)9 ( )]tj
0.025 tc 0 tw t*
(shall be payable on or before 31 december 2021.)tj
0 -2.4 td
(on 7 may 2020, the ruixin fund was registered in the prc as a limited pa\
rtnership.)tj
0.029 tc 0.079 tw t*
[(on)4 ( )0.6 (2)4 (3)4 ( )0.5 (june)4.1 ( )0.5 (2)4 (0)4 (2)4 (0)4 (,)4 ( )0.5 (the)4.1 ( )0.5 (ruix)0.5 (in)4 ( )0.5 (sub)0.5 (scr)0.5 (iptio)0.5 (n)4 ( )0.5 (and)4 ( )0.5 (t)0.5 (he)4 ( )0.5 (ru)0.5 (ixin)4 ( )0.5 (l)0.5 (pa)4 ( )0.5 (we)0.5 (re)4 ( )0.5 (a)0.5 (ppro)0.5 (ved)4 ( )0.5 (by)4 ( )0.6 (the)4 ( )0.5 (s)0.5 (hare)0.5 (hold)0.5 (ers)4 ( )0.5 (o)0.5 (f)4 ( )0.5 (the)4 ( )]tj
0.026 tc 0.082 tw 0 -1.2 td
[(company)1 ( )0.5 (and)1 ( )0.5 (the)1 ( )0.5 (company)1 ( )0.5 (paid)1 ( )0.5 (the)1.1 ( )0.5 (initial)1 ( )0.5 (capital)1 ( )0.5 (call)1.1 ( )0.5 (of)1 ( )0.5 (rmb)1 (1)1 (.)1 (0)1 (0)1 ( )0.5 (million)1 ( )0.5 (to)1 ( )0.5 (the)1 ( )0.5 (ruixin)1 ( )0.5 (fund.)1 ( )0.5 (as)1 ( )0.5 (at)0.9 ( )0.6 (3)1 (0)0.9 ( )]tj
t*
[(june)1 ( )0.6 (2)1 (0)1 (2)1 (0)1 (,)1 ( )0.5 (the)1 ( )0.5 (non-current)1 ( )0.5 (financial)1 ( )0.5 (asset)1 ( )0.5 (at)1 ( )0.5 (fair)1 ( )0.6 (value)1 ( )0.5 (through)1 ( )0.5 (profit)1 ( )0.5 (or)1.1 ( )0.5 (loss)1 ( )0.5 (represents)1 ( )0.5 (the)1 ( )0.5 (investment)1 ( )0.5 (in)1 ( )]tj
0.025 tc 0 tw t*
(ruixin fund.)tj
0 -2.4 td
(on 24 july 2020, the company paid capital call of rmb 24.00 million to t\
he ruixin fund.)tj
/t1_1 1 tf
t*
(int fund)tj
/t1_0 1 tf
0.053 tw t*
[(according to )0.5 (the company\222s )0.5 (announcement )0.5 (dated 19 )0.5 (march 2020 )0.5 (and the circular dated 22 )0.5 (may 2020, the )]tj
0.061 tw 0 -1.2 td
[(company )0.5 (and )0.5 (ningbo )0.5 (huaige )0.6 (health )0.5 (\(as )0.5 (the )0.5 (fund )0.6 (manager\) )0.5 (conditionally )0.6 (entered )0.5 (into )0.5 (the )0.5 (int )0.5 (subscription )]tj
0.038 tc 0.07 tw t*
[(memorandum)12.5 ( \(the)12.5 ( \223)]tj
/t1_1 1 tf
[(int)12.6 ( subscription)]tj
/t1_0 1 tf
[(\224\))12.5 ( in)12.5 ( relation)12.5 ( to)12.5 ( the)12.5 ( establishment)12.5 ( of,)12.5 ( and)12.6 ( investment)12.5 ( in,)12.6 ( shanghai)13 ( )]tj
0.025 tc 0.05 tw t*
(huaige int venture investment partnership \(limited partnership\)* \()tj
/c0_0 1 tf
-0.025 tw <026a090e157f08f80e8309070bf40e3804b30f1f03a50fab03860e38>tj
/t1_0 1 tf
0 tc 0 tw (\()tj
/c0_0 1 tf
0.025 tc -0.025 tw 43.896 0 td
<03de0822>tj
-43.896 -1.2 td
<03a50fab>tj
/t1_0 1 tf
0.009 tw (\)\)\(the \223)tj
/t1_1 1 tf
(int fund)tj
/t1_0 1 tf
(\224\). under the int subscription, the total capital contribution by th\
e general partner and )tj
0.048 tw t*
(all the limited partners of the int fund is not less than rmb110.00 mill\
ion and not more than rmb200.00 )tj
0 tw t*
(million, and the capital contribution by the company as a limited partne\
r will be rmb50.00 million.)tj
0.036 tc 0.072 tw 0 -2.4 td
[(the)11.1 ( )0.5 (primary)11 ( )0.5 (objective)11.1 ( )0.5 (of)11 ( )0.5 (int)11 ( )0.5 (fund)11 ( )0.5 (is)11 ( )0.6 (venture)11 ( )0.5 (investments)11 ( )0.5 (in,)11 ( )0.5 (among)11 ( )0.5 (others,)10.9 ( )0.5 (equity)11 ( )0.5 (interests,)11 ( )0.5 (convertible)11 ( )]tj
0.025 tc 0 tw 0 -1.2 td
(loans and/or financial assets in relation to start-ups or early-stage bu\
sinesses in the medical devices industry )tj
0.036 tc 0.072 tw t*
[(mainly)10.9 ( )0.6 (in)11 ( )0.5 (the)11 ( )0.5 (prc.)11 ( )0.5 (the)11 ( )0.5 (investment)11 ( )0.5 (priorities)11.1 ( )0.5 (of)11 ( )0.5 (the)11 ( )0.5 (int)11 ( )0.5 (fund)11 ( )0.5 (include)11 ( )0.5 (start-ups)11.1 ( )0.5 (or)11 ( )0.5 (early-stage)11 ( )0.5 (businesses)11 ( )]tj
0.053 tc 0.07 tw t*
[(principally)12.5 ( engaged)12.6 ( in)12.6 ( the)12.6 ( research)12.6 ( and)12.6 ( development)12.6 ( of)12.5 ( cardiovascular)12.5 ( interventional)12.6 ( devices,)12.5 ( neuro)28 ( )]tj
0.025 tc 0 tw t*
(interventional procedural medical devices and other interventional medic\
al devices.)tj
0 -2.4 td
(the int subscription was approved by the shareholder of the company on 2\
3 june 2020. )tj
0.007 tw t*
[(on )0.6 (14 )0.6 (august )0.5 (2020, )0.5 (all )0.6 (partners )0.5 (of )0.6 (the )0.5 (int )0.5 (fund )0.6 (entered )0.5 (into )0.5 (a )0.6 (partnership )0.5 (agreement )0.6 (\(\223)]tj
/t1_1 1 tf
[(int )0.5 (lpa)]tj
/t1_0 1 tf
[(\224\), )0.6 (pursuant )]tj
0 tw 0 -1.2 td
[(t)0.5 (o)0.5 ( )0.5 (w)0.5 (h)0.5 (ic)0.6 (h )0.5 (t)0.5 (h)0.5 (e)0.5 ( )0.5 (c)0.5 (o)0.5 (m)0.5 (pa)0.6 (ny)0.5 (\222)0.5 (s)0.5 ( )0.5 (c)0.5 (a)0.5 (p)0.5 (i)0.5 (t)0.5 (a)0.5 (l)0.5 ( c)0.6 (on)0.5 (t)0.5 (r)0.5 (i)0.5 (b)0.5 (u)0.5 (t)0.5 (i)0.5 (on)0.5 ( )0.5 (c)0.5 (o)0.5 (m)0.5 (m)0.5 (i)0.5 (t)0.5 (m)0.5 (en)0.5 (t)0.5 ( )0.5 (w)0.5 (a)0.5 (s)0.5 ( )0.5 (r)0.5 (m)0.5 (b)0.5 (5)0.5 (0)0.5 (.0)0.5 (0)0.5 ( )0.5 (m)0.5 (i)0.5 (l)0.5 (l)0.5 (i)0.5 (on)0.5 ( )0.5 (w)0.5 (h)0.5 (i)0.5 (c)0.5 (h)0.5 ( )0.5 (s)0.5 (h)0.5 (a)0.5 (l)0.5 (l )0.5 (b)0.5 (e)0.5 ( )0.5 (p)0.5 (a)0.5 (y)0.5 (a)0.5 (b)0.5 (l)0.5 (e)0.5 ( )0.5 (on )]tj
0.043 tc 0.07 tw t*
[(or)12.1 ( before)12.1 ( 3)12.1 (1)12.2 ( december)12.1 ( 2)12.1 (0)12.1 (2)12.1 (1)12.1 (.)12.1 ( on)12.1 ( 1)12.1 (8)12.1 ( august)12.1 ( 2)12.1 (0)12.1 (2)12.1 (0)12.1 (,)12.1 ( the)12.2 ( int)12.1 ( fund)12.1 ( was)12.1 ( registered)12.1 ( in)12.1 ( the)12.1 ( prc)12.1 ( as)12.1 ( a)12.1 ( limited)18 ( )]tj
0.025 tc -0.025 tw t*
(partnership.)tj
et
endstream
endobj
74 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 12 \226)tj
/t1_1 1 tf
10 0 0 10 56.6929 728.7079 tm
(9)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(trade and other payables)tj
33.148 -2.4 td
(at 30 june)tj
-0.025 tw 2.761 -1.2 td
(2020)tj
/t1_0 1 tf
0 tw 3.078 1.2 td
(at 31 december)tj
-0.025 tw 4.859 -1.2 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_0 1 tf
0 tw -41.883 -2.4 td
(trade payables)tj
/t1_1 1 tf
-0.025 tw 35.109 0 td
(18,123)tj
/t1_0 1 tf
7.937 0 td
(16,430)tj
0 tw -43.046 -1.2 td
(payroll payables)tj
/t1_1 1 tf
-0.025 tw 35.109 0 td
(13,350)tj
/t1_0 1 tf
7.937 0 td
(14,754)tj
0 tw -43.046 -1.2 td
(amounts due to related parties)tj
/t1_1 1 tf
-0.025 tw 36.434 0 td
(186)tj
/t1_0 1 tf
7.937 0 td
(277)tj
-44.371 -1.2 td
(others)tj
/t1_1 1 tf
35.109 0 td
(15,841)tj
/t1_0 1 tf
7.937 0 td
(11,127)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 391.1811 616.2489 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 616.0159 tm
( )tj
et
q 1 0 0 1 470.5511 616.2489 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8819 616.0159 tm
( )tj
0.025 tc 10 0 0 10 79.37 593.6989 tm
(total trade and other payables)tj
/t1_1 1 tf
-0.025 tw 35.109 0 td
(47,500)tj
/t1_0 1 tf
7.937 0 td
(42,588)tj
et
1.11 w
q 1 0 0 1 391.181 589.048 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.181 586.948 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5117 586.6201 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 589.048 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 586.948 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 586.6201 tm
( )tj
0.025 tc 10 0 0 10 79.3701 566.0031 tm
(all of the trade and other payables are expected to be settled within on\
e year.)tj
/t1_1 1 tf
0 -2.4 td
(\(a\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(ageing analysis)tj
/t1_0 1 tf
0.022 tw t*
(as of the end of the reporting period, the ageing analysis of trade paya\
bles, based on the invoice date, )tj
0 tw 0 -1.2 td
(is as follows:)tj
/t1_1 1 tf
30.881 -2.4 td
(at 30 june)tj
-0.025 tw 2.761 -1.2 td
(2020)tj
/t1_0 1 tf
0 tw 3.078 1.2 td
(at 31 december )tj
-0.025 tw 4.859 -1.2 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_0 1 tf
0 tw -39.616 -2.4 td
(within 3 months)tj
/t1_1 1 tf
-0.025 tw 32.842 0 td
(15,499)tj
/t1_0 1 tf
7.937 0 td
(16,116)tj
0 tw -40.779 -1.2 td
(3 to 6 months)tj
/t1_1 1 tf
-0.025 tw 33.367 0 td
(1,287)tj
/t1_0 1 tf
8.737 0 td
(152)tj
0 tw -42.104 -1.2 td
(6 months to 1 year)tj
/t1_1 1 tf
-0.025 tw 33.367 0 td
(1,239)tj
/t1_0 1 tf
9.262 0 td
(19)tj
0 tw -42.629 -1.2 td
(over 1 year)tj
/t1_1 1 tf
-0.025 tw 34.692 0 td
(98)tj
/t1_0 1 tf
7.412 0 td
(143)tj
et
0.5 w
q 1 0 0 1 391.1811 393.544 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 393.311 tm
( )tj
et
q 1 0 0 1 470.5511 393.544 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8819 393.311 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 10 0 0 10 430.4625 370.994 tm
(18,123)tj
/t1_0 1 tf
7.937 0 td
(16,430)tj
et
1.11 w
q 1 0 0 1 391.181 366.3432 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.181 364.2432 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5117 363.9152 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 366.3432 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 364.2432 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 363.9152 tm
( )tj
/t1_1 1 tf
0.025 tc 0.943 tw 10 0 0 10 56.6928 343.2982 tm
(10)tj
/span<>> bdc
( )tj
emc
(dividends)tj
/t1_0 1 tf
0.05 tc 0.07 tw 2.268 -2.4 td
[(dividends)12.4 ( payable)12.4 ( to)12.4 ( equity)12.4 ( shareholders)12.4 ( of)12.4 ( the)12.4 ( company)12.4 ( attributable)12.4 ( to)12.4 ( the)12.4 ( previous)12.4 ( financial)12.4 ( year,)25.1 ( )]tj
0.025 tc 0 tw t*
(approved and paid during the interim period.)tj
/t1_1 1 tf
-0.025 tw 35.909 -2.4 td
(2020)tj
/t1_0 1 tf
7.937 0 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_0 1 tf
0 tw -41.883 -2.4 td
(final dividend in respect of the previous financial year, approved and )tj
1.001 -1.2 td
(paid during the interim period, rmb0.175 per ordinary share \(2019: )tj
t*
(rmb1.27 per ordinary share\))tj
/t1_1 1 tf
-0.025 tw 34.109 0 td
(29,050)tj
/t1_0 1 tf
7.937 0 td
(53,382)tj
et
1.11 w
q 1 0 0 1 391.181 218.6474 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.181 216.5474 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5117 216.2194 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 218.6474 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 216.5474 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 216.2194 tm
( )tj
0.043 tc 0.07 tw 10 0 0 10 79.3699 195.6023 tm
[(pursuant)12.2 ( to)12.3 ( the)12.3 ( shareholders\222)12.3 ( approval)12.3 ( of)12.3 ( the)12.3 ( company)12.3 ( held)12.3 ( on)12.3 ( 1)12.3 (8)12.3 ( may)12.3 ( 2)12.3 (0)12.3 (2)12.2 (0)12.3 (,)12.3 ( a)12.3 ( final)12.3 ( cash)12.3 ( dividend)12.3 ( of)18 ( )]tj
0.025 tc 0.032 tw t*
(rmb0.175 per share in respect of the year ended 31 december 2019 based o\
n 166,000,000 ordinary shares )tj
0 tw t*
(totaling amount of rmb29,050,000 was declared and paid during the six-mo\
nth period ended 30 june 2020.)tj
et
endstream
endobj
73 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 11 \226)tj
/t1_1 1 tf
10 0 0 10 56.6929 728.7079 tm
(7)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(earnings per share)tj
/t1_0 1 tf
0.06 tc 0.07 tw 0 -2.4 td
[(t)0.5 (h)0.5 (e)12.9 ( )0.5 (c)0.5 (a)0.5 (l)0.5 (cu)0.5 (l)0.5 (a)0.5 (ti)0.5 (o)0.5 (n)13 ( o)0.5 (f)13 ( )0.5 (ba)0.5 (s)0.5 (i)0.5 (c)13 ( a)0.5 (n)0.5 (d)13 ( d)0.5 (i)0.5 (lu)0.5 (t)0.5 (e)0.5 (d)13 ( e)0.5 (a)0.5 (r)0.5 (ni)0.5 (n)0.5 (g)0.5 (s)12.9 ( )0.5 (p)0.5 (e)0.5 (r)13 ( s)0.5 (h)0.5 (a)0.5 (re)13 ( )0.5 (i)0.5 (s)13 ( b)0.5 (a)0.5 (s)0.5 (e)0.5 (d)12.9 ( )0.5 (o)0.5 (n)13 ( t)0.5 (h)0.5 (e)12.9 ( )0.5 (p)0.5 (r)0.5 (o)0.5 (fi)0.5 (t)13 ( a)0.5 (t)0.5 (t)0.5 (r)0.5 (ib)0.5 (u)0.5 (ta)0.5 (b)0.5 (l)0.5 (e)13 ( t)0.5 (o)13 ( )0.5 (eq)0.5 (u)0.5 (i)0.5 (ty)35 ( )]tj
0.025 tc 0.016 tw 0 -1.2 td
(shareholders of the company of rmb67,393,000 \(six-month period ended 30\
june 2019: rmb47,266,000\), )tj
0.033 tw t*
(and the weighted average number of shares of 166,000,000 \(2019: 120,000\
,000\) in issue during the interim )tj
-0.025 tw t*
(period.)tj
0.027 tc 0.081 tw 0 -2.4 td
[(there)2 ( )0.5 (were)2 ( )0.5 (no)2 ( )0.5 (potential)2.1 ( dilutive)2 ( )0.5 (ordinary)2 ( )0.5 (shares)2 ( )0.5 (during)2 ( )0.5 (the)2 ( )0.5 (interim)2 ( )0.5 (period)2 ( )0.5 (and)2 ( therefore)2 ( )0.5 (dilutive)2 ( )0.5 (earnings)2 ( )]tj
0.025 tc 0 tw 0 -1.2 td
(per share are the same as the basic earnings per share.)tj
/t1_1 1 tf
-2.268 -2.4 td
(8)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(trade and other receivables)tj
33.148 -2.4 td
(at 30 june)tj
-0.025 tw 2.761 -1.2 td
(2020)tj
/t1_0 1 tf
0 tw 3.078 1.2 td
(at 31 december)tj
-0.025 tw 4.859 -1.2 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_0 1 tf
0 tw -41.883 -4.8 td
(receivables from third parties)tj
/t1_1 1 tf
-0.025 tw 35.109 0 td
(12,847)tj
/t1_0 1 tf
7.937 0 td
(11,507)tj
0 tw -43.046 -1.2 td
(receivables from related parties)tj
/t1_1 1 tf
-0.025 tw 35.634 0 td
(3,413)tj
/t1_0 1 tf
7.937 0 td
(3,254)tj
0 tw -43.571 -1.2 td
(less: losses allowance on trade receivables)tj
/t1_1 1 tf
-0.025 tw 36.576 0 td
(\(73\))tj
/t1_0 1 tf
7.937 0 td
(\(60\))tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 391.181 484.2489 cm
0 0 m
68.031 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5117 484.0159 tm
( )tj
et
q 1 0 0 1 470.5511 484.2489 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 484.0159 tm
( )tj
0.025 tc 10 0 0 10 79.3699 461.6989 tm
(trade receivables, net of loss allowance)tj
/t1_1 1 tf
-0.025 tw 35.109 0 td
(16,187)tj
/t1_0 1 tf
7.937 0 td
(14,701)tj
0 tw -43.046 -2.4 td
(other receivables)tj
/t1_1 1 tf
-0.025 tw 36.434 0 td
(168)tj
/t1_0 1 tf
7.937 0 td
(238)tj
et
q 1 0 0 1 391.1809 433.2398 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5116 433.0068 tm
( )tj
et
q 1 0 0 1 470.551 433.2398 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8817 433.0068 tm
( )tj
0.025 tc 10 0 0 10 79.3698 410.6898 tm
(trade and other receivables, net)tj
/t1_1 1 tf
-0.025 tw 35.109 0 td
(16,355)tj
/t1_0 1 tf
7.937 0 td
(14,939)tj
et
1.11 w
q 1 0 0 1 391.1808 406.039 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1808 403.939 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5116 403.611 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5509 406.039 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5509 403.939 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8817 403.611 tm
( )tj
/t1_1 1 tf
0.025 tc 10 0 0 10 79.3698 382.994 tm
(\(a\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(ageing analysis)tj
/t1_0 1 tf
0.029 tc 0.079 tw 0 -2.4 td
[(a)0.5 (s)4 ( )0.5 (o)0.5 (f)4 ( )0.5 (t)0.5 (h)0.5 (e)4 ( )0.5 (e)0.5 (n)0.5 (d)4 ( )0.5 (o)0.5 (f)4 ( )0.5 (t)0.5 (h)0.5 (e)4 ( )0.5 (r)0.5 (e)0.5 (p)0.5 (o)0.5 (rt)0.5 (i)0.5 (n)0.5 (g)4 ( )0.5 (p)0.5 (e)0.5 (r)0.5 (i)0.5 (od)0.5 (,)4 ( )0.5 (t)0.5 (h)0.5 (e)4 ( )0.5 (a)0.5 (g)0.5 (e)0.5 (i)0.5 (n)0.5 (g)4 ( )0.5 (a)0.5 (n)0.5 (a)0.5 (l)0.5 (y)0.5 (s)0.5 (is)4 ( )0.6 (of)4.1 ( )0.5 (tr)0.5 (a)0.5 (d)0.5 (e)4 ( )0.5 (r)0.5 (e)0.5 (c)0.5 (e)0.5 (i)0.5 (v)0.5 (a)0.5 (b)0.5 (l)0.5 (e)0.5 (s)0.5 (,)4 ( )0.5 (b)0.5 (as)0.5 (e)0.5 (d)4 ( )0.6 (on)4 ( )0.5 (t)0.5 (h)0.5 (e)4 ( )0.5 (i)0.5 (n)0.5 (v)0.5 (o)0.5 (ic)0.5 (e)4.1 ( )]tj
0.025 tc 0 tw 0 -1.2 td
(date and net of loss allowance, is as follows:)tj
/t1_1 1 tf
30.881 -2.4 td
(at 30 june)tj
-0.025 tw 2.761 -1.2 td
(2020)tj
/t1_0 1 tf
0 tw 3.078 1.2 td
(at 31 december)tj
4.584 -1.2 td
( 2019)tj
/t1_2 1 tf
-0.025 tw -9.793 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_0 1 tf
0 tw -39.616 -2.4 td
(within 3 months)tj
/t1_1 1 tf
-0.025 tw 32.842 0 td
(15,936)tj
/t1_0 1 tf
7.937 0 td
(13,598)tj
0 tw -40.779 -1.2 td
(3 to 6 months)tj
/t1_1 1 tf
-0.025 tw 34.692 0 td
(49)tj
/t1_0 1 tf
6.612 0 td
(1,103)tj
0 tw -41.304 -1.2 td
(6 to 9 months)tj
/t1_1 1 tf
-0.025 tw 34.167 0 td
(202)tj
/t1_0 1 tf
0 tc 0 tw 8.987 0 td
(\226)tj
et
0.5 w
q 1 0 0 1 391.1808 246.5349 cm
0 0 m
68.031 0 l
s
q
bt
/t1_1 1 tf
0.1 0 0 0.1 385.5115 246.3019 tm
( )tj
et
q 1 0 0 1 470.5509 246.5349 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8816 246.3019 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 10 0 0 10 430.4622 223.9849 tm
(16,187)tj
/t1_0 1 tf
7.937 0 td
(14,701)tj
et
1.11 w
q 1 0 0 1 391.1807 219.3341 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1807 217.2341 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5114 216.9061 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5508 219.3341 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5508 217.2341 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8815 216.9061 tm
( )tj
0.025 tc 0.035 tw 10 0 0 10 102.0469 196.289 tm
(trade receivables are generally due within 30 to 90 days from the date o\
f billing. all of the trade and )tj
0 tw t*
(other receivables are expected to be recovered or recognised as expense \
within one year.)tj
et
endstream
endobj
14 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
15 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
16 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
17 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
18 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
85 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 281.8878 24.0557 tm
(\226 10 \226)tj
/t1_1 1 tf
10 0 0 10 56.6929 728.7079 tm
(6)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(income tax in the consolidated statement of profit or loss)tj
31.271 -2.4 td
(six-month period ended 30 june)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 391.1811 700.2488 cm
0 0 m
147.402 0 l
s
q
bt
0 tc 0.1 0 0 0.1 385.5118 700.0159 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 438.4626 689.6989 tm
(2020)tj
/t1_0 1 tf
7.937 0 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_0 1 tf
0 tw -41.883 -2.4 td
(current tax \227 prc corporate income tax \(\223)tj
/t1_1 1 tf
-0.025 tw (cit)tj
/t1_0 1 tf
(\224\))tj
/t1_1 1 tf
35.109 0 td
(11,745)tj
/t1_0 1 tf
8.462 0 td
(7,914)tj
0 tw -43.571 -1.2 td
(deferred tax)tj
/t1_1 1 tf
-0.025 tw 36.959 0 td
(73)tj
/t1_0 1 tf
7.554 0 td
(\(19\))tj
et
q 1 0 0 1 391.1811 637.2398 cm
0 0 m
68.031 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 637.0068 tm
( )tj
et
q 1 0 0 1 470.5512 637.2398 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8819 637.0068 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 79.37 614.6898 tm
(total)tj
/t1_1 1 tf
35.109 0 td
(11,818)tj
/t1_0 1 tf
8.462 0 td
(7,895)tj
et
1.11 w
q 1 0 0 1 391.1811 610.0391 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1811 607.939 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 607.6111 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 610.0391 cm
0 0 m
68.031 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 607.939 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8819 607.6111 tm
( )tj
/t1_1 1 tf
0.025 tc 10 0 0 10 79.3701 586.994 tm
(prc cit)tj
/t1_0 1 tf
0.037 tw 0 -2.4 td
(\(i\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(effective from 1 january 2008, under the prc corporate income tax law, t\
he prc statutory income )tj
0.033 tc 0.075 tw 0 -1.2 td
[(tax)8 ( )0.5 (rate)8.1 ( )0.5 (is)8 ( )0.6 (2)8 (5)8 (%.)8.1 ( )0.5 (the)8 ( )0.5 (group\222s)8.1 ( )0.5 (subsidiaries)8 ( )0.5 (in)8 ( )0.5 (the)8 ( )0.6 (prc)8 ( )0.5 (are)8 ( )0.5 (subject)8 ( )0.5 (to)8 ( )0.5 (prc)8 ( )0.5 (income)8 ( )0.5 (tax)8 ( )0.5 (at)8 ( )0.5 (2)8 (5)8 (%)8 ( )0.5 (unless)8 ( )]tj
0.025 tc 0 tw t*
(otherwise specified.)tj
-2.268 -2.4 td
(\(ii\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(high and new technology enterprise \(\223)tj
/t1_1 1 tf
-0.025 tw (hnte)tj
/t1_0 1 tf
(\224\))tj
0.029 tw 0 -2.4 td
(according to the prc income tax law and its relevant regulations, entiti\
es that qualified as hnte are )tj
0.057 tc 0.07 tw 0 -1.2 td
[(entitled)12.6 ( to)12.6 ( a)12.6 ( preferential)12.6 ( income)12.6 ( tax)12.6 ( rate)12.6 ( of)12.6 ( 1)12.6 (5)12.6 (%.)12.6 ( the)12.6 ( company)12.6 ( and)12.6 ( one)12.6 ( of)12.5 ( its)12.6 ( subsidiaries)12.6 ( are)32 ( )]tj
0.025 tc 0 tw t*
(qualified as hnte and are subject to income tax at 15% for the three-yea\
r ending 31 december 2021.)tj
0.054 tc 0.07 tw 0 -2.4 td
[(the)12.5 ( 1)12.5 (5)12.6 (%)12.5 ( preferential)12.5 ( tax)12.6 ( rate)12.5 ( applicable)12.5 ( to)12.5 ( hnte)12.6 ( is)12.5 ( subject)12.6 ( to)12.5 ( renewal)12.6 ( approval)12.6 ( jointly)12.5 ( by)12.5 ( the)29.1 ( )]tj
0.049 tc 0 -1.2 td
[(relevant)12.8 ( authorities,)12.8 ( upon)12.8 ( expiry)12.8 ( of)12.8 ( the)12.9 ( three-year)12.8 ( grant)12.8 ( period,)12.8 ( according)12.9 ( to)12.9 ( the)12.8 ( then)12.8 ( prevailing)24 ( )]tj
0.025 tc 0 tw t*
(income tax regulations.)tj
-2.268 -2.4 td
(\(iii\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(small and micro enterprise \(\223)tj
/t1_1 1 tf
-0.025 tw (sme)tj
/t1_0 1 tf
(\224\))tj
0.023 tc 0 tw 0 -2.4 td
[(according to the prc income tax law and its relevant regulations issued \
in 2019, entities that qualified)-2 ( )]tj
0.025 tc 0.031 tw 0 -1.2 td
[(as )0.5 (sme are entitled )0.5 (to a preferential )0.5 (income tax rate )0.5 (of 5% )0.5 (\(taxable income less )0.5 (than rmb1,000,000\) )]tj
0.037 tw t*
(or 10% \(taxable income range between rmb1,000,000 to rmb3,000,000\). ce\
rtain subsidiaries in the )tj
0.057 tw t*
[(prc )0.5 (were )0.5 (qualified as )0.5 (sme )0.5 (and )0.5 (entitled )0.5 (to )0.5 (a preferential )0.5 (rate )0.5 (of )0.5 (5% for )0.5 (the )0.5 (six-month )0.5 (periods )0.5 (ended )]tj
0 tw t*
(30 june 2020 and 2019.)tj
0.041 tc 0.07 tw -2.268 -2.4 td
[(\()16 (i)16 (v)16 (\))]tj
/span<>> bdc
1.544 0 td
( )tj
emc
0.724 0 td
[(according)12.7 ( to)12.7 ( the)12.7 ( prc)12.7 ( income)12.7 ( tax)12.7 ( law)12.8 ( and)12.7 ( its)12.7 ( relevant)12.7 ( regulations,)12.7 ( an)12.7 ( additional)12.7 ( 7)12.7 (5)12.7 (%)12.7 ( of)12.7 ( qualified)16 ( )]tj
0.025 tc 0.024 tw t*
[(research )0.5 (and )0.5 (development )0.5 (expenses )0.5 (so incurred )0.5 (is allowed )0.5 (to be )0.5 (deducted )0.5 (from )0.5 (taxable )0.5 (income for )0.5 (the )]tj
0 tw t*
(three-year ending 31 december 2020.)tj
/t1_1 1 tf
-2.268 -2.4 td
(hong kong profit tax)tj
/t1_0 1 tf
0.04 tw 0 -2.4 td
(the company\222s subsidiary incorporated in hong kong is subject to hong\
kong profits tax at 8.25% of the )tj
0.058 tc 0.07 tw 0 -1.2 td
[(taxable)12.7 ( profit)12.6 ( less)12.7 ( than)12.6 ( hkd)12.6 (2)12.7 (,)12.6 (0)12.6 (0)12.6 (0)12.6 (,)12.6 (0)12.7 (0)12.6 (0)12.6 ( or)12.6 ( 1)12.6 (6)12.7 (.)12.6 (5)12.6 (%)12.6 ( of)12.6 ( the)12.6 ( taxable)12.6 ( profit)12.7 ( exceeding)12.6 ( hkd)12.7 (2)12.6 (,)12.6 (0)12.6 (0)12.6 (0)12.7 (,)12.6 (0)12.6 (0)12.6 (0)12.6 (.)12.6 ( no)33 ( )]tj
0.044 tc t*
[(provision)12.7 ( for)12.6 ( hong)12.7 ( kong)12.7 ( profits)12.6 ( tax)12.7 ( has)12.7 ( been)12.6 ( made)12.6 ( as)12.7 ( the)12.7 ( subsidiary)12.6 ( in)12.7 ( hong)12.7 ( kong)12.7 ( has)12.7 ( no)12.7 ( assessable)19 ( )]tj
0.025 tc 0 tw t*
(profits for the six-month periods ended 30 june 2020 and 2019.)tj
et
endstream
endobj
84 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 9 \226)tj
/t1_1 1 tf
10 0 0 10 56.6929 728.7079 tm
(4)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(other income)tj
31.271 -2.4 td
(six-month period ended 30 june)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 391.1811 700.2488 cm
0 0 m
147.402 0 l
s
q
bt
0 tc 0.1 0 0 0.1 385.5118 700.0159 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 438.4626 689.6989 tm
(2020)tj
/t1_0 1 tf
7.937 0 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_0 1 tf
0 tw -41.883 -2.4 td
(government grants )tj
/t1_3 1 tf
-0.025 tw (\(note\))tj
/t1_1 1 tf
35.634 0 td
(7,674)tj
/t1_0 1 tf
7.937 0 td
(2,067)tj
0 tw -43.571 -1.2 td
(interest income from bank deposits)tj
/t1_1 1 tf
-0.025 tw 35.109 0 td
(15,304)tj
/t1_0 1 tf
8.462 0 td
(1,002)tj
0 tw -43.571 -1.2 td
(net realised and unrealised gains from fair value changes on)tj
0 tc ( )tj
0.025 tc 1.001 -1.2 td
(wealth management products)tj
/t1_1 1 tf
-0.025 tw 35.434 0 td
(347)tj
/t1_0 1 tf
7.137 0 td
(3,807)tj
-43.571 -1.2 td
(others)tj
/t1_1 1 tf
35.634 0 td
(1,493)tj
/t1_0 1 tf
8.879 0 td
(\(76\))tj
et
q 1 0 0 1 391.1811 601.2398 cm
0 0 m
68.031 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 601.0068 tm
( )tj
et
q 1 0 0 1 470.5512 601.2398 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8819 601.0068 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 10 0 0 10 430.4625 578.6898 tm
(24,818)tj
/t1_0 1 tf
8.462 0 td
(6,800)tj
et
1.11 w
q 1 0 0 1 391.1811 574.0391 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1811 571.939 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 571.6111 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 574.0391 cm
0 0 m
68.031 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 571.939 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8819 571.6111 tm
( )tj
/t1_3 1 tf
0.025 tc -0.025 tw 10 0 0 10 79.3701 550.994 tm
(note:)tj
/t1_0 1 tf
0.036 tw /span<>> bdc
( )tj
emc
3.402 0 td
(government grants include subsidies received from government for encoura\
gement of research and )tj
0.035 tc 0.073 tw 0 -1.2 td
[(development)10 ( )0.6 (projects)10 ( )0.5 (and)10 ( )0.6 (compensation)10 ( )0.5 (on)10 ( )0.5 (the)10 ( )0.5 (capital)10 ( )0.5 (expenditure)10 ( )0.5 (of)10 ( )0.5 (medical)10 ( )0.5 (device)10 ( )0.5 (production)10 ( )]tj
0.025 tc -0.025 tw t*
(lines.)tj
/t1_1 1 tf
0 tw -5.669 -2.4 td
(5)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(profit before taxation)tj
/t1_0 1 tf
0 -2.4 td
(profit before taxation is arrived at after charging:)tj
/t1_1 1 tf
31.271 -2.4 td
(six-month period ended 30 june)tj
et
0.5 w
q 1 0 0 1 391.1811 450.5351 cm
0 0 m
147.402 0 l
s
q
bt
0 tc 0.1 0 0 0.1 385.5118 450.3021 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 438.4626 439.985 tm
(2020)tj
/t1_0 1 tf
7.937 0 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_1 1 tf
0 tw -41.883 -2.4 td
(\(a\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(finance costs)tj
/t1_0 1 tf
-0 -2.4 td
(interest on lease liabilities)tj
/t1_1 1 tf
-0.025 tw 34.692 0 td
(48)tj
/t1_0 1 tf
6.612 0 td
(1,471)tj
et
1.11 w
q 1 0 0 1 391.1809 375.3342 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1809 373.2342 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5117 372.9062 tm
( )tj
et
1.11 w
q 1 0 0 1 470.551 375.3342 cm
0 0 m
68.031 0 l
s
q
0.45 w
q 1 0 0 1 470.551 373.2342 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8817 372.9062 tm
( )tj
/t1_1 1 tf
0.025 tc 10 0 0 10 79.3699 350.5892 tm
(\(b\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(other items)tj
/t1_0 1 tf
-0 -2.4 td
(depreciation and amortisation)tj
0 -1.2 td
(\227 property, plant and equipment)tj
/t1_1 1 tf
-0.025 tw 33.367 0 td
(8,134)tj
/t1_0 1 tf
7.937 0 td
(4,924)tj
0 tw -41.304 -1.2 td
(\227 right-of-use assets)tj
/t1_1 1 tf
-0.025 tw 33.367 0 td
(1,593)tj
/t1_0 1 tf
7.937 0 td
(4,059)tj
0 tw -41.304 -1.2 td
(\227 intangible assets)tj
/t1_1 1 tf
-0.025 tw 34.167 0 td
(291)tj
/t1_0 1 tf
7.937 0 td
(136)tj
0 tw -42.104 -2.4 td
(impairment loss on trade and other receivables)tj
/t1_1 1 tf
-0.025 tw 34.692 0 td
(13)tj
/t1_0 1 tf
7.937 0 td
(41)tj
0 tw -42.629 -2.4 td
(research and development costs)tj
0 tc 5.83 0 0 5.83 239.7952 245.9192 tm
( )tj
0.025 tc 10 0 0 10 113.3855 230.5892 tm
(\(other than depreciation and amortisation\))tj
/t1_1 1 tf
-0.025 tw 31.708 0 td
(28,758)tj
/t1_0 1 tf
7.937 0 td
(11,568)tj
et
endstream
endobj
83 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 8 \226)tj
/t1_1 1 tf
10 0 0 10 79.3701 728.7079 tm
(\(b\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(segment reporting)tj
/t1_2 1 tf
0 -2.4 td
(\(i\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(segment results)tj
/t1_0 1 tf
0.063 tw t*
(information regarding the group\222s reportable segments are provided to\
the group\222s most senior )tj
0.063 tc 0.07 tw 0 -1.2 td
[(executive)12.5 ( management)12.5 ( for)12.6 ( the)12.5 ( purpose)12.6 ( of)12.5 ( resource)12.5 ( allocation)12.5 ( and)12.6 ( assessment)12.5 ( of)12.5 ( segment)38 ( )]tj
0.025 tc 0 tw t*
(performance for the period is set out below:)tj
/t1_1 1 tf
9.5 0 0 10 349.0081 632.7079 tm
(six-month period ended 30 june 2020)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 320.3149 628.2488 cm
0 0 m
218.268 0 l
s
q
bt
0 tc 0.1 0 0 0.1 314.6456 628.0159 tm
( )tj
0.025 tc -0.025 tw 9.5 0 0 10 319.6205 617.6989 tm
(cardiovascular)tj
0.611 -1.2 td
(interventional)tj
2.593 -1.2 td
(business)tj
0 tw 7.369 0 td
(all others)tj
-0.025 tw 10.097 0 td
(total)tj
/t1_2 1 tf
-17.941 -1.2 td
(rmb\222000)tj
8.056 0 td
(rmb\222000)tj
8.056 0 td
(rmb\222000)tj
/t1_1 1 tf
0 tw -39.358 -2.4 td
(revenue from external customers)tj
-0.025 tw 24.051 0 td
(165,263)tj
9.106 0 td
(6,581)tj
7.006 0 td
(171,844)tj
/t1_0 1 tf
0 tw -40.164 -2.4 td
(inter-segment revenue)tj
/t1_1 1 tf
-0.025 tw 25.101 0 td
(1,609)tj
8.056 0 td
(5,163)tj
8.056 0 td
(6,272)tj
et
q 1 0 0 1 320.315 529.2398 cm
0 0 m
65.197 0 l
s
q
bt
0 tc 0 tw 0.095 0 0 0.1 314.6457 529.0068 tm
( )tj
et
q 1 0 0 1 396.8504 529.2398 cm
0 0 m
65.197 0 l
s
q
bt
0.095 0 0 0.1 391.1811 529.0068 tm
( )tj
et
q 1 0 0 1 473.3858 529.2398 cm
0 0 m
65.197 0 l
s
q
bt
0.095 0 0 0.1 467.7166 529.0068 tm
( )tj
0.025 tc 9.5 0 0 10 124.7245 506.6898 tm
(segment revenue)tj
-0.025 tw 24.051 0 td
(166,872)tj
8.581 0 td
(11,744)tj
7.531 0 td
(178,616)tj
et
1.11 w
q 1 0 0 1 320.315 502.0391 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 320.315 499.9391 cm
0 0 m
65.197 0 l
s
q
bt
0 tc 0 tw 0.095 0 0 0.1 314.6457 499.6111 tm
( )tj
et
1.11 w
q 1 0 0 1 396.8504 502.0391 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 396.8504 499.9391 cm
0 0 m
65.197 0 l
s
q
bt
0.095 0 0 0.1 391.1812 499.6111 tm
( )tj
et
1.11 w
q 1 0 0 1 473.3859 502.0391 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 473.3859 499.9391 cm
0 0 m
65.197 0 l
s
q
bt
0.095 0 0 0.1 467.7166 499.6111 tm
( )tj
0.025 tc 9.5 0 0 10 124.7245 477.294 tm
(segment net profit/\(loss\))tj
-0.025 tw 24.576 0 td
(72,118)tj
8.198 0 td
(\(3,263\))tj
7.914 0 td
(68,855)tj
et
1.11 w
q 1 0 0 1 320.315 472.6432 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 320.315 470.5432 cm
0 0 m
65.197 0 l
s
q
bt
0 tc 0 tw 0.095 0 0 0.1 314.6457 470.2152 tm
( )tj
et
1.11 w
q 1 0 0 1 396.8504 472.6432 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 396.8504 470.5432 cm
0 0 m
65.197 0 l
s
q
bt
0.095 0 0 0.1 391.1812 470.2152 tm
( )tj
et
1.11 w
q 1 0 0 1 473.3859 472.6432 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 473.3859 470.5432 cm
0 0 m
65.197 0 l
s
q
bt
/t1_0 1 tf
0.095 0 0 0.1 467.7166 470.2152 tm
( )tj
0.025 tc 10 0 0 10 348.9543 449.5982 tm
(six-month period ended 30 june 2019)tj
et
0.5 w
q 1 0 0 1 320.315 445.1392 cm
0 0 m
218.268 0 l
s
q
bt
0 tc 0.1 0 0 0.1 314.6457 444.9062 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 321.7228 434.5892 tm
(cardiovascular)tj
0.444 -1.2 td
(interventional)tj
2.371 -1.2 td
(business)tj
0 tw 7.021 0 td
(all others)tj
-0.025 tw 9.64 0 td
(total)tj
/t1_3 1 tf
-17.134 -1.2 td
(rmb\222000)tj
7.654 0 td
(rmb\222000)tj
7.654 0 td
(rmb\222000)tj
/t1_1 1 tf
0 tw -37.348 -2.4 td
(revenue from external customers)tj
/t1_0 1 tf
-0.025 tw 22.679 0 td
(128,923)tj
8.704 0 td
(6,146)tj
6.604 0 td
(135,069)tj
0 tw -37.986 -2.4 td
(inter-segment revenue)tj
-0.025 tw 23.729 0 td
(1,757)tj
7.654 0 td
(3,135)tj
7.654 0 td
(4,892)tj
et
q 1 0 0 1 320.315 346.1301 cm
0 0 m
65.197 0 l
s
q
bt
0 tc 0 tw 0.1 0 0 0.1 314.6457 345.8971 tm
( )tj
et
q 1 0 0 1 396.8504 346.1301 cm
0 0 m
65.197 0 l
s
q
bt
0.1 0 0 0.1 391.1811 345.8971 tm
( )tj
et
q 1 0 0 1 473.3858 346.1301 cm
0 0 m
65.197 0 l
s
q
bt
0.1 0 0 0.1 467.7166 345.8971 tm
( )tj
/t1_1 1 tf
0.025 tc 10 0 0 10 124.7244 323.5801 tm
(segment revenue)tj
/t1_0 1 tf
-0.025 tw 22.679 0 td
(130,680)tj
8.704 0 td
(9,281)tj
6.604 0 td
(139,961)tj
et
1.11 w
q 1 0 0 1 320.315 318.9293 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 320.315 316.8293 cm
0 0 m
65.197 0 l
s
q
bt
0 tc 0 tw 0.1 0 0 0.1 314.6457 316.5013 tm
( )tj
et
1.11 w
q 1 0 0 1 396.8504 318.9293 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 396.8504 316.8293 cm
0 0 m
65.197 0 l
s
q
bt
0.1 0 0 0.1 391.1811 316.5013 tm
( )tj
et
1.11 w
q 1 0 0 1 473.3858 318.9293 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 473.3858 316.8293 cm
0 0 m
65.197 0 l
s
q
bt
0.1 0 0 0.1 467.7166 316.5013 tm
( )tj
/t1_1 1 tf
0.025 tc 10 0 0 10 124.7244 294.1843 tm
(segment net profit)tj
/t1_0 1 tf
-0.025 tw 23.204 0 td
(48,043)tj
8.979 0 td
(848)tj
6.329 0 td
(48,891)tj
et
1.11 w
q 1 0 0 1 320.315 289.5335 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 320.315 287.4335 cm
0 0 m
65.197 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 314.6457 287.1055 tm
( )tj
et
1.11 w
q 1 0 0 1 396.8504 289.5335 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 396.8504 287.4335 cm
0 0 m
65.197 0 l
s
q
bt
0.1 0 0 0.1 391.1811 287.1055 tm
( )tj
et
1.11 w
q 1 0 0 1 473.3858 289.5335 cm
0 0 m
65.197 0 l
s
q
0.45 w
q 1 0 0 1 473.3858 287.4335 cm
0 0 m
65.197 0 l
s
q
bt
0.1 0 0 0.1 467.7166 287.1055 tm
( )tj
/t1_2 1 tf
0.025 tc 10 0 0 10 102.0472 266.4885 tm
(\(ii\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(reconciliation of segment profit)tj
/t1_1 1 tf
26.736 -2.4 td
(six-month period ended 30 june)tj
et
0.5 w
q 1 0 0 1 391.1811 238.0294 cm
0 0 m
147.402 0 l
s
q
bt
0 tc 0.1 0 0 0.1 385.5118 237.7964 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 438.4626 227.4794 tm
(2020)tj
/t1_0 1 tf
7.937 0 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_1 1 tf
-37.348 -2.4 td
(revenue)tj
/t1_0 1 tf
0 tw t*
(segment revenue)tj
/t1_1 1 tf
-0.025 tw 30.049 0 td
(178,616)tj
/t1_0 1 tf
7.937 0 td
(139,961)tj
0 tw -37.986 -1.2 td
(elimination of inter-segment revenue)tj
/t1_1 1 tf
-0.025 tw 30.716 0 td
(\(6,772\))tj
/t1_0 1 tf
7.937 0 td
(\(4,892\))tj
et
q 1 0 0 1 391.1811 163.0204 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 162.7874 tm
( )tj
et
q 1 0 0 1 470.5511 163.0204 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 162.7874 tm
( )tj
/t1_1 1 tf
0.025 tc 10 0 0 10 124.7244 140.4704 tm
(consolidated revenue)tj
-0.025 tw 30.049 0 td
(171,844)tj
/t1_0 1 tf
7.937 0 td
(135,069)tj
et
1.11 w
q 1 0 0 1 391.1811 135.8196 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1811 133.7196 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 133.3916 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 135.8196 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 133.7196 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 133.3916 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 10 0 0 10 124.7244 111.0745 tm
(profit)tj
/t1_0 1 tf
0 tw t*
(segment net profit)tj
/t1_1 1 tf
-0.025 tw 30.574 0 td
(68,855)tj
/t1_0 1 tf
7.937 0 td
(48,891)tj
0 tw -38.511 -1.2 td
(elimination of inter-segment net profit)tj
/t1_1 1 tf
-0.025 tw 30.716 0 td
(\(4,154\))tj
/t1_0 1 tf
7.937 0 td
(\(2,335\))tj
et
0.5 w
q 1 0 0 1 391.1811 82.6155 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 82.3825 tm
( )tj
et
q 1 0 0 1 470.5511 82.6155 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 82.3825 tm
( )tj
/t1_1 1 tf
0.025 tc 10 0 0 10 124.7244 60.0655 tm
(consolidated net profit)tj
-0.025 tw 30.574 0 td
(64,701)tj
/t1_0 1 tf
7.937 0 td
(46,556)tj
et
1.11 w
q 1 0 0 1 391.1811 55.4147 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1811 53.3147 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 52.9867 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 55.4147 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 53.3147 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 52.9867 tm
( )tj
et
endstream
endobj
82 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 7 \226)tj
/t1_1 1 tf
10 0 0 10 56.6929 728.7079 tm
(3)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(revenue and segment reporting)tj
/t1_0 1 tf
0.055 tc 0.07 tw 0 -2.4 td
[(the)12.1 ( group)12.1 ( manages)12.1 ( its)12.1 ( businesses)12.2 ( by)12.1 ( divisions,)12.1 ( which)12.2 ( are)12.2 ( organised)12.1 ( by)12.1 ( business)12.2 ( lines.)12.2 ( in)12.2 ( a)12.2 ( manner)29.9 ( )]tj
0.031 tc 0.077 tw 0 -1.2 td
[(consistent)6 ( )0.5 (with)6 ( )0.6 (the)6 ( )0.5 (way)6 ( )0.5 (in)6 ( )0.5 (which)6 ( )0.5 (information)6 ( )0.5 (is)6 ( )0.5 (reported)6 ( )0.5 (internally)6 ( )0.5 (to)6 ( )0.5 (the)6 ( )0.5 (group\222s)6.1 ( )0.5 (most)6 ( )0.5 (senior)6 ( )0.5 (executive)6 ( )]tj
0.025 tc 0.059 tw t*
(management for the purposes of resource allocation and performance asses\
sment, the group has identified )tj
0.043 tc 0.07 tw t*
[(one)12.7 ( reportable)12.7 ( segment,)12.7 ( the)12.8 ( cardiovascular)12.8 ( interventional)12.7 ( business,)12.6 ( which)12.7 ( is)12.7 ( primary)12.7 ( engaged)12.7 ( in)12.7 ( sales,)18 ( )]tj
0.025 tc 0.053 tw t*
(manufacture, research and development of cardiovascular interventional m\
edical devices as well as related )tj
t*
(moulds, accessories and masks. other segments, which are currently engag\
ed in research and development )tj
0.052 tc 0.07 tw t*
[(of)12.7 ( other)12.7 ( interventional)12.7 ( and)12.7 ( implantable)12.7 ( medical)12.7 ( devices,)12.7 ( such)12.7 ( as)12.7 ( neurological)12.7 ( interventional)12.7 ( medical)27 ( )]tj
0.025 tc 0 tw t*
(devices and endocardial implantable medical devices, etc, are combined i\
n all other segments.)tj
/t1_1 1 tf
0 -2.4 td
(\(a\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(disaggregation of revenue)tj
/t1_0 1 tf
t*
(\(i\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(disaggregation of revenue from contracts with customers by major product\
s is as follows:)tj
/t1_1 1 tf
26.736 -2.4 td
(six-month period ended 30 june)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 391.1811 544.2488 cm
0 0 m
147.402 0 l
s
q
bt
0 tc 0.1 0 0 0.1 385.5118 544.0159 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 438.4626 533.6989 tm
(2020)tj
/t1_0 1 tf
7.937 0 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_1 1 tf
0 tw -37.348 -2.4 td
(revenue from contracts with customers within )tj
0 tc ( )tj
0.025 tc 1.001 -1.2 td
(the scope of hkfrs 15)tj
/t1_0 1 tf
-1.001 -2.4 td
(disaggregated by major products)tj
0 -1.2 td
(\227)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(sales of interventional medical devices)tj
/t1_3 1 tf
t*
(cardiovascular devices)tj
/t1_1 1 tf
-0.025 tw 27.781 0 td
(116,448)tj
/t1_0 1 tf
7.937 0 td
(122,910)tj
/t1_3 1 tf
0 tw -35.718 -1.2 td
(orthopaedics and other devices)tj
/t1_1 1 tf
-0.025 tw 29.631 0 td
(253)tj
/t1_0 1 tf
7.937 0 td
(256)tj
et
q 1 0 0 1 391.1811 421.2398 cm
0 0 m
68.031 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 421.0068 tm
( )tj
et
q 1 0 0 1 470.5511 421.2398 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8819 421.0068 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 124.7244 398.6898 tm
(subtotal)tj
/t1_1 1 tf
30.049 0 td
(116,701)tj
/t1_0 1 tf
7.937 0 td
(123,166)tj
0 tw -37.986 -2.4 td
(\227)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(sales of masks)tj
/t1_1 1 tf
-0.025 tw 28.306 0 td
(43,676)tj
/t1_0 1 tf
0 tc 0 tw 10.312 0 td
(\226)tj
0.025 tc -40.886 -1.2 td
(\227)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(sales of medical accessories)tj
/t1_1 1 tf
-0.025 tw 28.831 0 td
(6,184)tj
/t1_0 1 tf
7.937 0 td
(7,490)tj
0.968 tw -39.036 -1.2 td
(\227)tj
/span<>> bdc
( )tj
emc
(others)tj
/t1_1 1 tf
-0.025 tw 31.099 0 td
(5,283)tj
/t1_0 1 tf
7.937 0 td
(4,413)tj
et
q 1 0 0 1 391.1811 346.2308 cm
0 0 m
68.031 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 345.9978 tm
( )tj
et
q 1 0 0 1 470.5511 346.2308 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8819 345.9978 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 10 0 0 10 425.2126 323.6808 tm
(171,844)tj
/t1_0 1 tf
7.937 0 td
(135,069)tj
et
1.11 w
q 1 0 0 1 391.1811 319.0299 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1811 316.9299 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 316.6019 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 319.0299 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 316.9299 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 316.6019 tm
( )tj
0.031 tc 0.077 tw 10 0 0 10 124.7244 295.9849 tm
[(during)6 ( )0.6 (the)6 ( )0.5 (six-month)6 ( )0.5 (periods)6 ( )0.5 (ended)6 ( )0.5 (3)6 (0)6 ( )0.5 (june)6 ( )0.5 (2)6 (0)6 (2)6 (0)6 ( )0.5 (and)6 ( )0.5 (2)6 (0)6 (1)6 (9)6 (,)6 ( )0.5 (the)6 ( )0.5 (group)6 ( )0.5 (recognised)6 ( )0.5 (its)6 ( )0.6 (revenue)6.1 ( )]tj
0.025 tc 0 tw t*
(from contract with customers at point in time.)tj
-2.268 -2.4 td
(\(ii\))tj
/span<>> bdc
( )tj
emc
2.268 0 td
(disaggregation of revenue by geographical location of external customers\
is as follows:)tj
/t1_1 1 tf
26.736 -2.4 td
(six-month period ended 30 june)tj
et
0.5 w
q 1 0 0 1 391.1811 231.5259 cm
0 0 m
147.402 0 l
s
q
bt
0 tc 0.1 0 0 0.1 385.5118 231.2929 tm
( )tj
0.025 tc -0.025 tw 10 0 0 10 438.4626 220.9758 tm
(2020)tj
/t1_0 1 tf
7.937 0 td
(2019)tj
/t1_2 1 tf
-10.068 -1.2 td
(rmb\222000)tj
/t1_3 1 tf
8.105 0 td
(rmb\222000)tj
/t1_0 1 tf
0 tw -37.348 -2.4 td
(mainland china)tj
/t1_1 1 tf
-0.025 tw 30.049 0 td
(102,647)tj
/t1_0 1 tf
8.462 0 td
(86,549)tj
-38.511 -1.2 td
(europe)tj
/t1_1 1 tf
30.574 0 td
(20,918)tj
/t1_0 1 tf
7.937 0 td
(19,006)tj
0 tw -38.511 -1.2 td
(the united states)tj
/t1_1 1 tf
-0.025 tw 31.099 0 td
(6,163)tj
/t1_0 1 tf
7.937 0 td
(5,884)tj
0 tw -39.036 -1.2 td
(other countries and regions)tj
/t1_1 1 tf
-0.025 tw 30.574 0 td
(42,116)tj
/t1_0 1 tf
7.937 0 td
(23,630)tj
et
q 1 0 0 1 391.1811 144.5168 cm
0 0 m
68.031 0 l
s
q
bt
/t1_1 1 tf
0.1 0 0 0.1 385.5118 144.2838 tm
(135,069)tj
et
q 1 0 0 1 470.5511 144.5168 cm
0 0 m
68.031 0 l
s
q
bt
/t1_0 1 tf
0 tc 0 tw 0.1 0 0 0.1 464.8819 144.2838 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 10 0 0 10 425.2126 121.9668 tm
(171,844)tj
/t1_0 1 tf
7.937 0 td
(135,069)tj
et
1.11 w
q 1 0 0 1 391.1811 117.316 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 391.1811 115.216 cm
0 0 m
68.032 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 385.5118 114.888 tm
( )tj
et
1.11 w
q 1 0 0 1 470.5511 117.316 cm
0 0 m
68.032 0 l
s
q
0.45 w
q 1 0 0 1 470.5511 115.216 cm
0 0 m
68.032 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 464.8818 114.888 tm
( )tj
0.025 tc 0.049 tw 10 0 0 10 124.7244 94.271 tm
(the geographical location of customers is based on the location at which\
the customers operate. )tj
0.041 tc 0.07 tw t*
[(a)0.5 (l)0.5 (l)13.1 ( )0.5 (o)0.5 (f)13 ( )0.5 (t)0.6 (h)0.5 (e)13 ( )0.5 (n)0.5 (o)0.5 (n)0.6 (-)0.5 (c)0.5 (u)0.5 (r)0.5 (r)0.6 (e)0.5 (n)0.5 (t)13 ( )0.5 (a)0.6 (s)0.5 (s)0.5 (e)0.5 (t)0.6 (s)13 ( )0.5 (o)0.5 (f)13 ( )0.6 (t)0.5 (h)0.5 (e)13 ( )0.5 (g)0.6 (r)0.5 (o)0.5 (u)0.5 (p)13 ( )0.6 (a)0.5 (r)0.5 (e)13 ( )0.6 (p)0.5 (h)0.5 (y)0.5 (s)0.5 (i)0.5 (c)0.6 (a)0.5 (l)0.5 (l)0.5 (y)13 ( )0.6 (l)0.5 (o)0.5 (c)0.5 (a)0.5 (t)0.6 (e)0.5 (d)13 ( )0.5 (i)0.5 (n)13 ( )0.6 (t)0.5 (h)0.5 (e)13 ( )0.5 (p)0.6 (e)0.5 (o)0.5 (p)0.5 (l)0.5 (e)0.6 (\222)0.5 (s)13 ( )0.5 (r)0.5 (e)0.6 (p)0.5 (u)0.5 (b)0.5 (l)0.5 (i)0.5 (c)13.1 ( )0.5 (o)0.5 (f)16 ( )]tj
0.025 tc 0 tw t*
(china \(the \223)tj
/t1_1 1 tf
-0.025 tw (prc)tj
/t1_0 1 tf
(\224\).)tj
et
endstream
endobj
81 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 6 \226)tj
/t1_1 1 tf
-0.025 tw -19.029 58.583 td
(notes)tj
/t1_2 1 tf
0 tw 0 -1.167 td
(\(expressed in rmb unless otherwise indicated\))tj
/t1_1 1 tf
10 0 0 10 56.6929 687.0479 tm
(1)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(basis of preparation)tj
/t1_0 1 tf
0.077 tw 0 -2.4 td
(this interim financial report has been prepared in accordance with the a\
pplicable disclosure provisions of )tj
0.035 tw 0 -1.2 td
(the rules governing the listing of securities on the stock exchange of h\
ong kong limited \(the \223)tj
/t1_1 1 tf
-0.025 tw (listing )tj
0.048 tc -0.048 tw t*
(rules)tj
/t1_0 1 tf
0.07 tw [(\224\))12.3 ( including)12.3 ( compliance)12.3 ( with)12.2 ( hong)12.3 ( kong)12.2 ( accounting)12.2 ( standard)12.3 ( \(\223)]tj
/t1_1 1 tf
-0.048 tw (hkas)tj
/t1_0 1 tf
0.07 tw [(\224\))12.3 ( 3)12.3 (4)12.2 (,)12.3 ( interim)12.3 ( financial)23 ( )]tj
0.037 tc 0.071 tw t*
[(reporting,)12 ( )0.5 (issued)12 ( )0.5 (by)12 ( )0.5 (the)12 ( )0.5 (hong)12 ( )0.5 (kong)12 ( )0.5 (institute)12.1 ( )0.5 (of)12 ( )0.6 (certified)12.1 ( )0.5 (public)12 ( )0.5 (accountants)12 ( )0.5 (\(\223)]tj
/t1_1 1 tf
-0.037 tw (hkicpa)tj
/t1_0 1 tf
0.071 tw [(\224\).)12.1 ( )0.5 (it)12 ( )0.5 (has)12 ( )0.5 (been)12 ( )]tj
0.025 tc 0 tw t*
(reviewed by the audit committee of the company and was authorised for is\
sue on 18 august 2020.)tj
0.05 tw 0 -2.4 td
(the interim financial report has been prepared in accordance with the sa\
me accounting policies adopted in )tj
0.043 tc 0.07 tw 0 -1.2 td
[(the)12.1 ( 2)12.1 (0)12.1 (1)12.1 (9)12.1 ( annual)12.1 ( financial)12.1 ( statements,)12.1 ( except)12.1 ( for)12.1 ( the)12.1 ( accounting)12.1 ( policy)12.1 ( changes)12.1 ( that)12.1 ( are)12.1 ( expected)12.1 ( to)12.1 ( be)18 ( )]tj
0.025 tc 0.056 tw t*
(reflected in the 2020 annual financial statements. details of any change\
s in accounting policies are set out )tj
0 tw t*
(in note 2.)tj
0.047 tw 0 -2.4 td
(the preparation of the interim financial report in conformity with hkas \
34 requires management to make )tj
0.004 tw 0 -1.2 td
(judgements, estimates and assumptions that affect the application of pol\
icies and reported amounts of assets )tj
0 tw 0 -1.2 td
(and liabilities, income and expenses on a year to date basis. actual res\
ults may differ from these estimates.)tj
0.023 tw 0 -2.4 td
(this interim financial report contains condensed consolidated financial \
statements and selected explanatory )tj
0.067 tw 0 -1.2 td
(notes. the notes include an explanation of events and transactions that \
are significant to an understanding )tj
0.063 tc 0.07 tw t*
[(of)12.8 ( the)12.8 ( changes)12.8 ( in)12.8 ( financial)12.8 ( position)12.8 ( and)12.8 ( performance)12.8 ( of)12.8 ( the)12.8 ( group)12.8 ( since)12.8 ( the)12.7 ( 2)12.8 (0)12.8 (1)12.8 (9)12.7 ( annual)12.7 ( financial)38 ( )]tj
0.025 tc 0.018 tw t*
(statements. the condensed consolidated interim financial statements and \
notes thereon do not include all of )tj
0.044 tc 0.07 tw t*
[(the)12.8 ( information)12.7 ( required)12.8 ( for)12.8 ( a)12.8 ( full)12.8 ( set)12.8 ( of)12.8 ( financial)12.8 ( statements)12.8 ( prepared)12.7 ( in)12.7 ( accordance)12.7 ( with)12.8 ( hong)12.7 ( kong)19 ( )]tj
0.025 tc 0 tw t*
(financial reporting standards \(\223)tj
/t1_1 1 tf
-0.025 tw (hkfrss)tj
/t1_0 1 tf
(\224\).)tj
0.043 tw 0 -2.4 td
[(the )0.5 (interim )0.5 (financial )0.5 (report )0.5 (is )0.5 (unaudited, )0.5 (but )0.5 (has )0.5 (been )0.5 (reviewed )0.6 (by )0.6 (kpmg )0.5 (in )0.5 (accordance )0.5 (with )0.5 (hong )0.5 (kong )]tj
0.064 tc 0.07 tw 0 -1.2 td
[(standard)12.7 ( on)12.7 ( review)12.7 ( engagements)12.7 ( 2)12.7 (4)12.7 (1)12.7 (0)12.8 (,)12.7 ( )]tj
/t1_2 1 tf
[(review)12.8 ( of)12.7 ( interim)12.7 ( financial)12.7 ( information)12.7 ( performed)12.7 ( by)12.7 ( the)39 ( )]tj
0.025 tc 0 tw t*
(independent auditor of the entity)tj
/t1_0 1 tf
(, issued by the hkicpa.)tj
0.038 tc 0.07 tw 0 -2.4 td
[(the)12.3 ( financial)12.3 ( information)12.3 ( relating)12.3 ( to)12.3 ( the)12.4 ( financial)12.3 ( year)12.3 ( ended)12.4 ( 3)12.3 (1)12.3 ( december)12.3 ( 2)12.3 (0)12.3 (1)12.3 (9)12.4 ( that)12.4 ( is)12.4 ( included)12.4 ( in)12.3 ( the)13 ( )]tj
0.025 tc 0.041 tw 0 -1.2 td
(interim financial report as comparative information does not constitute \
the company\222s annual consolidated )tj
0.075 tw t*
(financial statements for that financial year but is derived from those f\
inancial statements. the company\222s )tj
0.047 tc 0.07 tw t*
[(annual)12.4 ( consolidated)12.4 ( financial)12.3 ( statements)12.4 ( for)12.3 ( the)12.3 ( year)12.3 ( ended)12.4 ( 3)12.4 (1)12.3 ( december)12.3 ( 2)12.3 (0)12.3 (1)12.4 (9)12.3 ( are)12.4 ( available)12.3 ( from)12.3 ( the)22 ( )]tj
0.055 tc t*
[(company\222s)12.6 ( registered)12.6 ( office.)12.6 ( the)12.6 ( auditors)12.6 ( have)12.7 ( expressed)12.6 ( an)12.6 ( unqualified)12.6 ( opinion)12.7 ( on)12.6 ( those)12.7 ( financial)30 ( )]tj
0.025 tc 0 tw t*
(statements in their report date 19 march 2020.)tj
/t1_1 1 tf
-2.268 -2.4 td
(2)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(changes in accounting policies)tj
/t1_0 1 tf
0.048 tc 0.07 tw 0 -2.4 td
[(the)12.7 ( hkicpa)12.7 ( has)12.6 ( issued)12.7 ( the)12.6 ( following)12.6 ( amendments)12.6 ( to)12.6 ( hkfrss)12.7 ( that)12.7 ( are)12.7 ( first)12.6 ( effective)12.7 ( for)12.6 ( the)12.7 ( current)23 ( )]tj
0.025 tc 0 tw 0 -1.2 td
(accounting period of the group:)tj
0 -2.4 td
(\225)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(amendments to hkfrs 3, definition of a business)tj
-2.268 -2.4 td
(\225)tj
/span<>> bdc
( )tj
emc
2.268 0 td
(amendments to hkfrs 16, covid-19-related rent concessions)tj
0.027 tc 0.081 tw -2.268 -2.4 td
[(none)2 ( )0.5 (of)2 ( )0.5 (these)2 ( )0.5 (developments)2 ( )0.5 (have)2 ( )0.5 (had)2 ( )0.5 (a)2 ( )0.5 (material)2 ( )0.5 (effect)2 ( )0.5 (on)2 ( )0.5 (how)2 ( )0.5 (the)2 ( )0.5 (group\222s)2 ( )0.5 (results)2 ( )0.5 (and)2 ( )0.5 (financial)2 ( )0.5 (position)2 ( )]tj
0.025 tc 0.045 tw 0 -1.2 td
[(for the current )0.5 (or prior periods have been prepared )0.5 (or presented in this interim financial report. the )0.5 (group )]tj
0 tw t*
(has not applied any new standard or interpretation that is not yet effec\
tive for the current accounting period.)tj
et
endstream
endobj
9 0 obj
<>/font<>/procset[/pdf/text]/properties<>>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
10 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
11 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
12 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
13 0 obj
<>/font<>/procset[/pdf/text]>>/trimbox[0.0 0.0 595.276 793.701]/type/page>>
endobj
93 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 5 \226)tj
/t1_1 1 tf
-19.029 58.583 td
(consolidated statement of financial position)tj
/t1_2 1 tf
0 -1.167 td
(as at 30 june 2020 \(unaudited\))tj
t*
(\(expressed in rmb\))tj
/t1_1 1 tf
29.615 -1.833 td
(30 june)tj
-0.025 tw 1.381 -1 td
(2020)tj
/t1_0 1 tf
0 tw 3.553 1 td
(31 december)tj
-0.025 tw 3.534 -1 td
(2019)tj
/t1_2 1 tf
-14.379 -1 td
(note)tj
/t1_3 1 tf
5.162 0 td
(rmb\222000)tj
/t1_2 1 tf
7.255 0 td
(rmb\222000)tj
/t1_1 1 tf
0 tw -36.12 -1.5 td
(non-current assets)tj
/t1_0 1 tf
0 -1 td
(property, plant and equipment)tj
/t1_1 1 tf
-0.025 tw 29.671 0 td
(127,369)tj
/t1_0 1 tf
7.087 0 td
(114,573)tj
0 tw -36.757 -1 td
(intangible assets)tj
/t1_1 1 tf
-0.025 tw 30.721 0 td
(5,639)tj
/t1_0 1 tf
7.087 0 td
(5,899)tj
0 tw -37.807 -1 td
(right-of-use assets)tj
/t1_1 1 tf
-0.025 tw 30.196 0 td
(43,317)tj
/t1_0 1 tf
7.087 0 td
(44,621)tj
0 tw -37.282 -1 td
(other non-current assets)tj
/t1_1 1 tf
-0.025 tw 30.196 0 td
(10,190)tj
/t1_0 1 tf
7.612 0 td
(7,978)tj
0 tw -37.807 -1 td
(financial assets at fair value through profit or loss)tj
/t1_2 1 tf
-0.025 tw 24.173 0 td
(11)tj
/t1_1 1 tf
6.548 0 td
(1,000)tj
/t1_0 1 tf
0 tc 0 tw 8.937 0 td
(\226)tj
0.025 tc -39.657 -1 td
(deferred tax assets)tj
/t1_1 1 tf
-0.025 tw 30.721 0 td
(1,773)tj
/t1_0 1 tf
7.087 0 td
(1,847)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 379.8425 558.2488 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 558.0158 tm
( )tj
et
q 1 0 0 1 464.8818 558.2488 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 558.0158 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 12 0 0 12 412.7433 542.0388 tm
(189,288)tj
/t1_0 1 tf
7.087 0 td
(174,918)tj
et
[1.992 1.992]0 d
q 1 0 0 1 379.8425 537.2397 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 537.0067 tm
( )tj
et
q 1 0 0 1 464.8819 537.2397 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 537.0067 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 521.0297 tm
(current assets)tj
/t1_0 1 tf
-0.025 tw t*
(inventories)tj
/t1_1 1 tf
30.196 0 td
(52,065)tj
/t1_0 1 tf
7.087 0 td
(43,421)tj
0 tw -37.282 -1 td
(trade and other receivables)tj
/t1_2 1 tf
0 tc 24.435 0 td
(8)tj
/t1_1 1 tf
0.025 tc -0.025 tw 5.761 0 td
(16,355)tj
/t1_0 1 tf
7.087 0 td
(14,939)tj
0 tw -37.282 -1 td
(other current assets)tj
/t1_1 1 tf
-0.025 tw 30.196 0 td
(15,297)tj
/t1_0 1 tf
7.612 0 td
(7,117)tj
0 tw -37.807 -1 td
(financial assets at fair value through profit or loss)tj
/t1_1 1 tf
-0.025 tw 30.196 0 td
(16,314)tj
/t1_0 1 tf
7.087 0 td
(21,402)tj
0 tw -37.282 -1 td
(cash and cash equivalents)tj
/t1_1 1 tf
-0.025 tw 28.871 0 td
(1,059,889)tj
/t1_0 1 tf
7.087 0 td
(1,036,783)tj
et
[]0 d
q 1 0 0 1 379.8425 456.2307 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 455.9977 tm
( )tj
et
q 1 0 0 1 464.8819 456.2307 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 455.9977 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 12 0 0 12 403.1433 440.0206 tm
(1,159,920)tj
/t1_0 1 tf
7.087 0 td
(1,123,662)tj
et
[1.992 1.992]0 d
q 1 0 0 1 379.8425 435.2216 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 434.9886 tm
( )tj
et
q 1 0 0 1 464.8819 435.2216 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 434.9886 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 419.0116 tm
(current liabilities)tj
/t1_0 1 tf
t*
(trade and other payables)tj
/t1_2 1 tf
0 tc 24.435 0 td
(9)tj
/t1_1 1 tf
0.025 tc -0.025 tw 5.761 0 td
(47,500)tj
/t1_0 1 tf
7.087 0 td
(42,588)tj
0 tw -37.282 -1 td
(contract liabilities)tj
/t1_1 1 tf
-0.025 tw 30.196 0 td
(11,048)tj
/t1_0 1 tf
7.612 0 td
(9,681)tj
0 tw -37.807 -1 td
(lease liabilities)tj
/t1_1 1 tf
-0.025 tw 31.521 0 td
(415)tj
/t1_0 1 tf
7.087 0 td
(206)tj
0 tw -38.607 -1 td
(deferred income)tj
/t1_1 1 tf
-0.025 tw 31.521 0 td
(548)tj
/t1_0 1 tf
7.087 0 td
(494)tj
0 tw -38.607 -1 td
(current taxation)tj
/t1_1 1 tf
-0.025 tw 30.721 0 td
(9,120)tj
/t1_0 1 tf
7.087 0 td
(6,234)tj
et
[]0 d
q 1 0 0 1 379.8425 354.2125 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 353.9795 tm
( )tj
et
q 1 0 0 1 464.8819 354.2125 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 353.9795 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 12 0 0 12 419.0433 338.0025 tm
(68,631)tj
/t1_0 1 tf
7.087 0 td
(59,203)tj
et
[1.992 1.992]0 d
q 1 0 0 1 379.8425 333.3679 cm
0 0 m
73.701 0 l
s
q
[]0 d
q 1 0 0 1 379.8425 331.4506 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 331.7176 tm
( )tj
et
[1.992 1.992]0 d
q 1 0 0 1 464.8819 333.3679 cm
0 0 m
73.701 0 l
s
q
[]0 d
q 1 0 0 1 464.8819 331.4506 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 331.7176 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 315.7405 tm
(net current assets)tj
-0.025 tw 28.871 0 td
(1,091,289)tj
/t1_0 1 tf
7.087 0 td
(1,064,459)tj
et
[1.992 1.992]0 d
q 1 0 0 1 379.8425 311.1059 cm
0 0 m
73.701 0 l
s
q
[]0 d
q 1 0 0 1 379.8425 309.1886 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 309.4556 tm
( )tj
et
[1.992 1.992]0 d
q 1 0 0 1 464.8819 311.1059 cm
0 0 m
73.701 0 l
s
q
[]0 d
q 1 0 0 1 464.8819 309.1886 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 309.4556 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 293.4786 tm
(total assets less current liabilities)tj
-0.025 tw 28.871 0 td
(1,280,577)tj
/t1_0 1 tf
7.087 0 td
(1,239,377)tj
et
[1.992 1.992]0 d
q 1 0 0 1 379.8425 288.6795 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 288.4465 tm
( )tj
et
q 1 0 0 1 464.8819 288.6795 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 288.4465 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 272.4695 tm
(non-current liabilities)tj
/t1_0 1 tf
t*
(lease liabilities)tj
/t1_1 1 tf
-0.025 tw 30.721 0 td
(1,505)tj
/t1_0 1 tf
7.087 0 td
(1,620)tj
0 tw -37.807 -1 td
(deferred income)tj
/t1_1 1 tf
-0.025 tw 30.721 0 td
(3,679)tj
/t1_0 1 tf
7.087 0 td
(3,442)tj
0 tw -37.807 -1 td
(deferred tax liabilities)tj
/t1_1 1 tf
-0.025 tw 32.046 0 td
(27)tj
/t1_0 1 tf
7.087 0 td
(28)tj
et
[]0 d
q 1 0 0 1 379.8425 231.6705 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 231.4375 tm
( )tj
et
q 1 0 0 1 464.8819 231.6705 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 231.4375 tm
( )tj
/t1_1 1 tf
0.025 tc -0.025 tw 12 0 0 12 425.3433 215.4605 tm
(5,211)tj
/t1_0 1 tf
7.087 0 td
(5,090)tj
et
[1.992 1.992]0 d
q 1 0 0 1 379.8425 210.8259 cm
0 0 m
73.701 0 l
s
q
[]0 d
q 1 0 0 1 379.8425 208.9085 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 209.1755 tm
( )tj
et
[1.992 1.992]0 d
q 1 0 0 1 464.8819 210.8259 cm
0 0 m
73.701 0 l
s
q
[]0 d
q 1 0 0 1 464.8819 208.9085 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 209.1755 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 193.1985 tm
(net assets)tj
-0.025 tw 28.871 0 td
(1,275,366)tj
/t1_0 1 tf
7.087 0 td
(1,234,287)tj
et
q 1 0 0 1 379.8425 188.3995 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 188.1665 tm
( )tj
et
q 1 0 0 1 464.8819 188.3995 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 188.1665 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 172.1895 tm
(capital and reserves)tj
/t1_0 1 tf
0 -1.167 td
(share capital)tj
/t1_1 1 tf
-0.025 tw 29.671 0 td
(166,000)tj
/t1_0 1 tf
7.087 0 td
(166,000)tj
-36.757 -1 td
(reserves)tj
/t1_1 1 tf
28.871 0 td
(1,089,112)tj
/t1_0 1 tf
7.087 0 td
(1,050,381)tj
et
q 1 0 0 1 379.8425 141.3904 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 141.1574 tm
( )tj
et
q 1 0 0 1 464.8819 141.3904 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 141.1574 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 125.1804 tm
(total equity attributable to equity shareholders )tj
0 tc ( )tj
0.025 tc 0.999 -1 td
(of the company)tj
-0.025 tw 27.872 0 td
(1,255,112)tj
/t1_0 1 tf
7.087 0 td
(1,216,381)tj
/t1_1 1 tf
0 tw -35.957 -1.5 td
(non-controlling interests)tj
-0.025 tw 30.196 0 td
(20,254)tj
/t1_0 1 tf
7.087 0 td
(17,906)tj
et
q 1 0 0 1 379.8425 90.3814 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 90.1484 tm
( )tj
et
q 1 0 0 1 464.8819 90.3814 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 90.1484 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 74.1713 tm
(total equity)tj
-0.025 tw 28.871 0 td
(1,275,366)tj
/t1_0 1 tf
7.087 0 td
(1,234,287)tj
et
1.11 w
q 1 0 0 1 379.8425 69.1805 cm
0 0 m
73.701 0 l
s
q
0.45 w
q 1 0 0 1 379.8425 67.0806 cm
0 0 m
73.701 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 374.1732 66.7525 tm
( )tj
et
1.11 w
q 1 0 0 1 464.8819 69.1805 cm
0 0 m
73.701 0 l
s
q
0.45 w
q 1 0 0 1 464.8819 67.0806 cm
0 0 m
73.701 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 459.2126 66.7525 tm
( )tj
et
endstream
endobj
92 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 4 \226)tj
/t1_1 1 tf
-19.029 58.583 td
(consolidated statement of profit or loss and other )tj
0 -1.167 td
(comprehensive income)tj
/t1_2 1 tf
t*
(for the six-month period ended 30 june 2020 \(unaudited\))tj
0 -1.167 td
(\(expressed in rmb\))tj
/t1_1 1 tf
25.555 -2.333 td
(six-month period ended 30 june)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 362.8346 652.2488 cm
0 0 m
175.748 0 l
s
q
bt
0 tc 0.1 0 0 0.1 357.1653 652.0158 tm
( )tj
0.025 tc -0.025 tw 12 0 0 12 420.1394 640.0388 tm
(2020)tj
/t1_0 1 tf
7.795 0 td
(2019)tj
/t1_3 1 tf
-9.926 -1.167 td
(rmb\222000)tj
/t1_2 1 tf
7.963 0 td
(rmb\222000)tj
/t1_1 1 tf
0 tw -36.12 -2.333 td
(profit for the period)tj
-0.025 tw 29.487 0 td
(64,701)tj
/t1_0 1 tf
7.795 0 td
(46,352)tj
et
q 1 0 0 1 362.8346 593.2397 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1653 593.0068 tm
( )tj
et
q 1 0 0 1 456.3779 593.2397 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7086 593.0068 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 567.0297 tm
(other comprehensive income for the period)tj
0 tc ( )tj
0.025 tc 0.999 -1.167 td
(\(after tax and reclassification adjustments\))tj
/t1_0 1 tf
-0.999 -2.333 td
(items that will not be reclassified subsequently to )tj
0 tc ( )tj
0.025 tc 0.999 -1.167 td
(profit or loss:)tj
-0.999 -2.333 td
(exchange differences on translation of )tj
0 tc ( )tj
0.025 tc 0.999 -1.167 td
(financial statements of overseas subsidiary)tj
/t1_1 1 tf
-0.025 tw 29.813 0 td
(388)tj
/t1_0 1 tf
7.795 0 td
(214)tj
et
q 1 0 0 1 362.8346 464.2307 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1653 463.9977 tm
( )tj
et
q 1 0 0 1 456.3779 464.2307 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7086 463.9977 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 438.0207 tm
(other comprehensive income)tj
-0.025 tw 30.812 0 td
(388)tj
/t1_0 1 tf
7.795 0 td
(214)tj
et
q 1 0 0 1 362.8346 433.2216 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1653 432.9886 tm
( )tj
et
q 1 0 0 1 456.3779 433.2216 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7086 432.9886 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 407.0116 tm
(total comprehensive income for the period)tj
-0.025 tw 29.487 0 td
(65,089)tj
/t1_0 1 tf
7.795 0 td
(46,566)tj
et
1.11 w
q 1 0 0 1 362.8346 402.0208 cm
0 0 m
82.205 0 l
s
q
0.45 w
q 1 0 0 1 362.8346 399.9208 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1653 399.5928 tm
( )tj
et
1.11 w
q 1 0 0 1 456.3779 402.0208 cm
0 0 m
82.205 0 l
s
q
0.45 w
q 1 0 0 1 456.3779 399.9208 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7086 399.5928 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 373.6158 tm
(attributable to:)tj
/t1_0 1 tf
0 -1.167 td
(equity shareholders of the company)tj
/t1_1 1 tf
-0.025 tw 29.487 0 td
(67,781)tj
/t1_0 1 tf
7.795 0 td
(47,480)tj
0 tw -37.282 -1.167 td
(non-controlling interests)tj
/t1_1 1 tf
-0.025 tw 29.629 0 td
(\(2,692\))tj
/t1_0 1 tf
8.595 0 td
(\(914\))tj
et
0.5 w
q 1 0 0 1 362.8346 340.8168 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1653 340.5838 tm
( )tj
et
q 1 0 0 1 456.3779 340.8168 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7086 340.5838 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6929 314.6068 tm
(total comprehensive income for the period)tj
-0.025 tw 29.487 0 td
(65,089)tj
/t1_0 1 tf
7.795 0 td
(46,566)tj
et
1.11 w
q 1 0 0 1 362.8346 309.6159 cm
0 0 m
82.205 0 l
s
q
0.45 w
q 1 0 0 1 362.8346 307.5159 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1653 307.1879 tm
( )tj
et
1.11 w
q 1 0 0 1 456.3779 309.6159 cm
0 0 m
82.205 0 l
s
q
0.45 w
q 1 0 0 1 456.3779 307.5159 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7086 307.1879 tm
( )tj
et
endstream
endobj
91 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 3 \226)tj
0.072 tc 0.07 tw -19.029 58.583 td
[(the)12.2 ( board)12.2 ( \(the)12.2 ( \223)]tj
/t1_1 1 tf
-0.072 tw (board)tj
/t1_0 1 tf
0.07 tw [(\224\))12.2 ( of)12.2 ( directors)12.3 ( \(the)12.2 ( \223)]tj
/t1_1 1 tf
-0.072 tw (directors)tj
/t1_0 1 tf
0.07 tw [(\224\))12.2 ( of)12.1 ( shanghai)12.2 ( kindly)12.2 ( medical)47 ( )]tj
0.026 tc 0.082 tw 0 -1.167 td
[(i)0.5 (n)0.6 (s)0.5 (t)0.6 (r)0.5 (u)0.6 (m)0.5 (e)0.6 (n)0.5 (t)0.6 (s)1 ( )0.5 (c)0.5 (o)0.6 (.)0.5 (,)1 ( )0.5 (l)0.5 (t)0.6 (d)0.5 (.)1 ( )0.5 (\()0.6 (t)0.5 (h)0.6 (e)1 ( )0.5 (\223)]tj
/t1_1 1 tf
-0.026 tw 12.066 0 td
[(c)0.6 (o)0.5 (m)0.5 (p)0.6 (a)0.5 (n)0.6 (y)]tj
/t1_0 1 tf
0.082 tw 4.345 0 td
[(\224)0.5 (\))1.1 ( )0.5 (i)0.5 (s)1 ( )0.5 (p)0.6 (l)0.5 (e)0.6 (a)0.5 (s)0.6 (e)0.5 (d)1 ( )0.5 (t)0.6 (o)1 ( )0.5 (a)0.5 (n)0.6 (n)0.5 (o)0.6 (u)0.5 (n)0.5 (c)0.6 (e)1 ( )0.5 (t)0.5 (h)0.6 (e)1 ( )0.5 (u)0.6 (n)0.5 (a)0.6 (u)0.5 (d)0.5 (i)0.6 (t)0.5 (e)0.6 (d)1 ( )0.5 (i)0.5 (n)0.6 (t)0.5 (e)0.6 (r)0.5 (i)0.6 (m)0.9 ( )0.6 (r)0.5 (e)0.6 (s)0.5 (u)0.6 (l)0.5 (t)0.5 (s)1 ( )]tj
0.025 tc 0.058 tw -16.411 -1.167 td
(of the company and its subsidiaries \(collectively, the \223)tj
/t1_1 1 tf
-0.025 tw (group)tj
/t1_0 1 tf
0.058 tw [(\224, )0.5 (\223)]tj
/t1_1 1 tf
-0.025 tw (we)tj
/t1_0 1 tf
0.058 tw (\224, \223)tj
/t1_1 1 tf
-0.025 tw (our)tj
/t1_0 1 tf
0.058 tw [(\224 )0.5 (or )0.5 (\223)]tj
/t1_1 1 tf
-0.025 tw (us)tj
/t1_0 1 tf
0.058 tw (\224\) for the )tj
0 tw 0 -1.167 td
(six-month period ended 30 june 2020 \(the \223)tj
/t1_1 1 tf
(reporting period)tj
/t1_0 1 tf
-0.025 tw (\224\).)tj
/t1_1 1 tf
0 tw 0 -2.333 td
(consolidated statement of profit or loss )tj
/t1_2 1 tf
0 -1.167 td
(for the six-month period ended 30 june 2020 \(unaudited\))tj
0 -1.167 td
(\(expressed in renminbi \(\223)tj
/t1_3 1 tf
-0.025 tw (rmb)tj
/t1_2 1 tf
(\224\)\))tj
/t1_1 1 tf
0 tw 25.555 -2.333 td
(six-month period ended 30 june)tj
et
0 0 0 1 k
0.5 w
q 1 0 0 1 362.8346 596.2488 cm
0 0 m
175.748 0 l
s
q
bt
0 tc 0.1 0 0 0.1 357.1653 596.0158 tm
( )tj
0.025 tc -0.025 tw 12 0 0 12 420.1394 584.0388 tm
(2020)tj
/t1_0 1 tf
7.795 0 td
(2019)tj
/t1_2 1 tf
-15.797 -1.167 td
(note)tj
/t1_3 1 tf
5.871 0 td
(rmb\222000)tj
/t1_2 1 tf
7.963 0 td
(rmb\222000)tj
/t1_1 1 tf
-36.12 -2.333 td
(revenue)tj
/t1_2 1 tf
0 tc 0 tw 23.018 0 td
(3)tj
/t1_1 1 tf
0.025 tc -0.025 tw 5.944 0 td
(171,844)tj
/t1_0 1 tf
7.795 0 td
(135,069)tj
0 tw -36.757 -1.167 td
(cost of sales)tj
/t1_1 1 tf
-0.025 tw 29.104 0 td
(\(58,022\))tj
/t1_0 1 tf
7.795 0 td
(\(52,098\))tj
et
q 1 0 0 1 362.8347 523.2397 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1654 523.0068 tm
( )tj
et
q 1 0 0 1 456.378 523.2397 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7087 523.0068 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.693 497.0297 tm
(gross profit)tj
-0.025 tw 28.962 0 td
(113,822)tj
/t1_0 1 tf
8.32 0 td
(82,971)tj
0 tw -37.282 -2.333 td
(other income)tj
/t1_2 1 tf
0 tc 23.018 0 td
(4)tj
/t1_1 1 tf
0.025 tc -0.025 tw 6.469 0 td
(24,818)tj
/t1_0 1 tf
8.32 0 td
(6,800)tj
0 tw -37.807 -1.167 td
(distribution costs)tj
/t1_1 1 tf
-0.025 tw 29.104 0 td
(\(12,757\))tj
/t1_0 1 tf
7.795 0 td
(\(10,059\))tj
0 tw -36.899 -1.167 td
(administrative expenses)tj
/t1_1 1 tf
-0.025 tw 29.104 0 td
(\(19,082\))tj
/t1_0 1 tf
7.795 0 td
(\(11,303\))tj
0 tw -36.899 -1.167 td
(research and development expenses)tj
/t1_1 1 tf
-0.025 tw 29.104 0 td
(\(30,221\))tj
/t1_0 1 tf
7.795 0 td
(\(12,650\))tj
0 tw -36.899 -1.167 td
(impairment losses)tj
/t1_1 1 tf
-0.025 tw 30.954 0 td
(\(13\))tj
/t1_0 1 tf
7.795 0 td
(\(41\))tj
et
q 1 0 0 1 362.8348 408.2307 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0.1 0 0 0.1 357.1655 407.9977 tm
(76,567)tj
et
q 1 0 0 1 456.3781 408.2307 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7088 407.9977 tm
(55,718)tj
/t1_1 1 tf
0 tw 12 0 0 12 56.6931 382.0207 tm
(profit from operations)tj
-0.025 tw 29.487 0 td
(76,567)tj
/t1_0 1 tf
7.795 0 td
(55,718)tj
0 tw -37.282 -2.333 td
(finance costs)tj
/t1_2 1 tf
-0.025 tw 22.397 0 td
(5\(a\))tj
/t1_1 1 tf
8.557 0 td
(\(48\))tj
/t1_0 1 tf
6.47 0 td
(\(1,471\))tj
et
q 1 0 0 1 362.8348 349.2216 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1655 348.9886 tm
( )tj
et
q 1 0 0 1 456.3781 349.2216 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7088 348.9886 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6931 323.0116 tm
(profit before taxation)tj
/t1_2 1 tf
0 tc 23.018 0 td
(5)tj
/t1_1 1 tf
0.025 tc -0.025 tw 6.469 0 td
(76,519)tj
/t1_0 1 tf
7.795 0 td
(54,247)tj
0 tw -37.282 -2.333 td
(income tax)tj
/t1_2 1 tf
0 tc 23.018 0 td
(6)tj
/t1_1 1 tf
0.025 tc -0.025 tw 6.086 0 td
(\(11,818\))tj
/t1_0 1 tf
8.32 0 td
(\(7,895\))tj
et
q 1 0 0 1 362.8349 290.2126 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1656 289.9796 tm
( )tj
et
q 1 0 0 1 456.3782 290.2126 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7089 289.9796 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6932 264.0026 tm
(profit for the period)tj
-0.025 tw 29.487 0 td
(64,701)tj
/t1_0 1 tf
7.795 0 td
(46,352)tj
et
q 1 0 0 1 362.8349 259.2035 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1656 258.9705 tm
( )tj
et
q 1 0 0 1 456.3782 259.2035 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.709 258.9705 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6932 232.9935 tm
(attributable to:)tj
/t1_0 1 tf
t*
(equity shareholders of the company)tj
/t1_1 1 tf
-0.025 tw 29.487 0 td
(67,393)tj
/t1_0 1 tf
7.795 0 td
(47,266)tj
0 tw -37.282 -1.167 td
(non-controlling interests)tj
/t1_1 1 tf
-0.025 tw 29.629 0 td
(\(2,692\))tj
/t1_0 1 tf
8.595 0 td
(\(914\))tj
et
q 1 0 0 1 362.835 200.1945 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1657 199.9615 tm
( )tj
et
q 1 0 0 1 456.3783 200.1945 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.709 199.9615 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6933 173.9845 tm
(profit for the period)tj
-0.025 tw 29.487 0 td
(64,701)tj
/t1_0 1 tf
7.795 0 td
(46,352)tj
et
1.11 w
q 1 0 0 1 362.835 168.9937 cm
0 0 m
82.205 0 l
s
q
0.45 w
q 1 0 0 1 362.835 166.8937 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1657 166.5657 tm
( )tj
et
1.11 w
q 1 0 0 1 456.3783 168.9937 cm
0 0 m
82.205 0 l
s
q
0.45 w
q 1 0 0 1 456.3783 166.8937 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.709 166.5657 tm
( )tj
/t1_1 1 tf
0.025 tc 12 0 0 12 56.6933 140.5887 tm
(earnings per share )tj
/t1_2 1 tf
-0.025 tw (\(rmb\))tj
0 tc 0 tw 23.018 0 td
(7)tj
/t1_0 1 tf
0.025 tc -23.018 -2.333 td
(basic and diluted )tj
/t1_2 1 tf
-0.025 tw (\(rmb\))tj
/t1_1 1 tf
30.537 0 td
(0.41)tj
/t1_0 1 tf
7.795 0 td
(0.39)tj
et
1.11 w
q 1 0 0 1 362.8351 107.5978 cm
0 0 m
82.205 0 l
s
q
0.45 w
q 1 0 0 1 362.8351 105.4978 cm
0 0 m
82.205 0 l
s
q
bt
/t1_1 1 tf
0 tc 0 tw 0.1 0 0 0.1 357.1658 105.1698 tm
( )tj
et
1.11 w
q 1 0 0 1 456.3784 107.5978 cm
0 0 m
82.205 0 l
s
q
0.45 w
q 1 0 0 1 456.3784 105.4978 cm
0 0 m
82.205 0 l
s
q
bt
/t1_0 1 tf
0.1 0 0 0.1 450.7091 105.1698 tm
( )tj
et
endstream
endobj
90 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 2 \226)tj
et
0 0 0 1 k
0.5 w
/gs1 gs
q 1 0 0 1 56.6929 736.7579 cm
0 0 m
482.39 0 l
s
q
q 1 0 0 1 56.9429 475.0866 cm
0 0 m
0 261.421 l
s
q
q 1 0 0 1 538.8326 475.0866 cm
0 0 m
0 261.421 l
s
q
q 1 0 0 1 56.6929 474.8366 cm
0 0 m
482.39 0 l
s
q
bt
/gs0 gs
0.08 tw 12 0 0 12 62.6122 720.5459 tm
(\225)tj
/span<>> bdc
( )tj
emc
1.89 0 td
[(the )0.5 (group\222s )0.5 (revenue )0.5 (in )0.5 (the )0.5 (reporting )0.5 (period )0.5 (was )0.5 (approximately )0.5 (rmb171.84 million, )]tj
0.024 tw 0 -1.167 td
(representing an increase of approximately 27.23% or approximately rmb36.\
77 million )tj
0.012 tw 0 -1.167 td
(as compared to approximately rmb135.07 million for the six-month period \
ended june )tj
0 tw 0 -1.167 td
(30, 2019, mainly due to the contribution from the manufacturing and sale\
s of masks.)tj
0.034 tc 0.074 tw -1.89 -2.333 td
(\225)tj
/span<>> bdc
0.375 0 td
( )tj
emc
1.515 0 td
[(during)9 ( )0.5 (the)9 ( )0.5 (reporting)8.9 ( )0.5 (period,)9 ( )0.5 (gross)9 ( )0.5 (profit)9 ( )0.5 (was)9 ( )0.5 (approximately)9 ( )0.5 (rmb)9.1 (1)8.9 (1)9.1 (3)8.9 (.)9 (8)9 (2)9 ( )0.5 (million,)9 ( )0.5 (as)9 ( )]tj
0.025 tc 0.02 tw t*
(compared to approximately rmb82.97 million for the six-month period ende\
d june 30, )tj
0.012 tw t*
(2019. gross profit margin increased from 61.43% to 66.24%, mainly due to\
the sales of )tj
0 tw 0 -1.167 td
(masks with a higher profit margin.)tj
0.043 tc 0.07 tw -1.89 -2.333 td
(\225)tj
/span<>> bdc
0.375 0 td
( )tj
emc
1.515 0 td
[(t)0.5 (h)0.6 (e)13 ( )0.5 (g)0.6 (r)0.5 (o)0.6 (u)0.5 (p)0.5 (\222)0.6 (s)13 ( )0.5 (p)0.6 (r)0.5 (o)0.5 (f)0.6 (i)0.5 (t)13 ( )0.6 (f)0.5 (o)0.5 (r)13.1 ( )0.5 (t)0.5 (h)0.6 (e)13 ( )0.6 (r)0.5 (e)0.5 (p)0.6 (o)0.5 (r)0.5 (t)0.6 (i)0.5 (n)0.5 (g)13 ( )0.6 (p)0.5 (e)0.6 (r)0.5 (i)0.5 (o)0.6 (d)13 ( )0.5 (w)0.6 (a)0.5 (s)13 ( )0.6 (a)0.5 (p)0.6 (p)0.5 (r)0.5 (o)0.6 (x)0.5 (i)0.5 (m)0.6 (a)0.5 (t)0.5 (e)0.6 (l)0.5 (y)13 ( )0.6 (r)0.5 (m)0.6 (b)13 (6)13 (4)13 (.)13.1 (7)13 (0)13 ( )0.6 (m)0.5 (i)0.5 (l)0.6 (l)0.5 (i)0.5 (o)0.6 (n)0.5 (,)18 ( )]tj
0.058 tc t*
[(representing)12.2 ( an)12.2 ( increase)12.2 ( of)12.2 ( approximately)12.2 ( 3)12.2 (9)12.2 (.)12.2 (5)12.2 (9)12.1 (%)12.2 ( as)12.2 ( compared)12.2 ( to)12.1 ( approximately)33 ( )]tj
0.025 tc 0 tw 0 -1.167 td
(rmb46.35 million for the six-month period ended june 30, 2019.)tj
0.074 tc 0.07 tw -1.89 -2.333 td
(\225)tj
/span<>> bdc
0.375 0 td
( )tj
emc
1.515 0 td
[(the)12.1 ( group\222s)12.1 ( basic)12.1 ( and)12 ( diluted)12.1 ( earnings)12.1 ( per)12.1 ( share)12.1 ( in)12.1 ( the)12.1 ( reporting)12 ( period)12.1 ( was)49 ( )]tj
0.025 tc 0 tw t*
(rmb0.41, as compared to rmb0.39 for the six-month period ended june 30, \
2019.)tj
-1.89 -2.333 td
(\225)tj
/span<>> bdc
( )tj
emc
1.89 0 td
(the board resolved not to declare any interim dividend for the reporting\
period.)tj
et
endstream
endobj
88 0 obj
<>
endobj
86 0 obj
<>stream
bt
0 0 0 1 k
/perceptual ri
/gs0 gs
/t1_0 1 tf
0.025 tc 12 0 0 12 285.0378 24.0557 tm
(\226 1 \226)tj
-0.025 tw 10 0 0 10 56.6929 56.9362 tm
(*)tj
/span<>> bdc
( )tj
emc
/t1_1 1 tf
0 tw 1.55 0 td
(for identification purposes only)tj
0.051 tw 12 0 0 12 56.6929 727.0479 tm
(hong kong exchanges and clearing limited and the stock exchange of hong \
kong limited )tj
0.046 tw 0 -1.167 td
(take no responsibility for the contents of this announcement, make no re\
presentation as to its )tj
0.06 tc 0.07 tw 0 -1.167 td
[(a)0.5 (cc)0.5 (u)0.5 (ra)0.5 (c)0.5 (y)12.9 ( )0.5 (or)13 ( )0.5 (co)0.5 (m)0.5 (pl)0.5 (e)0.5 (te)0.5 (ne)0.5 (s)0.5 (s)13 ( a)0.5 (nd)13 ( e)0.5 (x)0.5 (pr)0.5 (e)0.5 (s)0.5 (sl)0.5 (y)13 ( d)0.5 (is)0.5 (c)0.5 (la)0.5 (im)13 ( )0.5 (an)0.5 (y)13 ( l)0.5 (ia)0.5 (bi)0.5 (l)0.5 (it)0.5 (y)13 ( w)0.5 (ha)0.5 (t)0.5 (so)0.5 (ev)0.5 (e)0.5 (r)12.9 ( )0.5 (f)0.5 (or)13 ( )0.5 (an)0.5 (y)13 ( l)0.5 (os)0.5 (s)35 ( )]tj
0.047 tc 0 -1.167 td
[(howsoever)12 ( arising)12.1 ( from)12.1 ( or)12.1 ( in)12.1 ( reliance)12.1 ( upon)12 ( the)12.1 ( whole)12 ( or)12 ( any)12.1 ( part)12 ( of)12 ( the)12.1 ( contents)12.1 ( of)12.1 ( this)22 ( )]tj
0.025 tc -0.025 tw t*
(announcement.)tj
et
/placedgraphic /mc0 bdc
emc
q
243.887 593.043 107.502 61.604 re
w n
1 1 0 0 k
/gs1 gs
q
0.25 0 0 -0.25 297.8878174 623.2514038 cm
q 1 0 0 1 -147.3142 -20.144 cm
0 0 m
27.014 -8.376 40.179 -38.942 19.034 -59.3 c
34.907 -53.294 48.142 -42.066 57.772 -33.583 c
80.32 -13.717 91.699 10.177 91.699 38.251 c
91.699 48.345 95.669 57.562 102.311 64.761 c
105.93 68.681 110.346 72.005 115.34 74.541 c
122.285 78.068 143.232 80.083 151.876 80.083 c
188.401 80.083 198.538 125.118 164.949 137.741 c
149.002 143.73 116.351 140.779 98.218 133.969 c
87.861 130.081 78.035 124.927 69.774 119.462 c
65.252 116.472 61.193 113.384 57.772 110.358 c
35.363 90.542 24.158 66.505 24.158 38.251 c
24.158 22.086 15.37 6.954 0 0 c
10.462 38.251 m
10.462 21.778 -5.201 8.25 -23.462 8.25 c
-41.767 8.25 -57.078 21.765 -57.078 38.251 c
-57.078 110.083 l
-57.078 126.371 -41.983 140.081 -23.462 140.081 c
-4.575 140.081 10.462 126.783 10.462 110.083 c
h
172.935 -33.583 m
172.935 -49.977 157.546 -63.58 139.008 -63.58 c
120.445 -63.58 105.393 -49.96 105.393 -33.583 c
105.393 38.251 l
105.393 54.54 120.484 68.248 139.008 68.248 c
157.712 68.248 172.935 54.431 172.935 38.251 c
h
f*
q
q
0 0 0 0 k
q
0.25 0 0 -0.25 297.8878174 623.2514038 cm
q 1 0 0 1 -166.7737 -93.9248 cm
0 0 m
27.189 0 49.23 17.215 49.23 38.45 c
49.23 59.686 27.189 76.901 0 76.901 c
-27.189 76.901 -49.23 59.686 -49.23 38.45 c
-49.23 17.215 -27.189 0 0 0 c
f*
q
q
1 1 0 0 k
q
0.25 0 0 -0.25 297.8878174 623.2514038 cm
q 1 0 0 1 -166.7732 -85.0858 cm
0 0 m
20.939 0 37.914 13.258 37.914 29.612 c
37.914 45.966 20.939 59.224 0 59.224 c
-20.939 59.224 -37.914 45.966 -37.914 29.612 c
-37.914 13.258 -20.939 0 0 0 c
f*
q
q
q
0.25 0 0 -0.25 297.8878174 623.2514038 cm
q 1 0 0 1 97.7264 -30.1298 cm
0 0 m
4.557 0 8.906 -0.718 13.046 -2.148 c
17.181 -3.575 20.812 -5.56 23.915 -8.086 c
27.018 -10.612 29.456 -13.521 31.214 -16.806 c
32.973 -20.091 33.854 -23.672 33.854 -27.547 c
33.854 -31.254 32.969 -34.795 31.214 -38.163 c
29.461 -41.528 27.018 -44.482 23.915 -47.009 c
20.812 -49.535 17.18 -51.52 13.046 -52.946 c
8.907 -54.376 4.546 -55.095 0 -55.095 c
-24.575 -55.095 l
-29.322 -55.095 -33.736 -54.375 -37.768 -52.946 c
-41.795 -51.519 -45.328 -49.534 -48.331 -47.009 c
-51.333 -44.483 -53.722 -41.528 -55.475 -38.163 c
-57.23 -34.795 -58.114 -31.254 -58.114 -27.547 c
-58.114 -19.965 -54.794 -13.474 -48.175 -8.086 c
-41.558 -2.7 -33.684 0 -24.575 0 c
h
f
q
q
q
0.25 0 0 -0.25 297.8878174 623.2514038 cm
q 1 0 0 1 119.4484 18.5431 cm
0 0 m
0 -4.052 -0.879 -7.922 -2.639 -11.605 c
-4.401 -15.287 -6.83 -18.512 -9.942 -21.274 c
-13.046 -24.035 -16.668 -26.203 -20.81 -27.768 c
-24.948 -29.334 -29.296 -30.117 -33.852 -30.117 c
-38.614 -30.117 -43.012 -29.334 -47.049 -27.768 c
-51.087 -26.203 -54.604 -24.035 -57.607 -21.274 c
-60.61 -18.512 -62.993 -15.287 -64.752 -11.605 c
-66.516 -7.922 -67.395 -4.052 -67.395 0 c
-67.395 72.11 l
-67.395 80.398 -64.082 87.487 -57.453 93.384 c
-50.831 99.276 -42.962 102.223 -33.852 102.223 c
-29.09 102.223 -24.639 101.44 -20.496 99.875 c
-16.358 98.309 -12.786 96.192 -9.783 93.521 c
-6.784 90.851 -4.401 87.672 -2.639 83.99 c
-0.879 80.305 0 76.347 0 72.11 c
h
f
q
q
1 1 0 0 k
6 w 22.926 m
q
0.25 0 0 -0.25 297.8878174 623.2514038 cm
q 1 0 0 1 178.1204 -122.5859 cm
0 0 m
18.16 0 32.883 14.722 32.883 32.882 c
32.883 51.042 18.16 65.764 0 65.764 c
-18.16 65.764 -32.882 51.042 -32.882 32.882 c
-32.882 14.722 -18.16 0 0 0 c
h
s
q
q
q
0.25 0 0 -0.25 297.8878174 623.2514038 cm
q 1 0 0 1 164.7984 -71.8481 cm
0 0 m
0 -35.216 l
15.608 -35.216 l
18.748 -35.216 21.133 -34.896 22.764 -34.265 c
24.395 -33.634 25.699 -32.519 26.675 -30.921 c
27.65 -29.322 28.134 -27.552 28.134 -25.617 c
28.134 -23.117 27.322 -21.01 25.707 -19.297 c
24.092 -17.583 21.6 -16.501 18.223 -16.034 c
19.461 -15.444 20.395 -14.854 21.035 -14.28 c
22.395 -13.034 23.682 -11.468 24.887 -9.591 c
30.978 0 l
25.158 0 l
20.502 -7.329 l
19.149 -9.452 18.026 -11.067 17.149 -12.19 c
16.263 -13.313 15.476 -14.091 14.78 -14.542 c
14.092 -14.985 13.379 -15.296 12.657 -15.477 c
12.133 -15.583 11.271 -15.641 10.066 -15.641 c
4.673 -15.641 l
4.673 0 l
h
4.673 -19.674 m
14.674 -19.674 l
16.804 -19.674 18.461 -19.895 19.657 -20.337 c
20.854 -20.772 21.764 -21.477 22.379 -22.453 c
23.002 -23.42 23.313 -24.469 23.313 -25.609 c
23.313 -27.272 22.715 -28.65 21.51 -29.724 c
20.305 -30.797 18.403 -31.331 15.804 -31.331 c
4.673 -31.331 l
h
f
q
q
0.216 w
q
0.25 0 0 -0.25 297.8878174 623.2514038 cm
q 1 0 0 1 164.7984 -71.8481 cm
0 0 m
0 -35.216 l
15.608 -35.216 l
18.748 -35.216 21.133 -34.896 22.764 -34.265 c
24.395 -33.634 25.699 -32.519 26.675 -30.921 c
27.65 -29.322 28.134 -27.552 28.134 -25.617 c
28.134 -23.117 27.322 -21.01 25.707 -19.297 c
24.092 -17.583 21.6 -16.501 18.223 -16.034 c
19.461 -15.444 20.395 -14.854 21.035 -14.28 c
22.395 -13.034 23.682 -11.468 24.887 -9.591 c
30.978 0 l
25.158 0 l
20.502 -7.329 l
19.149 -9.452 18.026 -11.067 17.149 -12.19 c
16.263 -13.313 15.476 -14.091 14.78 -14.542 c
14.092 -14.985 13.379 -15.296 12.657 -15.477 c
12.133 -15.583 11.271 -15.641 10.066 -15.641 c
4.673 -15.641 l
4.673 0 l
0 0 l
h
4.673 -19.674 m
14.674 -19.674 l
16.804 -19.674 18.461 -19.895 19.657 -20.337 c
20.854 -20.772 21.764 -21.477 22.379 -22.453 c
23.002 -23.42 23.313 -24.469 23.313 -25.609 c
23.313 -27.272 22.715 -28.65 21.51 -29.724 c
20.305 -30.797 18.403 -31.331 15.804 -31.331 c
4.673 -31.331 l
4.673 -19.674 l
h
s
q
q
q
bt
/t1_2 1 tf
0 tw 16 0 0 16 122.503 573.0436 tm
(shanghai kindly medical instruments co., ltd.)tj
/t1_0 1 tf
0 tc 12 0 0 12 466.7726 577.5436 tm
(*)tj
/c0_0 1 tf
0.225 tc -0.225 tw 16 0 0 16 152.4378 553.0436 tm
<026a090e0a7011430d3a153c1415129c0adb0670038503de082202ae0321>tj
/t1_1 1 tf
0.025 tc 0 tw 10 0 0 10 100.4494 539.0437 tm
(\(a joint stock company incorporated in the people\222s republic of chin\
a with limited liability\))tj
/t1_2 1 tf
12 0 0 12 246.4282 523.0437 tm
(\(stock code: 1501\))tj
14 0 0 14 164.5767 493.0437 tm
(interim results announcement)tj
-3.589 -1.143 td
(for the six-month period ended june 30, 2020)tj
et
0 0 0 1 k
0.5 w
/gs2 gs
q 1 0 0 1 56.6929 460.7537 cm
0 0 m
204.344 0 l
s
q
q 1 0 0 1 56.9429 443.9191 cm
0 0 m
0 16.585 l
s
q
q 1 0 0 1 261.0374 460.7537 cm
0 0 m
93.543 0 l
s
q
q 1 0 0 1 354.5807 460.7537 cm
0 0 m
93.543 0 l
s
q
q 1 0 0 1 448.124 460.7537 cm
0 0 m
90.959 0 l
s
q
q 1 0 0 1 538.8326 443.9191 cm
0 0 m
0 16.585 l
s
q
q 1 0 0 1 56.9429 427.0844 cm
0 0 m
0 16.835 l
s
q
q 1 0 0 1 538.8326 427.0844 cm
0 0 m
0 16.835 l
s
q
q 1 0 0 1 56.9429 410.2498 cm
0 0 m
0 16.835 l
s
q
q 1 0 0 1 538.8326 410.2498 cm
0 0 m
0 16.835 l
s
q
q 1 0 0 1 56.9429 390.4151 cm
0 0 m
0 16.835 l
s
q
q 1 0 0 1 538.8326 390.4151 cm
0 0 m
0 16.835 l
s
q
q 1 0 0 1 56.9429 376.4151 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 538.8326 376.4151 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 56.9429 362.4151 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 538.8326 362.4151 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 56.9429 348.4151 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 538.8326 348.4151 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 56.9429 334.4151 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 538.8326 334.4151 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 56.9429 320.4152 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 538.8326 320.4152 cm
0 0 m
0 14 l
s
q
q 1 0 0 1 56.9429 286.9958 cm
0 0 m
0 33.419 l
s
q
q 1 0 0 1 538.8326 286.9958 cm
0 0 m
0 33.419 l
s
q
q 1 0 0 1 56.6929 286.7458 cm
0 0 m
204.344 0 l
s
q
q 1 0 0 1 261.0374 286.7458 cm
0 0 m
93.543 0 l
s
q
q 1 0 0 1 354.5807 286.7458 cm
0 0 m
93.543 0 l
s
q
q 1 0 0 1 448.124 286.7458 cm
0 0 m
90.959 0 l
s
q
q 1 0 0 1 56.9429 407.2498 cm
0 0 m
0 3 l
s
q
q 1 0 0 1 538.8326 407.2498 cm
0 0 m
0 3 l
s
q
bt
/gs0 gs
12 0 0 12 62.6122 445.959 tm
(financial highlights)tj
16.913 -2.806 td
(six-month period ended june 30,)tj
et
q 1 0 0 1 266.7066 407.4998 cm
0 0 m
175.748 0 l
s
q
bt
0 tc 0.1 0 0 0.1 261.0374 407.2668 tm
( )tj
0.025 tc -0.025 tw 12 0 0 12 324.0114 392.4551 tm
(2020)tj
/t1_0 1 tf
7.795 0 td
(2019)tj
/t1_2 1 tf
6.231 0 td
(change)tj
/t1_3 1 tf
-16.157 -1.167 td
(rmb\222000)tj
/t1_1 1 tf
7.963 0 td
(rmb\222000)tj
/t1_0 1 tf
-27.616 -2.333 td
(revenue)tj
/t1_2 1 tf
20.458 0 td
(171,844)tj
/t1_0 1 tf
7.795 0 td
(135,069)tj
7.751 0 td
(27.23%)tj
0 tw -36.005 -1.167 td
(gross profit)tj
/t1_2 1 tf
-0.025 tw 20.458 0 td
(113,822)tj
/t1_0 1 tf
8.32 0 td
(82,971)tj
7.226 0 td
(37.18%)tj
0 tw -36.005 -1.167 td
(profit for the period)tj
/t1_2 1 tf
-0.025 tw 20.983 0 td
(64,701)tj
/t1_0 1 tf
7.795 0 td
(46,352)tj
7.226 0 td
(39.59%)tj
0 tw -36.005 -1.167 td
(earnings per share )tj
0 tc ( )tj
0.025 tc 0.999 -1.167 td
(basic and diluted )tj
/t1_1 1 tf
(\(in rmb\))tj
/t1_2 1 tf
-0.025 tw 21.034 0 td
(0.41)tj
/t1_0 1 tf
7.795 0 td
(0.39)tj
6.701 0 td
(5.13%)tj
et
endstream
endobj
89 0 obj
<>
endobj
94 0 obj
<>stream
application/postscript
int最终logo1
admin
adobe illustrator cc 2017 (windows)
2020-02-06t10:45:25 08:00
2020-02-06t10:45:25 08:00
2020-02-06t10:45:25 08:00
xmp.did:64666c01-c36d-4843-911f-3342a60b5225
xmp.iid:64666c01-c36d-4843-911f-3342a60b5225
uuid:bcb1d3ba6187e91190f0aa1956bbcf79
uuid:71d23c07-684b-4596-bc82-ac8341a7972a
uuid:bcb1d3ba6187e91190f0aa1956bbcf79
uuid:bcb1d3ba6187e91190f0aa1956bbcf79
saved
xmp.iid:64666c01-c36d-4843-911f-3342a60b5225
2020-02-06t10:45:25 08:00
adobe illustrator cc 2017 (windows)
/
1
false
false
595.275585
841.889779
points
cyan
magenta
預設色票群組
0
adobe pdf library 8.00
endstream
endobj
87 0 obj
<>
endobj
95 0 obj
<>
endobj
xref
0 96
0000000000 65535 f
0000000016 00000 n
0000000124 00000 n
0000009136 00000 n
0000000000 00000 f
0000009206 00000 n
0000009298 00000 n
0000009391 00000 n
0000009484 00000 n
0000195908 00000 n
0000196308 00000 n
0000196624 00000 n
0000196965 00000 n
0000197306 00000 n
0000161516 00000 n
0000161845 00000 n
0000162186 00000 n
0000162527 00000 n
0000162868 00000 n
0000123860 00000 n
0000124201 00000 n
0000124542 00000 n
0000124871 00000 n
0000125200 00000 n
0000009605 00000 n
0000009946 00000 n
0000010263 00000 n
0000010580 00000 n
0000010897 00000 n
0000011226 00000 n
0000011543 00000 n
0000011860 00000 n
0000012177 00000 n
0000086278 00000 n
0000046439 00000 n
0000094300 00000 n
0000015800 00000 n
0000016377 00000 n
0000094418 00000 n
0000080191 00000 n
0000074311 00000 n
0000070031 00000 n
0000063620 00000 n
0000016925 00000 n
0000059536 00000 n
0000053288 00000 n
0000046550 00000 n
0000012518 00000 n
0000015684 00000 n
0000042316 00000 n
0000033757 00000 n
0000034348 00000 n
0000026002 00000 n
0000026504 00000 n
0000017476 00000 n
0000018008 00000 n
0000018615 00000 n
0000027110 00000 n
0000034992 00000 n
0000042341 00000 n
0000042472 00000 n
0000042537 00000 n
0000042806 00000 n
0000042939 00000 n
0000099153 00000 n
0000094885 00000 n
0000095252 00000 n
0000095681 00000 n
0000099178 00000 n
0000099311 00000 n
0000099376 00000 n
0000099649 00000 n
0000099876 00000 n
0000155508 00000 n
0000150156 00000 n
0000140848 00000 n
0000133653 00000 n
0000125541 00000 n
0000132653 00000 n
0000132815 00000 n
0000133096 00000 n
0000189459 00000 n
0000181855 00000 n
0000173668 00000 n
0000169104 00000 n
0000163209 00000 n
0000220638 00000 n
0000234321 00000 n
0000220526 00000 n
0000230543 00000 n
0000217426 00000 n
0000210304 00000 n
0000206450 00000 n
0000197647 00000 n
0000230580 00000 n
0000234434 00000 n
trailer
<]>>
startxref
234617
%%eof